ABSTRACT OF PROCEEDINGS 
UNITED STATES PHARMACOPOEAL CONVENTION 
1910 PRESIDENT 1890-1910 ABSTRACT OF PROCEEDINGS 
UNITED STATES PHARMACOPOEAL CONVENTION 
1910 
COMPILED AND EDITED 
BY THE SECRETARY OF THE CONVENTION 
Published by the Board of Trustees, November 30, 1910 PREFACE. 
In accordance with the motion of E. H. Bartley (See p. 35), Acting 
Chairman Wall appointed, as a committee to draft suitable resolutions 
to be forwarded to President Wood, Reid Hunt and M. I. Wilbert. 
This committee, after due consideration, made the following recom- 
mendations to the Board of Trustees: 
1. That in the event that the proceedings of the United States Phar- 
macopceial Convention are published either complete or in abstract, 
a suitably engraved portrait of Dr. Horatio C. Wood be inserted as a 
frontispiece, and 
2. That the President, the Secretary and the members of the Board 
of Trustees of the United States Pharmacopoeial Convention sign and 
forward to Dr. Horatio C. Wood a request for his permission to have this 
done, and 
3. That this request set forth the reasons for their desire, and the 
desire of the members of the United States Pharmacopoeial Convention, 
to honor the former President. 
1 INTRODUCTORY. 
The first general convention for the formation of a national pharma- 
copoeia assembled in the Capitol, at Washington, January 1, 1820. This 
convention was composed of medical delegates from district conventions, 
who appointed a committee to compile, revise and publish the material 
then available, and provided for a similar convention in 1830. Through 
some misunderstanding, two conventions were held in 1830, one at Wash- 
ington and one at New York; the former arranging for a second revision 
in 1840, the latter for one in 1835. The latter plan was abandoned and, 
the several interests having apparently been harmonized, the convention 
which assembled in Washington, January 1, 1840, was more represen- 
tative than either of its predecessors. The pharmacopoeias of 1820 
and 1830 were practically prepared by the conventions themselves; 
beginning with that of 1840 the general work of revision was referred to 
a committee, and it was in the convention of 1850 that pharmaceutical 
organizations were first formally represented. 
With the increasing size of the successive decennial conventions, and 
the growing importance and complexity of the work, it became neces- 
sary to differentiate the business from the scientific functions of the 
organization. Moreover, for nearly a century, the organization had no 
written law for its government. These conditions were reviewed by Dr. 
H. C. Wood, in his presidential address to the convention of 1900, and as 
a result of his recommendations the convention of 1900 adopted a Con- 
stitution and By-Laws, elected, in addition to a Revision Committee, 
a Board of Trustees, and instructed the latter to secure articles of in- 
corporation. 
2 ARTICLES OF INCORPORATION. 
In accordance with the instructions of the United States Pharmaco- 
poeial Convention of May, 1900, the Board of Trustees directed its Chair- 
man, Mr. W. S. Thompson, of Washington, D. C., to employ an attor- 
ney who should take out articles of incorporation for the Convention 
under the laws of the District of Columbia. 
The first difficulty encountered was in the fact that the laws aforesaid 
require that a majority of the Incorporators be residents of the District 
of Columbia. This made it, at least, impracticable to include among 
these Incorporators the Officers and Committee of Revision elected by 
the Convention. It was then determined to ask the Committee on 
Credentials, and Arrangements to officiate in this capacity, and because 
of the latter’s absence from the country, the Treasurer, Dr. W. M. Mew, 
took the place of Dr. J. E. Brackett. 
These preliminaries having been arranged, the following certificate 
of incorporation was drawn up, signed, and recorded, finally, on the 11th 
day of July, 1900: 
This is to certify that we, whose names are hereunto subscribed, citizens of the 
United States, of full age, and a majority citizens of the District of Columbia, do 
associate ourselves together, pursuant to the provisions of sections 545-552 inclu- 
sive of the Revised Statutes of the United States relating to the District of Colum- 
bia and of the act of Congress to amend the same, approved the twenty-third day 
of April, 1884, under the corporate name of The United States Pharmacopoeial 
Convention. 
This Association is organized for a period of nine hundred and ninety-nine years. 
The particular objects and business of this Association are the encouragement 
and promotion of the science and art of medicine and pharmacy by selecting by 
research and experiment and other proper methods and by naming such materials 
as may be properly used as medicines and drugs with formulas for their prepara- 
tion; by establishing one uniform standard and guide for the use of those engaged 
in the practice of medicine and pharmacy in the United States whereby the iden- 
tity, strength, and purity of all such medicines and drugs may be accurately de- 
termined, and for other like and similar purposes; and by printing and distribut- 
ing, at suitable intervals, such formulas and the results of such and similar selec- 
tions, names and determinations among the members of this Association, pharm- 
acists, and physicians generallv in the United States and others interested in 
pharmacy and medicine. 
3 The management and control of the affairs, funds, and property of this Associa 
tion for the first year of its existence shall be vested in a Board of Trustees consist- 
ing of the seven following persons:1 
* Albert E. Ebert, 
ISamuel A. D. Sheppard, 
*William S. Thompson, 
Charles E. Dohme, 
*George W. Sloan, 
Horatio C. Wood, 
*Charles Rice. 
In testimony whereof we have hereunto set our hands and affixed our seals this 
seventh day of July, 1900. 
*William S. Thompson. [seal.] 
G. Lloyd Magruder. [seal.] 
*John T. Winter. [Seal.] 
Thomas C. Smith. [seal.] 
Murray Galt Motter. [seal.] 
*William M. Mew. [seal.] 
Frank M. Cr swell. [seal.] 
The incorporation having become a fact, it was necessary, next, for 
the Incorporators to meet and adopt a Constitution and By-Laws. 
Some minor changes were necessary in order to make the organization 
complete and legally sound. Under the law, when the Certificate was 
recorded, the United States Pharmacopceial Convention embraced only 
the seven Incorporators and the seven members of the Board of Trus- 
tees named in the certificate. Therefore, at a meeting of the Incor- 
porators, held on the thirty-first day of October, 1900, a Constitution2 
and By-Laws were adopted and the officers and members of the Com- 
mittee of Revision appointed at the late Convention were, by a formal 
resolution, recognized as the “Associates” of the Incorporators. This 
having been done, the functions of the Incorporators ceased. They 
are, because of their being Incorporators, of course, members of the 
United States Pharmacopceial Convention during their several lives 
but having adopted a Constitution and By-Laws, which place the manage- 
ment of all the affairs of the Convention in the hands of its Board of 
Trustees, they are without further power in the premises. 
1 The laws of the District of Columbia with regard to corporations require that 
the Board of Trustees or Directors, for the first year, shall be named in the Certi- 
ficate of Incorporation. 
* Deceased. 
t Resigned. Lbc*?, 
2 This Constitution was the same as that adopted by the Convention in Wash- 
ington, with a few verbal and other necessary minor changes. 
4 The membership of the convention having thus been provided for, it 
was necessary to elect Officers and a Committee of Revision. According 
to the Constitution and By-Laws, this function was to be performed by 
the Board of Trustees, in order to bridge over the interval between the 
date of incorporation and the next succeeding meeting of the Pharma- 
copceial Convention in 1910. 
On the 31st of October, therefore, the Chairman of the Board of Trus- 
tees, by their direction, cast the ballot of the Board for the Officers and 
Committee of Revision elected by the Convention of May, 1900. (See 
below.) In this way, then, the wishes of the Convention have been car- 
ried out in every detail, in spite of the complications arising necessarily 
in the process of securing the act of incorporation. 
OFFICERS OF THE CONVENTION 1900-1910. 
President, H. C. Wood, M.D., Philadelphia, Pennsylvania. 
First Vice-President, A. B. Prescott, M.D., Ann Arbor, Michigan. (Died 
February 25, 1905.) 
Second Vice-President, Otto A. Wall, M.D., St. Louis, Missouri. 
Third Vice-President, Reynold W. Wilcox, M.D., New York, New York. 
Fourth Vice-President, N. S. Davis, Jr., M.D., Chicago, Illinois. 
Fifth Vice-President, A. L. Lengfeld, M.D., San Francisco, California. 
Secretary, Henry M. Whelpley, M.D., 2342 Albion Place, St. Louis, Missouri. 
Assistant Secretary, Murray Galt Motter, M.D., Hygienic Laboratory, 25th 
and E Sts., N. W., Washington, D. C. 
Treasurer,William M. Mew, M.D.,Washington, D.C. (Died September 19,1902.) 
G. Wythe Cook, M.D., Washington, D. C. (Elected November 1, 1902.) 
BOARD OF TRUSTEES. 
William S. Thompson, Chairman, 1900, Washington, D. C. (Died September 
26, 1901.) 
Ex Officio, Charles Rice, Ph.D., New York, New York. (Died May 13, 1901.) 
George W. Sloan, Indianapolis, Indiana. (Died February 15, 1903.) 
Albert E. Ebert, Ph.M., Chicago, Illinois. (Died November 20, 1906.) 
Samuel A. D. Sheppard, Ph.M., Boston, Massachusetts. (Resigned November 
24, 1908.) 
Chairman, Charles E. Dohme, Ph.M., Pratt and Howard Sts., Baltimore, 
Maryland. 
James H. Beal, Sc.D., Scio, Ohio. (Elected October 21, 1901.) 
Frederick W. Meissner, Ph.G., La Porte, Indiana. (Elected January 9,1907.) 
Henry W. Whelpley, M.D., St. Louis, Missouri. (Elected April 14, 1903.) 
George H. Simmons, M.D., Chicago, 111. (Elected November 17, 1909.) 
Ex Officio, H. C. Wood, M.D., Philadelphia, Pennsylvania. 
Ex Officio, Joseph P. Remington, Ph.M., Philadelphia, Pennsylvania. 
5 COMMITTEE OF REVISION, 1900-1910. 
Chairman, Charles Rice, Ph.D., 1900, New York, New York. (Died May 13, 
1901.) 
Chairman, Joseph P. Remington, Ph.M., 1832 Pine St., Philadelphia, Pennsyl- 
vania. (Elected June 6, 1901.) 
First Vice-Chairman, C. Lewis Diehl, Ph.M., Louisville, Kentucky. (Elected 
October 10, 1910.) 
Second Vice-Chairman, Reynold W. Wilcox, M.D., New York, New York. 
Secretary, Alfred R. L. Dohme, Ph.D., 303 West Pratt St., Baltimore, Maryland. 
John J. Abel, M.D., Baltimore, Maryland. 
Charles Caspari, Jr., Phar.D., Baltimore, Maryland. 
Virgil Coblentz, Ph.D., New York, New York. 
N. S. Davis, Jr., M.D., Chicago, Illinois. 
James M. Good, Ph.G., St. Louis, Missouri. 
Willis G. Gregory, M.D., Buffalo, New York. 
Walter S. Haines, M.D., Chicago, Illinois. 
Carl S. N. Hallberg, Ph.D., Chicago, Illinois. 
H. A. Hare, M.D., Philadelphia, Pennsylvania. 
Henry Kraemer, Ph.D., Philadelphia, Pennsylvania. 
Edward Kremers, Ph.D., Madison, Wisconsin. 
A. B. Lyons, M.D., Detroit, Michigan. 
John Marshall, M.D., Philadelphia, Pennsylvania. 
Oscar Oldberg, Phar.D., Chicago, Illinois. 
George F. Payne, M.D., Atlanta, Georgia. 
Henry H. Rusby, M.D., New York, New York. (Elected October 10, 1901.) 
Samuel P. Sadtler, Ph.D., Philadelphia, Pennsylvania. 
Lucius E. Sayre, Ph.M., Lawrence, Kansas. 
Wilbur L. Scoville, Detroit, Michigan. 
Edward H. Squibb, M.D., Brooklyn, New York. 
Alviso B. Stevens, Ph.C., Ann Arbor, Michigan. 
Ur-Officio, H. C. Wood, M.D., Philadelphia, Pennsylvania. 
6 UNITED STATES PHARMACOPCEIAL CONVENTION. 
Decennial Meeting of 1910. 
The Convention met at the New Willard Hotel, Washington, 
D. C., on Tuesday, May 10, 1910, at 10 o’clock, A.M., and in 
the absence of the President, Horatio C. Wood, Sr., was called to 
order by the Second Vice-President, Otto A. Wall, who introduced 
Hon. Charles Nagel, Secretary of Commerce and Labor. 
WELCOMING ADDRESS OF HON. CHARLES NAGEL. 
Mr. President, Ladies and Gentlemen: 
It is a matter of special gratification to me to appear before you this 
morning, particularly because of my long-standing acquaintance with 
your Acting-President, whom I am glad to welcome here in the capacity 
which he occupies. 
I have been given to understand that I am here as a substitute; in 
other words, that you had intended to have Secretary Wilson deliver 
this welcoming address. I do not wonder at your first choice. He 
would have been mine; but I am glad to have this occasion used to illus- 
trate the ready and generous cooperation which is always found between 
Secretary Wilson and myself, not only officially but personally. It is 
true that in one sense his department and mine appear to be separated 
widely, but it is also true that in many spheres we are expected to co- 
operate. In other words, Secretary Wilson is somewhat intent upon 
making rules that shall insure the protection of the public, and I am 
somewhat interested in not having those rules go any further than is 
necessary in order that commerce may not be unduly interfered with. 
At the same time I am glad to say that we have had no difficulty in arriv- 
ing at conclusions. I think we have both endeavored to be reasonable, 
and after hammering it out we have usually been able to find rules that 
have received the approval of both. 
7 It has seemed to me that there ought to be more general cooperation 
than has been had in late years in every field of activity. I believe for 
instance that governments ought to cooperate more than they have. I 
believe that the Federal Government and the State authorities ought 
to work hand in hand to solve the great commercial and other problems 
that come to us, instead of apparently antagonizing each other, each 
jealous of the jurisdiction of the other. Industry, commerce and the 
Government, ought to cooperate more than they have. I believe that 
very much of the agitation which has been had in this country might 
have been obviated if industry and commerce had been more ready 
to concede that some legislation was bound to be had. In other words, 
the resistance that was offered by large interests added to the necessity 
for the legislation; and if the energies and talents employed in many in- 
stances in creating obstacles had been used to facilitate progress, to sug- 
gest and point the way, a satisfactory basis of cooperation would in my 
judgment have been found long ago. 
But the most valuable contribution that industry and commerce can 
make to the success of the common government goes even further than 
that. The best assistance that can be offered is so to conduct business 
and to promote and adopt such standards that regulation, will become 
entirely unnecessary; and I take it from what I understand, Gentlemen, 
that you are here at this time, as always, to consult and confer in order 
that you may so elevate your own business and so regulate your own af- 
fairs that the activities of Government will be gradually displaced. The 
greatest aid that any citizen or any aggregation of citizens can give to 
the Government is to elevate the standards of their own concerns in 
such fashion that no interference and no regulation for the public good 
may be needed; in other words, to find such standards that they will not 
only afford protection to the public, but that they may be adopted by 
the Government itself as the standards to which all comers will have 
to conform. Understanding that that is your purpose, I have every 
reason to welcome you; and Mr. President and gentlemen, I particu- 
larly welcome you to the task which you have imposed upon yourselves 
at this meeting. 
The Chairman then introduced His Excellency, the Envoy 
Extraordinary and Minister Plenipotentiary of Costa Rica, who 
addressed the Convention as follows: 
8 ADDRESS OF THE MINISTER OF COSTA RICA, SENOR DON 
JOAQUIN BERNARDO CALVO. 
Gentlemen: 
Through the deference, which I greatly appreciate, of the Board of 
Trustees of the Pharmacopoeial Convention, I now have the pleasure of 
being among you, and the honor to address you, extending my most cor- 
dial greetings and expressing my earnest wishes for the highest success 
of your important labors. 
That a Spanish-speaking Latin American should have received this 
distinction, does not seem to be an isolated fact, but the result of a log- 
ical consequence of the great step with which you have illustrated the 
works of these Conventions, that of offering to our physicians and pharm- 
acists who do not speak English the Pharmacopoeia of the United States 
translated into Spanish; one of the most useful works of its kind, if not 
the most useful, among those published up to the present date. 
The Spanish-American population, you know, reaches nearly fifty 
million, and that of Spain, eighteen million; therefore, the new work in 
Spanish is a valuable service rendered to sixty-eight million people. 
I feel sure, gentlemen, that so worthy a contribution shall be duly 
appreciated by all the countries whose mother tongue is the beautiful 
language of Castile, and that the time is not far when the Pharmacopoeia 
of the United States shall be adopted in all of them. 
The tendency toward the universality of scientific knowledge has been 
one of the most evident signs of the advance of civilization; and the 
tendency toward the unification of ideas, in many other respects, in our 
hemisphere, shows that we respond to the call made by the various inter- 
ests which, like those of territory, bind us in common. Particularly 
during the last few years, a great advance has been made in this direc- 
tion, and it is an act of justice to recognize and proclaim the very active 
and commendable part of the people of this privileged nation in strength- 
ening more and more the ties that bind it together with the other Ameri- 
can Republics. 
To mention what unification means in the important matter that 
brings you here would have no object, as this is the aim to which for 
nearly a century these conventions have devoted their praiseworthy 
and constant efforts. 
The Latin-American countries have in the prodigious resources of their 
soil, many of the products universally used to the greatest advantage 
in medicine, as quinine, cocaine, pilocarpus, ipecac, and so forth. And, 
on the other hand, Mexico, you know, was the first of the American na- 
9 tions to adopt the system of uniformity in regard to the most important 
drugs as it was proposed at a conference in Brussels, about ten years ago. 
From information published in this country in 1904 and 1906, the state- 
ments were made that the Pharmacopoeia of the United States is the 
officially designated pharmacopoeia of the Republic of Costa Rica, and 
that in the other Central American States, Liberia, Peru. Uruguay, and 
Venezuela, it is either the chief or one of the several pharmacopoeias 
recognized. 
From the very beginning of the marvelous development of the United 
States, you have endeavored to meet a necessity in so delicate a matter 
as that relating to the safety of medicines; and the greater the progress 
achieved by medical science and everything concerning it, the higher 
the merit of your labors. I would like to see your field of action enlarged 
and, just as we have already periodical Pan-American Medical Confer- 
ences and International Sanitary Conventions, also Pan-American, we 
should likewise have a similar system for the unification of all that per- 
tains to the Pharmacopoeia. Although I am totally ignorant of the 
science it is based upon, it seems to me evident that its interest is in- 
creased when more attention is devoted to the universality with which 
the problems of medicine are now studied, for instance, as in the cure 
of tuberculosis, which has originated notable international universal 
congresses. 
You have accomplished your purpose in the United States of Amer- 
ica, and in offering the result of your persevering labors to the other 
countries of the Continent, in an edition carefully prepared in their own 
language, you give them an opportunity to share with you the same 
benefits you have secured for your own country. 
I believe myself to be a faithful interpreter of the sentiments of the 
Latin countries of America when I express most earnestly the sincerest 
recognition of this significant proof of Pan-American confraternity. 
After thanking the Secretary of Commerce and Labor and His 
Excellency, the Envoy Extraordinary and Minister Plenipotentiary 
of Costa Rica, the Chairman read the address of the President, 
H. C. Wood, Sr., Reynold W. Wilcox, Third Vice-President, 
presiding. 
10 PRESIDENTIAL ADDRESS. 
UNITED STATES PHARMACOPGEIAL CONVENTION. 
1910. 
H. C. Wood, M.D. 
Morituri salutamus! From a sick-bed the President of the U. S. Phar- 
macopoeial Convention of 1890 and of 1900 sends salutation to the men 
of the Convention of 1910, with a brief account of his stewardship during 
the last decade. 
It is a striking example of the payment which in this mad country 
of America eminence requires of the men who would gain it, that of 
the Board of Trustees—seven in number, appointed in the Act of Incor- 
poration on the 11th day of July, 1900—three are permanently inval- 
ided and four are dead. None of these men were old. Omitting the 
Secretaries, chosen for theii youthful activity, of the five officers elected 
by the Convention in 1900, the first Vice-President and the Treasurer 
are dead, and the President is as he is. 
I have thought in looking over the propositions for changes in the 
Constitution and By-Laws, recommended to you by the Board of 
Trustees, that if the original Board elected by the Convention were 
still alive some of these recommendations might not have been made, 
and I beg of you, when it comes to the final decision, that you think 
carefully over the matter, and if any doubt arises cleave to that which 
is old rather than that which is new and experimental, the experience 
of a busy life has taught me the wisdom of the old adage “It is better 
to let well-enough alone.” 
Since the Spanish translation of the U. S. Pharmacopoeia has become 
the official Pharmacopoeia of Cuba, I believe that the University of 
Havana should be given the inherent right to send a delegate or dele- 
gates to the Convention, because to the University of Havana we ought 
to look for the translation of the Pharmacopoeia into the Spanish lan- 
guage. 
In regard to the constitution of the Committee of Revision, I am very 
stiongly of the opinion that any enlargement of its membership would 
make its working much more cumbersome and expensive and yield no 
better fruit. 
The work of the President of the U. S. Pharmacopoeial Convention 
during the ten years that elapses between the successive meetings of 
the Convention, is little more than that of a member of the Boaid of 
11 Trustees and the Committee of Revision, and of this I have performed 
such part as my health would permit. The fact is, however, that the 
work of the physician upon the Committee of Revision is very slight 
and comparatively unimportant, and so I have felt I could leave such 
duties to the competent hands in which it was placed by the Conven- 
tion of 1910, and have taken very little part in that work. On the other 
hand, in the early and more important years of the Board of Trustees, 
I was able to attend the meetings of the Board and to take my full 
share in its work. 
The detailed reports which you will receive from the respective Chair- 
men of the Board of Trustees and of the Committee of Revision make it 
unnecessary for me to say much on the results of their labors, suffice it 
to call attention to the facts that both Committees have done an enor- 
mous amount of work, faithfully and honestly, and that the Pharma- 
copoeia produced by the Committee of Revision is generally acknowl- 
edged to be the best ever made; it has also been recognized by Con- 
gress, so that in matters within its scope it is the law of the land whilst 
the Spanish translation has not only been made the official Pharmaco- 
poeia of Cuba but every drug-store in that island has been required by 
law to have a copy of the book. 
The credit of this success is shared in greater or less measure by every 
member of the Committee of Revision, but as honor is given to the leader 
of a successful army, so do I believe that in large measure the credit is 
due to the Chairman of the Committee of Revision. By his knowledge 
of human nature, by his patience, by his unceasing labor and unflagging 
energy, as well as by his thorough mastery of the whole subject, has he 
obtained unity of action from a body of men highly favored by natural 
endowment and education for the purpose but accustomed to work 
independently, and thereby has he led to victory. To him should be 
given acknowledgment of the appreciation of his fellows. Intimately 
conversant with all matters pharmacopceial, for thirty, perhaps forty, 
years he has been in the midst of the fray, and as a master-mind among 
men worked honestly and effectively for the general good. 
In the opinion of your President the future life of the U. S. Pharma- 
copceial Convention rests largely upon the labors of the Committee on 
Credentials and Arrangements, and the subsequent action of the Con- 
vention in reviewing the work which they have done. The position of 
the Convention is so anomalous that a parallel is very difficult to find, 
but the lighting and buoying of the English coast is under the control 
of a Corpoiation which is analogous to the U. S. Pharmacopceial Con- 
vention in that it exercises legal governmental authority although an 
12 independent body. Its power to erect and take charge of the light- 
houses and beacons of the coast of England was given to it by Queen 
Elizabeth in 1573, and its work has been so satisfactory that whilst the 
coasts of Scotland and Ireland are under government care, the Brothers 
of the Trinity still remain masters of the English coast. 
As it was with the Corporation of Trinity House, so originated in 
the early days of the American Republic, not by law but by voluntary 
action and consent, the Convention of the U. S. Pharmacopoeia; but 
to-day, incorporated and its actions legalized, it constitutes the power 
which regulates the relations between the professions of pharmacy and 
medicine, and gives the standard of legal purity for certain substances 
used widely for other than medical intent. 
The Corporation of Trinity House has maintained its supremacy 
and the character of its work by its conservatism, and by its refusal 
to widen the circle of the Executive or the character of its membership. 
As with it so do I believe that the U. S. Pharmacopoeial Convention 
will, to the great benefit of the professions of pharmacy and medicine 
and of the people of the United States, maintain its own existence by 
conservatism, by guarding well the portal of entrance to the Conven- 
tion, and by making scientific and practical fitness rather than geo- 
graphic representation the requirements for membership, especially in 
its Executive. 
The Committee on Credentials and Arrangements has worked hon- 
estly and efficiently. If there has been any error it is in leaning to leni- 
ency rather than to over-strictness, and I trust most earnestly that the 
Convention will exeicise supreme care in recognizing any delegates 
whose credentials have been reported by the Committee as of doubtful 
or disputed eligibility. 
In 1902, your President and Dr. Frederick B. Power, Ph.D., an Amer- 
ican chemist, Director of the Wellcome Chemical Research Labora- 
tories of London, were appointed by the Secretary of State as 
delegates to represent the U. S. Government in the International Con- 
ference for the Unification of the Formulae of Heroic Medicines, which 
had been called by the Belgian Government and which met in Brussels 
in September, 1902. Although attempts had been made before to obtain 
such unification, and failed, this Conference fully achieved the object 
for which it was summoned, namely—the making of a list of drugs which 
were considered actively remedial and yet capable of doing great harm, 
with a list of preparations and their strength; so that the traveller can, 
when the work of the Conference has been accepted by the various 
nations individually, have a prescription compounded of the same 
13 strength in any city of a Nation party to the Conference. The Com- 
mittee of Revision of the U. S. Pharmacopceial Convention has in great 
measure conformed to the recommendation of the meeting at Brussels. 
The failure to do so completely seems to me the one blot on their work. 
Nov. 11th, 1908, I received from the Acting Secretary of State a 
translation copy of a letter from the Belgian Legation concerning the 
creation of a permanent institution, to be called the International Sec- 
retariate for the Unification of Pharmacopoeias, located at Brussels, its 
expenses to be paid by annual quotas from the adhering nations. In 
reply, I wrote to the Hon. Robert Bacon that such a Secretariate seemed 
to me so foreign to the immediate objects of the U. S. Pharmacopceial 
Convention, and so open to the possibilities of serious pecuniary respon- 
sibilities, that I personally could not endorse it, but would refer the mat- 
ter to theU. S. Pharmacopceial Convention of 1910. I have heard 
nothing further concerning this subject, and have transferred all my 
correspondence to Dr. Murray G. Motter, Secretary of the U. S. Phar- 
macopoeial Convention. With this information I leave this subject to 
be decided as may be thought fit by you. 
Gentlemen of the Convention: In April, 1860, as a medical stu- 
dent, eighteen years of age. by finishing a paper on the Carboniferous 
Flora of the United States, published in June by the Philadelphia Acad- 
emy of Natural Sciences, I commenced my public scientific career; in 
April, 1910, with the writing of this address I close it. A half-century 
has passed, most of it spent in over-strenuous labor, so that the evil 
days spoken of by Solomon the Poet-King have come to me before the 
three-score and ten years have ended: and so I bid you farewell. 
On motion of Charles H. LaWall, a committee of five was 
appointed, consisting of C. H. LaWall, E. G. Eberle, Theo. D. 
Wetterstroem, W. B. Day, and J. M. Good, to consider the recom- 
mendations in the President’s address. (See page 34.) 
On motion of Solomon Solis Cohen, seconded by James M. 
Good, the Convention extended its hearty greeting to the Presi- 
dent, H. C. Wood, Sr., by telegraph. 
The Secretary of the Committee on Credentials and Arrange- 
ments, M. G. Motter, read the report of that Committee and on 
motion of George M. Kober the reading of the list of delegates, 
which was already available in print, the notification of whose 
appointment has been received and approved, was dispensed with. 
On motion of H. A. Hare, the report of the Committee was adopted. 
14 The Secretary then presented a list of credentials which had 
been questioned or which appeared to be of doubtful validity, 
as not included under the Constitutional requirements: the 
Department of Pharmacy of the Oregon Agricultural College and 
the College of Pharmacy of the Winona Technical Institute. 
On motion of 0. T. Osborne these institutions were admitted to 
the Convention. 
On motion of the Secretary, the recommendations of the 
Committee on Credentials, that each member when speaking 
shall give both his name and number and that no member be 
allowed to speak longer than five minutes on one subject, were 
adopted. 
After a recess of five minutes the roll was called and the mem- 
bers of the Nominating Committee announced. 
On motion of C. S. N. Hallberg, the following resolution was 
unanimously agreed to: 
“Resolved, That all members of Congress, especially medical 
members, be invited to attend the sessions of the Pharmacopoeial 
Convention,” and on motion of C. F. Claassen the members of 
Congress who were pharmacists were also unanimously invited. 
The Secretary of the Convention, Henry M. Whelpley, read his 
report which, on motion, was adopted, as follows: 
REPORT OF THE SECRETARY 
Henry M. Whelpley. 
To the United States Pharmacopoeia! Convention of 1910: 
My first work after the adjournment of the Convention of 1900 was 
to look after the minutes recorded by the stenographer who had been 
entrusted with reporting the proceedings. It soon developed that the 
stenographer was incapacitated for his work and the only record we 
have of the proceedings of the 1900 Convention is very incomplete. 
Since all resolutions, motions and leports were submitted to the Con- 
vention in writing, these features of the proceedings are accurately 
recorded but the stenographer’s report on discussions is incomplete and 
the portions given inaccurate. The records, such as they are, ha\e been 
bound in a single volume, for preservation. 
15 I also have a bound volume of the stenographer’s report of the Conven- 
tion of 1890 which, as far as I can judge, is both complete and accurate. 
Soon after the adjournment of the Convention of 1900, I was in- 
structed by the Board of Trustees, to prepare an abstract of the pro- 
ceedings. This was published in a limited edition and has long since 
been out of print. 
On request of the Chairman of the Committee of Revision, I prepared a 
brief introduction for the U. S. P. VIII. and an abstract of the proceed- 
ings of the National Convention of 1900 for revising the Pharmacopoeia. 
By resolution of the Board of Trustees, I was directed to inform the 
electors of vacancies occurring in the Board of Trustees and to call for 
nominations and a vote. The records of the balloting have been placed 
in the hands of the Chairman of the Board of Trustees. 
Considerable correspondence of a miscellaneous nature has accumu- 
lated in my office during the past ten years. Under direction of the 
Board of Trustees, this has been turned over to the historian of the Amer- 
ican Pharmaceutical Association for permanent preservation. 
The report of the Treasurer, G. Wythe Cook, was read and, 
after some discussion, was, on motion of H. A. Hare, received. 
REPORT OF THE TREASURER. 
G. Wythe Cook. 
Mr. President and Members of the Convention: 
The function of the Treasurer is simply to receive money and pay it 
out by order of the Board of Trustees. Since I have held the office, 
from November 15, 1902, up to the present time, I make the following 
statement of receipts and expenditures:— 
RECEIVED 
PAID 
From Nov. 15,1902, to April 9, 1903 
$5,712.82 
$3,174.20 
From April 8,1903, to April 25,1904 
5,344.56 
5,283.32 
From April 25,1904, to May 7, 1905 
2,975.54 
4,667.06 
From May 7, 1905, to April 26,1906 
59,013.37 
49,825.09 
From April 26,1906, to April 30,1907 
17,376.42 
17,324.13 
From April 30, 1907, to May 12, 1908 
7,501.27 
8,752.72 
From May 12, 1908, to May 14,1909 
7,777.88 
6,470.06 
From May 14,1909, to April 30, 1910 
8,734.91 
10,550.18 
Balance 
8,394.01 
$114,440.77 
$114,440.77 
16 This is simply a statement of the annual receipts and expenditures. 
A yearly report is made to the Board of Trustees, showing the amounts 
received. 
The report of the Board of Trustees was read by the Acting- 
Chairman, Janies H. Beal, and after some discussion was, on 
motion of H. J. Lohmann, amended by W. C. Anderson, referred 
to the Committee on the President’s Address, a rising vote of 
thanks and appreciation being, at the same time, extended to 
the Board. (See page 35.) 
REPORT OF THE BOARD OF TRUSTEES. 
James H. Beal. 
Mr. President and Members of the Convention: 
You have already been reminded of the fact that of the original seven 
members of the Board of Trustees two only remain, and both of these 
by reason of continued ill health unable to give close attention to the 
always important, and frequently arduous labors of the Board. 
The object of this comparatively brief report of the Acting-Chairman 
is to present the salient features of the Board’s activities during the 
decade, in so far as they have not been covered by the more detailed 
repoits of the Secretary and Treasurer, the Chairman of the Committee 
of Revision, and by the reports of the officers of the Convention. 
Early in its history the Board was brought to a sharp realization of 
the fact that the new plan of organization adopted by the last Conven- 
tion imposed many new duties and obligations which needed most 
serious consideration. 
The Board has also realized that its decisions would, for good or ill, 
be quoted as precedents in future cases, and in the exercise of its func- 
tions it has therefore purposely pursued a conservative course, deeming 
it to be less difficult to supply omitted actions than to correct unwise 
ones. 
FINANCIAL. 
At the very beginning the Board was hampered by the slender finan- 
cial resources at its command. After the 1900 Convention there was 
an immediate falling off in the sales of the preceding Pharmacopoeia 
17 and a corresponding reduction of income. The surplus funds in hand 
were early used up in the discharge of obligations and the completion 
of work either expressly or impliedly authorized by the 1900 Conven- 
tion, or which came as an inheritance from the old Committee of Revi- 
sion. 
As a consequence the Board was at an early date confronted by a 
nearly empty treasury, which unfortunately occurred at the time when 
the demand upon-its resources was greatest. 
The Convention being without tangible assets upon the value of 
which funds could be raised, it was necessary for the members to pledge 
their individual credit for this purpose. Notes were negotiated at 
various banks secured by the personal endorsements of the members, 
and the money raised in order that the work of revision and publica- 
tion might go forward without delay. 
All funds at the disposal of the Board have been at all times so depos- 
ited as to draw interest upon semi-annual balances. 
METHOD OF DISBURSEMENT. 
The method of bookl eeping employed by the Secretary, while simple, 
is sufficient to present at all times an accurate and complete outline of 
the receipts and disbursements. 
Though the amount of money handled is in the aggregate consider- 
able, the accounts over which it is distributed are few in number and 
simple in character, and it is believed that the adoption of a more elabor- 
ate system of accounting would not be of sufficient value to justify the 
additional expense which it would entail. 
The method of payment of bills is as follows: 
The member of the Board who authorizes the expenditure or under 
whose supervision it was made certifies to the accuracy of the bill. The 
Chairman of the Executive Committee then passes upon the legality 
of the expenditure, and if found by him to be properly authorized by 
the rules or action of the Board certifies it for payment. 
All payments are made by voucher checks bearing the signatures of 
the Chairman, Secretary and Treasurer. 
All receipted checks, warrants, invoices and other vouchers are con- 
secutively numbered and permanently kept on file. 
The accounts of the Secretary and Treasurer have been regularly 
audited each year, and have invariably been found correct. 
18 MEETINGS OF THE BOARD. 
Many of the functions of the Board are of such a character that they 
can not be satisfactorily settled by the slow and cumbersome method 
of correspondence. 
Since its creation the Board has held at least one meeting yearly, and 
such special meetings as were made necessary by reason of business 
that could not otherwise be satisfactorily disposed of. 
More meetings might perhaps have been held with advantage to the 
work, but it should be remembered that the frequent calling together 
of the Board would have entailed a hea\y item of expense which the 
condition of the treasury would scarcely warrant. 
It should also be remembered that the members of the Board serve 
entirely without compensation, and do not receive honoraria, their 
expense allowance covering only necessary traveling and hotel expenses. 
Since nearly all members of the Board are also members of the Amer- 
ican Pharmaceutical Association, advantage has been taken of that fact 
to hold one or more sessions during the annual meetings of that Asso- 
ciation thus materially decreasing the expense to the Convention. 
SALES. 
The sales of the 8th Revision were, of course, heaviest in the year 
immediately following its appearance. The next year following, being 
that of the enactment of the Federal Food and Drugs Act, also, resulted 
in sales nearly one-third as large as the year before. 
Since then, notwithstanding the adoption of the Pharmacopoeia as 
a standard by numerous state enactments, and the active U. S. P. 
propaganda carried on by various pharmaceutical and medical associa- 
tions and journals, the sales have not been materially greater than for 
the corresponding years following the appearance of the preceding Revi- 
sion. 
THE SPANISH TRANSLATION. 
Following the appearance of the regular English edition of the 8th 
Revision, the attention of the Board was called to the demand for a 
Spanish translation for use in the colonial possessions of the U. S., and 
in the Spanish American Republics. This demand was emphasized by 
the adoption by the Second International Sanitary Conference of Pan- 
American Republics of a resolution favoring the publication of such a 
Spanish edition of the book. After a careful canvass of the whole ques- 
19 tion, and the securing of such data as were available, a Spanish trans- 
lation was decided upon. The translation of the text was made by Prof. 
Jose G. Diaz, of the University of Havana, and the book was manufac- 
tured by the printers of the regular edition. 
Since its appearance it has been adopted as the legal standard of 
Cuba and several of the Spanish American countries, and seems to be 
growing in favor. The first edition was for 2,000 copies. A second edi- 
tion of 2,000 has already been ordered, upon the recommendation of 
the agent, and it is hoped that the Spanish edition will not only repay 
the expense of translation and printing, but may possibly show a small 
balance in its favor. 
RECOMMENDATIONS. 
As required by the Constitution, the Board of Trustees has submitted 
certain recommendations to the consideration of the Convention. The 
most important of these are, perhaps, those concerning the size and 
functions of the lie vision Committee. 
During the work of revision, the fact became evident that the Com- 
mittee as previously constituted was both too large and too small—too 
large for the close and consecutive conduct of the work of revision neces- 
sary to secure its speedy conclusion, and too small to afford representa- 
tion to all sections and interests which might properly lay claim to be 
represented. 
The Board has accordingly submitted a recommendation to change 
the number on the Revision Committee from 25 to 50, and to change 
its title to General Committee of Revision. 
The General Committee of Revision is then to select an Executive 
Committee of 15 to which the immediate work of re\ision shall be 
en 11 sted, reserving to the General Committee certain advisory and 
supervisory powers, and the duty of filling vacancies which may occur 
in the Executive Committee. 
After a consideration of the subject for more than two years, the 
Board is convinced that the proposed change, if adopted, will do more 
to expedite the work of revision than any of the various other sugges- 
tions which have been brought to its attention. 
PROTECTION OF COPYRIGHT. 
Prior to the creation of the Board of Trustees, but little attention 
was paid by authors and publishers to the Pharmacopoeia copyright. 
Some few authors and publishers were courteous enough to secure per- 
20 mission and to pay for use of the Pharmacopoeial text, but the greater 
number entirely ignored the property rights of the Convention. 
As a consequence the sale of the Pharmacopoeia was hampered, and 
possibly considerably curtailed by the sale of substitutes for the official 
volume. 
Early in its history the Board took up the question of curing this 
abuse, and notwithstanding vigorous protests in some quarters, has 
made a great improvement in conditions. 
After careful consideration, it was found impracticable to impose a 
volume royalty upon the books making use of the text, and it was finally 
decided to classify such works according to their character and the extent 
to which the text was employed, and to charge a gross sum for the priv- 
ilege. The sums charged have varied from $500, in the case of dispen- 
satories, to merely nominal compensation for small books, in which the 
use of the text was limited. 
In every case the publisher has been required to print upon the reverse 
of the title page a suitable acknowledgment of the Convention’s copyright. 
It has not been the object of this policy to make this use of the text 
a source of revenue, but simply to protect the integrity of the copy- 
right, and the dignity of the Pharmacopoeia. 
Thus far all cases have been settled without resorting to litigation, 
though it is possible that the successors of the present Board may find 
it necessary to take legal action with respect to a pending case in which 
satisfactory adjustments have not yet been made. 
UNITED STATES PUBLIC HEALTH AND MARINE-HOSPITAL SERVICE. 
Upon the appearance of the 8th Revision of the Pharmacopoeia, the 
Board of Trustees received a request from the Surgeon-General of the 
U. S. Public Health and Marine-Hospital Service, Dr. Walter Wyman, 
for permission to have prepared under the direction of the Hygienic 
Laboratory of the Service, a bulletin of the changes and additions made 
by such revision. The Board granted the permission requested, and 
the changes and additions were embodied in a publication of the Hygi- 
enic Laboratory known as Bulletin 23. 
This publication was received with general favor and is recognized 
by the Board as having assisted greatly in bringing the various changes 
in the Pharmacopoeia to the knowledge of the professions of medicine 
and pharmacy in a thorough and effective manner. 
By a further understanding, the Surgeon-General has had prepared 
by the Hygienic Laboratory a compilation and digest of Criticisms and 
21 Comments upon the Pharmacopoeia which have appeared in two Bul- 
letins, numbered respectively “49” and “58.” 
The completeness and great value of these digests as aids to more 
perfect pharmacopoeia revision are so well known, that further comment 
would be altogether superfluous. A third Bulletin of Comment and 
Criticisms has been prepared, and its appearance is expected at an early 
date. 
In addition to the compilation referred to, certain investigations 
have been carried on in the Hygienic Laboratory respecting the solu- 
bilities and melting points of official substances. The results obtained 
have been of great value and will prove of material benefit to the next 
Committee of Revision. 
It is the opinion of the Board of Trustees that the U. S. Public Health 
and Marine-Hospital Service should receive the thanks of the U. S. P. 
Convention for these contributions to the conservation of the public 
health and to the progress of American Medicine and Pharmacy. 
The report of the Chairman of the Committee of Revision, was 
read by the Chairman, J. P. Remington, and was, on motion of 
I. V. S. Stanislaus, referred to a committee of five, this committee 
consisting of I. V. S. Stanislaus, O. T. Osborne, Henry Beates, 
Robert A. Hatcher and J. W. Sturmer, was appointed by the 
Chair, a rising vote of thanks being, at the same time extended to 
the Chairman. (See page 45.) 
REPORT OF THE CHAIRMAN OF THE COMMITTEE OF 
REVISION. 
Joseph P. Remington. 
It becomes my duty, according to Article IV, Chapter 5 of the By- 
Laws of this Body, to make a report upon the work of revision of the 
United States Pharmacopoeia. History will, undoubtedly, record the 
fact that the Eighth Revision was by far the most important of all, not 
excepting the first Edition of 1820. In the course of events, just one 
year after the first copies of the present Pharmacopoeia left the press, 
the Federal Food and Drugs Act was signed by President Roosevelt 
and the United States Pharmacopoeia, for the first time in its history, 
became the law of the land. 
22 It was, undoubtedly, wise on the part of the present Committee 
that, unheeding the clamor and jibes of the unthinking and impatient 
public who demanded an early issue of the book, the members of the 
Committee worked earnestly but not hurriedly until the work of revi- 
sion was accomplished. No previous Committee was beset with such 
difficulties as were confronted by your retiring Committee. 
The work was commenced with a Chairman already marked by 
death as a victim, he was unable to be present at the Decennial Con- 
vention of 1900, but, after a temporary rally, Dr. Charles Rice took up 
the work and, fighting manfully against the ravages of disease, he finally 
laid down his burden, May 13, 1901, the first Chairman of a Committee 
of Revision to die during the period of active work. It would seem as 
if the Angel of Death had never before been so industrious among phar- 
macopceial workers since the first revision. Dr. E. R. Squibb, although 
not a member of the Committee of Revision, but who assisted in every 
possible way for forty years, died in 1900, our beloved and talented 
Chairman was the next to be called in 1901, the Chairman of the new 
Board of Trustees, William S. Thompson, died four months afterward, 
the Treasurer, Dr. William M. Mew, was called home one year after 
that in 1902, Dr. Walter Reed, the hero of sanitary science and Chair- 
man of the Committee on Diphtheria Antitoxin, died in the same year, 
Dr. George W. Sloan of Indianapolis, member of the Board of Trustees, 
died in 1903, Dr. Albert B. Prescott, 1st Vice-President, in 1905, Pro- 
fessor Albert E. Ebert in 1906. 
Reorganizations, which caused delays, necessarily followed and, 
although the work was pushed steadily, it was not until 1905, that the 
first copy of the present revision was issued. It is safe to say that much 
more interest was awakened by the appearance of the Eighth Revision 
than that of any previous issue. This was shown by the enormous sales 
of the book (nearly 40,000 copies the first year) far exceeding those of 
any previous issue and this was not due to the passage of the Food and 
Drugs Act but was solely the result of an awakened interest in the 
United States Pharmacopoeia. 
Its favorable reception not only by competent judges in this country, 
as well as abroad, was very gratifying to the Committee and the accept- 
ance of the book as a standard by the United States Government one 
year later gave the necessary and final touch of approval, but, when 
the work was reviewed in detail, and manufacturers and others realized 
that they were vitally and financially interested and their pocketbooks 
affected, there was naturally much industry expended in studying their 
particular points of contact. Tests which were entirely too severe or 
23 were theoretical or academic were overhauled and the authority vested 
in the Committee of Revision to publish a supplement was utilized, and 
this took the form of “Additions and Corrections” which was issued in 
1907. This was one of the most important acts of the Committee, 
occurring as it did at a most crucial time, when not only the Food and 
Drugs Act but the authority of the Pharmacopoeia itself hung in the 
balance. 
The willingness on the part of the Committee to appoint hearings 
and receive courteously all complaints and finally to investigate the sug- 
gestions was favorably received and the hearings were fair and equi- 
table to all, although every criticism was not accepted, for if the objectors 
did not get everything that they wanted, they did get a prompt hear- 
ing and a quick decision when it was proved that a few of the standards 
were unattainable and the critics were convinced that there was no dis- 
position on the part of the Committee to decline to hear every complaint, 
however trivial, and to afford relief when it was shown that it was abso- 
lutely necessary. There was no circumlocution, no necessity to consult 
heads of departments, no unnecessary etiquette, no “red tape.” The 
Committee from the manufacturers finally departed assured of immediate 
relief, provided their cause was just. 
A study of the list of additions and corrections will show that they 
numbered 431 in a total of 1297 articles, test solutions and assays, but 
of this number (431) 157 were changes made necessary through the adop- 
tion of one change in one part of the book which compelled a similar 
correction in other parts of the book, thus the assay committee, in order 
to satisfy a preference by a number of chemists for cochineal over hema- 
toxylin as an indicator, required a repetition of this correction 33 times; 
then again the few changes for standards for crude drugs, ipecac, bella- 
donna, stramonium, etc., caused corresponding changes in the tables 
in the appendix and elsewhere. There were 27 of these. A slight change 
in the bismuth standard necessitated a similar change in all the bismuth 
salts. 
A further analysis reveals the fact that the physical constants which 
had to be changed, such as specific gravity, melting points, saponifi- 
cation and iodine value, optical rotation, solubility, congealing points, 
ash and residue after incineration, amounted to 83. In nearly every 
case these changes were made to allow a wider range or to modify the 
severity of the test. A number of them were, of course, interdependent, 
a change in the specific gravity for the standard involving also a change 
in the boiling or melting point. A large proportion of the alterations 
in the standard for crude drugs involved corresponding changes in the 
24 preparations, and thus the list was swelled. It was found after confer- 
ence with the chemical manufacturers that the “Heavy Metal Test,” 
particularly in respect to the presence of traces of iron, was too stringent, 
and it was corrected. This involved 15 changes. The reasons presented 
by the chemical manufacturers were convincing, they stated that in 
making chemical salts in large quantities, often by the ton, the use of 
glass, porcelain or enameled vessels was out of the question, because 
of the inability to procure them in large sizes, and the loss and expense 
through breakage, and though the product was purified by re-crystaliza- 
tion, minute traces of iron which did not unfit the salt for medical pur- 
poses could not be separated without adding greatly to the cost. The 
concession caused no alarm, since the present test permits the presence of 
only two one-hundredths of one per cent of iron as an allowable impurity. 
In every case where a concession was granted because of the extreme 
rigidity of a test, the sub-committee having charge made careful experi- 
ments, examining the salts made by different manufacturers before a 
decision was reached. 
In some cases it became necessary to add a word or delete another, 
to render the language of a test more definite or accurate, these did not 
make any difference in the standards, but the number of these changes 
amounted to 66. Twelve tests throughout the book were omitted 
because they were not conclusive or were more efficiently covered by 
another, or, for some other reason, were undesirable. 
Thirty-three changes were made in chemical tests in which the word 
“absence” was replaced by the words “limit of,” because it was not 
desirable to compel the salt to be absolutely free from contaminating 
substances, and a detailed test was inserted which prescribed definitely 
the percentage of allowable impurities. Two changes were made for the 
better preservation of the official substance, two changes to fix the limit 
for the presence of arsenic. Nine changes were made to describe more ac- 
curately and less rigidly chemical substances. One new indicator (ro- 
solic acid) was added to the list because it was preferred to phenolphtha- 
lein, and lithium sulphate was added to the table of molecular weights, 
because it was used in a gra\imetric test. There were ten errors in 692 
pages, typographical, editorial, or which could be laid to the door of the 
proof-reader. These last were all detected and corrected after the first 
issue from the plates so that they can only be found in the first print- 
ing of Series A, 2,000 Pharmacopoeias out of the total of 50,000. 
None of these errors could be said to be 'vital, and not one of them 
dangerous to life, but such errors always cause annoyance and regret, 
and it seems impossible to evade the trite saying “To err is human.” 
25 The Board of Trustees decided that in as much as the Pharmacopoeia 
had just been issued, and that prosecutions were likely to follow by the 
National Government, it was of the utmost importance that a depart- 
ure be made from established precedent and that the additions and cor- 
rections should be given the widest publicity, and that the purchasers 
of a book of standards just issued, should have, practically without 
cost, the necessary data to make their book up to date. Those who did 
not care to correct their book were given the opportunity of purchasing 
another Pharmacopoeia in which the corrections were incorporated in 
the text of the book. This book is bound in a lighter shade of blue than 
the old issue, so that they can easily be distinguished when standing 
side by side upon a bookshelf. 
The sheep-bound copies have a red label on the outside to distinguish 
them from the old issue, which bore a dark blue label. 
Having endeavored to give a brief review of the work of the present 
Committee of Revision it may now be proper to offer a few comments 
upon the future, from the Chairman’s point of view, in no spirit of dic- 
tation and certainly without the slightest desire to be officious. The 
succeeding Committee who will have the Ninth Revision to prepare 
will be confronted with many grave responsibilities. 
Pharmacopoeial revision differs, in many respects, from other kinds 
of bookmaking. It is cooperative work, one member may be positive 
and dogmatic in the extreme, so that he cannot conceive of a possible 
objection to his view, but when twenty-five other minds, filled with an 
equal sense of responsibility, fail to accept such a view there is nothing 
left for him to do, but surrender. This is often a hard trial, but the very 
nature of the work demands a cheerful compliance with the law of the 
majority. No single member of the Committee obtained everything 
that he wanted or voted for and everyone can point to this test, that 
process or the other standard, and may say to himself, “I personally 
disapproved of that, nevertheless I was outvoted and probably was 
wrong.” 
No greater tribute can be paid to the present Committee of Revision 
than this that, after a fair presentation, the will of the majority pre- 
vailed. While, at times, in the heat of argument, words were written 
which are now regretted by the writer, time has mellowed personal feel- 
ing and this has passed out of memory, for, while the book has been sub- 
jected to the most severe criticism that a Pharmacopoeia ever received, 
it has stood the strain. The favorable comments have far exceeded in 
importance and value the defects which are inherent in all human 
endeavor. The very object of revision is to revise, if there were no need 
26 of revision then what is the meaning of this Convention of delegates 
selected from the best in the land who have come here from all parts of 
the country to sit in judgment upon, not only the subject matter of the 
present Pharmacopoeia, but to determine, in the light of more knowl- 
edge and vastly better equipment, what shall be done to improve upon 
the past and to determine not only how the next revision is to be accom- 
plished, but to select the men who shall be charged with the graver 
responsibility of furnishing the text for the new book. The next Com- 
mittee should not be bound too strictly in matters of detail by the votes 
of the Convention. This appears to be a startling statement but you 
will doubtless pardon me for a moment for explanation, the will of the 
Convention must always be kept strictly in view and never departed 
from except upon rare occasions when necessity demands a change. 
Knowledge is advancing and conditions which may appear to be settled 
to-day may be overthrown to-morrow. 
The present Committee were confronted with an important decision 
in the case of Diphtheria Antitoxin. At the last Convention a motion 
was made by a physician that the Committee of Revision be instructed 
to introduce the serums into the next Pharmacopoeia. The resolution 
was not adopted, yet, when the value of Diphtheria Antitoxin was after- 
wards demonstrated and the United States Government, through the 
Public Health and Marine-Hospital Service, formulated a standard, the 
situation was entirely changed. A special committee was appointed of 
bacteriological experts who reported that it was in every way desirable 
that the serum product, Diphtheria Antitoxin, should be admitted. 
Probably no one to-day will question the wisdom of such action as it has 
undoubtedly resulted in the saving of many lives. The Committee rose 
to the occasion, although some members objected on the ground of the 
resolution not receiving the necessary number of votes in the previous 
Convention. It being a critical moment, it was believed that the next 
Committee would realise that there was no disposition on the part of 
the Committee to depart from the general principles laid down by the 
Convention but that a resolution presented by a member might be 
adopted, if public exigency demanded it. This, I believe, was the only 
case in which the Committee of Revision took such an important step, 
and should not some way be provided, such as calling for a confirmatory 
vote from the officers of the Contention and Trustees, to sanction such 
an action in the future, for it must be recognized that the general prin- 
ciples voted by the Convention must be carried out by the Committee 
and, except when conditions have arisen which would work injury to the 
community, no deviation should be permitted. 
27 Much has been written about the preponderance of medical influ- 
ence in the Pharmacopoeias of 1820 and 1830 and in some quarters the 
interests of pharmacy, which have grown in later years, has been de- 
plored. These writers almost invariably praise the work of pharmacists 
and unh ersally deplore the lack of interest by physicians in the Phar- 
macopoeia, but is not this due to natural causes beyond the power of 
anyone to control? The Pharmacopoeia contains much which is of prac- 
tically no interest to the practicing physician. It has become a book of 
standards charged with the important mission of providing honest, safe, 
and reliable medicines to be used by the medical profession. No one can 
doubt that, since the Food and Drugs Act has been passed, the purity 
and strength of official products has been vastly improved. Without 
the work of chemists and pharmacists this would not have been possible. 
The physicians of this country have an important interest in their Phar- 
macopoeia and while many have neglected it in the past, there is reason 
to believe that a large number are coming back to the use of official 
preparations. They have found that just as good, and in many cases 
better, results can be had by prescribing the preparations whose com- 
position is known and whose effects have been carefully studied; no 
intelligent physician desires to be prevented, in the treatment of cer- 
tain cases, from prescribing anything which he believes will help his 
patient. There is much hope for the future on account of the propa- 
ganda, for the return to use of official medicines is extending and due 
appreciation should be given to those pharmaceutical organizations who 
have worked sedulously and with much expenditure of time and money 
to bring about this worthy consummation. 
Liberal quotations from the Pharmacopoeias of 1820 and 1830 have 
been made to show what the savants of seventy and eighty years ago 
believed to be essential for their time and generation, while according 
our just meed of praise to these men, should we not remember that we 
to-day have vastly greater problems and responsibilities than they had? 
The materia medica of their time was lilliputian compared with the 
vast number of medicines employed at the present time, pharmacy was 
then in its infancy in this country, but one college of pharmacy in the 
United States then eked out a bare existence, and the chemistry and 
pharmacy of to-day show tremendous advances and it was no wonder 
that in 1840 physicians, composing the Pharmacopoeia Committee dis- 
carded, almost entirely, their work and accepted a Pharmacopoeia pre- 
pared by pharmacists. Far be it from this writer to discredit the work 
of those medical practitioners who, while vastly in the minority, have 
earnestly striven to maintain the interest of their brothers in the pro- 
28 fession against great odds, but the logic of events and conditions, far 
over-shadowing those that existed in 1820, have operated to make the 
Pharmacopoeia a work of casual interest to the great majority of Amer- 
ican physicians. That this condition may be changed is the confident 
hope of all who sincerely have pharmacopceial interests at heart. 
In making this report I wish to bear testimony to the unflagging inter- 
est and labors of the medical members of the Eighth Revision of the U. 
S. P. It is true that they repeatedly declined to vote upon such ques- 
tions as the choice of indicators, the assay processes, the test for chem- 
ical substances, and other questions out of their province. Other 
branches of the work, which they were more than competent to vote 
upon received their earnest consideration. 
The Pharmacopoeia is a composite work and one of the defects in the 
l$st revision was the fact that the whole committee were expected to 
vote upon questions of detail, the vote of each member having the same 
value. This should be changed, and, upon special subjects the Sub- 
Committee having these in charge, should have much greater weight 
in the final decision than heretofore. This can be done by referring, for 
example, assay subjects, which have been before the General Committee, 
back to the Sub-Committee if necessary, and each member of that Com- 
mittee might have two votes on the final decision, the same rule to apply 
to all sub-committees. 
Another way of meeting this difficulty would be to allow any mem- 
ber of the General Committee, not especially posted upon matters of 
detail, to transfer his right to vote to a member of the sub-committee 
in whom he has confidence. This vital defect in pharmacopoeial revi- 
sion might then be overcome. The best way of all is doubtless the one 
which will be duly presented by the Board of Trustees and Committee 
of Revision 
It may be said, that the next Committee of Revision will receive most 
substantial aid from importers, manufacturers and others engaged on a 
large scale in furnishing drugs for the sick. They have accumulated 
through reports and systematic analyses of vast quantities of drugs 
entering our ports, information which was difficult to obtain before 
June 30, 1906. Before this time the Committee were compelled to rely 
upon a few public spirited firms and corporations who freely gave sta- 
tistics and records of experiments upon large quantities of drugs, etc., 
but the majority not feeling the necessity of taking any trouble in the 
matter, withheld their support. Now, all is changed, the next Commit- 
tee will be embarrassed with riches and the difficulty will be to make a 
selection and arrive at a decision. 
29 The fear that has been expressed that some self-seeking manufac- 
turer will try to impose upon the Committee, by aiming to have some 
test or some special product recognized which would exclusively inure 
to his benefit, need not, in the writer’s opinion, cause much concern, 
for, if publicity is given to changes in tests or new tests, competing manu- 
facturers or importers will be very quick to expose the self-seeker. 
There can be no question that the Convention of 1900 acted most 
wisely in divorcing the business interests from those which were strictly 
concerned in the actual work of revising the book, and, undoubtedly, 
a report from the Board of Trustees will be presented at this time. It 
would be an act of supererogation on the part of the writer to comment 
upon this report but from the standpoint of the Committee of Revi- 
sion should there not be, in view of the greatly increased responsibility 
of the members of the Committee of Revision hereafter and the neces- 
sity for giving the work of revision more active attention, a larger hon- 
orarium to the individual members than was possible in the 8th Revi- 
sion? There were some members of this Committee who gave an im- 
mense amount of their time to the work and who could illy afford to 
make this sacrifice. The Board of Trustees could not appropriate an 
adequate honorarium for they could not foresee that the future demands 
of the book would be large, nor exactly what the sales and profits would 
be, and they had also to realize that the new committee would need 
some capital to start the work on the 9th Revision. For these reasons, 
is it not the duty of this Convention or of the Board of Trustees to pro- 
vide a plan for financing the work of the next Revision? If it is deter- 
mined by this Convention that a member of the new Committee of Revi- 
sion must give his whole time or, if a few members, having to bear the 
greatest burdens of the work, should be asked to give their whole time, 
then special provision for the creation of a fund should be made for this 
purpose. 
The publication of the translation into Spanish of the United States 
Pharmacopoeia for the especial benefit of those using this language, par- 
ticularly those who are wards of our Nation, was one of the achieve- 
ments of the Board of Trustees and Committee of Revision. This 
action of extending the influence of North America in South American 
countries, Porto Rico and the Phillipines has proved successful, and to 
Professor Jos6 Guillermo Diaz of the University of Havana must be 
given credit for the able manner in which he has performed this task. 
The present Committee of Revision are expected, by resolution of 
the last Convention, to propose a plan for revising the next Pharmaco- 
poeia, and, following the example of the former Convention I have 
30 requested the present Committee to frame what has come to be known 
as “General Principles/’ These will be presented in a separate report 
and are, of course, subject to revision and addition by this Convention, 
the whole object being to assist in the future work of revision, this affords 
for this Convention only a nucleus. This is essentially proper for it 
must be remembered that this is a chartered body and the work of the 
Convention is continuous. Undoubtedly, this Convention, through our 
acting president, will fix a time for the discussion of these general prin- 
ciples. 
While the present United States Pharmacopoeia has been under- 
going, in “esse” and in “posse,” a thorough and critical scrutiny and 
its merits and defects publicly commented upon, I am persuaded that 
this Convention fully realizes that American Medicine and American 
Pharmacy can no longer afford to ignore the opinions of those who have 
not enjoyed the privilege of living in this Republic but who have honestly 
recorded their convictions. It is satisfying to know that the verdict has 
been favorable on the whole and one competent critic, Schelentz, has 
declared that, “the United States Pharmacopoeia is the aristocrat of 
all the pharmacopoeias of the world.” 
Our country is awakening to the fact that whether we want to live 
to ourselves or not, we are now an integral part of the Congress of 
Nations. While we may differ among ourselves about minor questions, 
as is always the case in families, let us approach the subject of revising 
the next Pharmacopoeia with a full realization of our responsibilities, 
and, recognizing that the health and well being of the American Nation 
in some measure, at least, rests with us, let us with high resolve indi- 
vidually and collectively decide that the needs of our own country in 
our Pharmacopoeia must be preeminently first. 
If we fail in this revision to reach the mark, so plainly set before us, 
then other hands more capable than ours must take up the work and the 
sceptre must pass from us forever. Public applause and the favorable 
comments of foreigners, however flattering, to the contrary, notwith- 
standing, we should have practical, comprehensive work, tenaciously 
holding on to the tried and true, but quick to admit the new, when of 
proved efficiency—let the next Pharmacopoeia represent the best efforts 
of a Committee of men, selected by this National Convention, of proved 
ability, unswerving integrity, moved by one thought, “the best and 
always the best.” And, casting aside every idea of personal preferment, 
class potentiality or selfish interest, make the Ninth Revision a book 
which will take its place as the “peer of them all.” 
31 A supplementary recommendation from the Board of Trustees, 
was presented by the Assistant-Secretary, M. G. Motter, and, on 
motion of O. T. Osborne, the representatives of the University 
of Havana were admitted to the courtesies of the floor. This 
courtesy was acknowledged, on behalf of the University of 
Havana, by Jos6 P. Alacan. 
After some discussion as to the time of meeting, the Convention 
took a recess until 3 o’clock P. M. of the same day. 
AFTER RECESS, TUESDAY, MAY 10, 1910. 
At the expiration of the noon-day recess, the Convention re- 
sumed its session. 
The proposed amendments to Articles II, Section 1 of the Con- 
stitution were read by the Assistant-Secretary, who called atten- 
tion to the requirements of the Constitution as to amendments 
and to the action of the Board of Trustees in compliance with 
these requirements. The several items were voted upon seriatim 
and representation in the Pharmacopceial Convention was ac- 
corded the following: the U. S. Department of Agriculture, the 
II. S. Department of Commerce and Labor, the Association of 
Official Agricultural Chemists, the Association of State and 
National Food and Dairy Departments, the National Whole- 
sale Druggists Association, and the National Dental Association. 
A proposed amendment to admit to representation the National 
Association of Retail Druggists was ruled out of order by the 
Chair on the ground that this proposition was in no sense an 
amendment to the proposition submitted by the Board of Trustees, 
was not germane thereto, and introduced a new proposition which 
could not come before the Convention, inasmuch as it had not 
received the favorable vote of five members of the Board of Trus- 
tees and had not been published in the medical and pharmaceuti- 
cal press three months before the decennial Convention, as required 
by the Constitution. An appeal was taken from the decision of the 
Chair, by W. C. Anderson, the original mover of the proposition, 
which, on motion of J. N. McCormack, was laid upon the table. 
The proposed amendments to reduce the representation of each 
32 organization and institution from three delegates to one delegate 
was, after considerable discussion, defeated; a motion to lay it on 
the table being defeated by a vote of 108 to 137. 
The amendment to Article IV of the Constitution, changing 
the title of the Committee of Revision to General Committee of 
Revision, was, on motion of Thomas F. Main, unanimously 
adopted. 
On motion of the Secretary, the Constitution, as amended, was 
adopted. 
(For full text of the Constitution, as amended, see pages 
92-94.) 
The Secretary of the Committee on Credentials and Arrange- 
ments presented the notification of the appointment of delegates 
from the U. S. Department of Agriculture, the Association of 
Official Agricultural Chemists, the National Wholesale Druggists 
Association, and the National Dental Association, and, on motion, 
the Committee on Registration was instructed to register these 
delegates. 
The Report of the Committee on the President’s Address was 
then called for, because of its bearing on the proposed amend- 
ments to the By-Laws and was as follows: 
REPORT OF COMMITTEE ON THE PRESIDENT’S ADDRESS. 
To the U. S. Pharmacopoeial Convention: 
The Committee appointed to consider the President’s address and 
report upon the suggestions contained therein hereby express their 
approval of the suggestion of the President that the University of Havana 
be given the right to send delegates to succeeding Conventions. 
We agree with the President that it is usually best to let well enough 
alone, but with reference to the question of the enlargement of the Com- 
mittee of Revision, we realize that in consideration of the rapid devel- 
opment of medicine and pharmacy and the largely increased scope and 
importance of the work, the time has come when the interests of all are 
best conserved by the enlargement of the Committee. 
We fully concur in the opinion expressed by the President that a 
large share of the credit for the success which has characterized the 
efforts of the retiring Revision Committee is due to the Chairman of 
the Committee of Revision. 
33 The diverse interests which necessarily are represented in a country 
as large as ours demand that the principle of geographical distribution 
of the General Committee of Revision should receive due consideration, 
but that in the selection of the Executive Committee of Revision prac- 
tical fitness for the work should be the prime requisite. 
In closing we believe it is fitting that this Convention enact an appro- 
priate testimonial of its appreciation of its President’s faithful and con- 
scientious discharge of his duties and the influence of his ennobling work 
of a life consecrated to scientific progress and the uplift of humanity. 
(Signed) 
Chas. H. LaWa^l, 
E. G. Eberle, 
W. B. Day, 
Theo. D. Wetterstroem, 
J. M. Good. 
On motion of M. I. Wilbert this report was accepted and the 
item referring to the admission of the University of Havana, 
which involved a further change in the Constitution, was referred 
to the Board of Trustees. 
On motion of E. H. Bartley, the Chairman was authorized to 
appoint a special committee to draft a proper resolution, to be 
forwarded to the President of the Convention, H. C. Wood, 
Sr. On motion of L. W. Andrews the report of the Committee, 
with the exception of the clause referring to the University of 
Havana was unanimously adopted. 
The same Committee reported as follows on the report of the 
Acting-Chairman of the Board of Trustees: 
REPORT OF THE COMMITTEE ON THE REPORT OF THE 
BOARD OF TRUSTEES. 
To the U. S. Pharmacopceial Convention: 
We, the Committee appointed to consider the recommendation sub- 
mitted by the Board of Trustees of the Pharmacopceial Convention, 
do hereby report that we favor the adoption of the recommendation 
as to the enlargement of the Revision Committee to a General Com- 
mittee of fifty, who shall select from their membership a suitable num- 
ber who shall constitute the Executive Committee of Revision. 
34 We also approve of the simplified plan of accounts which has been thus 
far used by the Board of Trustees in regard to expenditures and receipts. 
We give our hearty endorsement to the expression of thanks for the 
aid rendered by the Public Health and Marine-Hospital Service to the 
Board of Trustees, and believe that this recognition should take the 
tangible form of a letter from the Secretary of the Convention to the 
Surgeon-General of this Department. 
We desire in closing to express our appreciation of the unselfish and 
self-sacrificing manner in which the members of the Board of Trustees 
individually pledged themselves to the financial support of the revision. 
(Signed) 
Chas. H. LaWall, 
E. G Eberle, 
W. B. Day, 
Theo. D. Wetterstroem, 
J. M. Good. 
On motion of I. Y. S. Stanislaus, this report, with the excep- 
tion of the first paragraph, referring to the proposed changes in 
the By-Laws, was unanimously adopted. 
A motion, by H. P. Hynson, that a committee of three be ap- 
pointed to consider ways and means of providing sufficient funds for 
the work of revision, was amended by H. H. Rusby and the whole 
question referred to the Board of Trustees. (See page 60). 
The proposed amendments to the By-Laws were then read by 
the Assistant-Secretary and considered seriatim. 
The amendment to Article I, Chapter V, of the By-Laws, chang- 
ing the title of the Committee of Revision to General Committee 
of Revision and increasing the membership from twenty-five to 
fifty, was unanimously adopted. 
Article II, Section 1, providing for the organization of the 
General Committee of Revision, was adopted as read. For Sec- 
tions 2, 3, and 4 of the same Article as submitted, a substitute, 
providing for the election of fifteen members of the General Com- 
mittee of Revision as an Executive Committee to have immediate 
charge of the work of revision, was adopted by a vote of 162 to 20. 
Section 5, as submitted, was made Section 3 and after the elimi- 
nation of the reference to the preceding Section, was adopted, 
as amended, Section 6, as submitted, was stricken out. 
35 Article III providing that the Executive Committee of Revision 
shall be guided by the instructions of the “Convention, the Gen- 
eral Committeeof Revision or the Board of Trustees,” was adopted 
as read. 
Article IV, as submitted, was amended by the provision that a 
vacancy in the office of Chairman shall be filled by the votes of 
the General Committee of Revision and was adopted as amended. 
Article V, as submitted, was amended by striking out the word 
“nominal” referring to the compensation of members of the Exec- 
utive Committee of Revision and was adopted as amended. 
Article VI, Sections 1 and 12, was adopted, as submitted. 
Article VII, as amended by the provision that members of the 
Executive Committee of Revision shall hold office subject to action 
by the General Committee of Revision, was adopted as amended. 
Article II, Chapter VI, was adopted, as submitted. 
Article II, Chapter VII was adopted as submitted. 
Section 3, Article III, Chapter IX was adopted as submitted. 
Section 5, Article III, Chapter IX was amended by the provision 
for discussion on General Principles to govern the action of the 
General and Executive Committee of Revision. 
On motion of J. H. Beal, the adoption of the revised By-Laws, 
as a whole, was postponed until the next session of the Convention. 
(For the full text of the By-Laws, as amended and finally 
adopted, see pages 94-101.) 
On motion of E. 0. Engstrom, the Nominating Committee was 
instructed to bring in fifty names, instead of twenty-five, for the 
General Committee of Revision. 
On motion of H. A. Hare, as amended by L. H. Taylor, the 
Convention adjourned until Wednesday, May 11th, 1910, at 
9:30 A. M. 
SECOND DAY, WEDNESDAY, MAY 11, 1910. 
The Convention was called to order at 9.45 A.M. by the Chair- 
man, O. A. Wall. 
The minutes of the preceding session were adopted as read, 
carrying therewith, the final adoption of the By-Laws as amended. 
36 The report of the Nominating Committee was then submitted, 
showing 148 members present, with H. A. Hare of Pennsylvania 
as Chairman and H. V. Arny of Ohio as Secretary. 
The Chair called attention to the fact that F. J. Wulling of 
Minnesota, nominated as a member of the General Committee of 
Revision, was not present as a member of the Convention and 
ruled “that any one elected a delegate here who has not come, is 
not a member of this Convention, cannot be elected a member of 
any Committee or as an officer.” On the question raised by A. R. 
L. Dohme that F. J. Wulling might retain membership in the pres- 
ent through membership in the last Convention, the Chair ruled 
“that as soon as the Credentials Committee reported the list 
of members of this Convention, that ends all previous membership. 
The successors to members of the last Convention were duly 
appointed when the report of the Committee on Credentials came 
here and was approved.” 
Thomas F. Main moved to substitute for the name of F. J. 
Wulling of Minnesota that of Albert Plaut of New York. C. E. 
Caspari nominated L. W. Andrews of Iowa. E. H. Long nomi- 
nated Solomon Solis Cohen of Pennsylvania. I. V. S. Stanislaus 
nominated Charles M. Ford of Colorado. J. N. McCormack 
nominated Virgil E. Simpson of Kentucky. Otto Raubenheimer 
nominated H. P. Hynson of Maryland. At this point, on motion 
of L. L. Walton, the report of the Committee on Nominations 
was referred to the Committee on Credentials for report as to 
the eligibility of the nominees therein submitted. 
A motion that the Secretary cast the ballot of the Convention 
for the officers and Board of Trustees as nominated, was lost in 
view of several negative votes, the Chair ruling that such action 
could be had only by unanimous consent. A motion by Thomas 
F. Main to reverse the order of the first two names submitted and 
to nominate N. S. Davis for President and H. W. Wiley for First 
Vice-President was defeated in a similar way, as ruled by the Chair. 
On motion, the Convention then proceeded to ballot for the office 
of President, the Chair announced H. W. Wiley of Washington 
and N. S. Davis of Chicago as the nominees and appointed Charles 
E. Caspari, Torald Sollmann, George F. Payne and Clement B. 
Lowe as tellers, who reported, 155 votes for H. W. Wiley, 61 for 
37 N. S. Davis and the Chair announced the election of H. W. Wiley 
as President of the Convention. A motion that the Secretary cast 
the ballot of the Convention for the other officers and the Board of 
Trustees as named by the Nominating Committee was again 
lost, the Chair announcing that the vote, not being unanimous it 
must be taken by ballot. On motion, the Secretary cast the ballot 
of the Convention successively for each of the remaining officers: 
1st, 2nd, 3rd, 4th, and 5th Vice-Presidents, Secretary, Assistant- 
Secretary and Treasurer. A motion, by J. N. McCormack, to 
reconsider the vote to take up the names of the Board of Trustees 
seriatim was, after discussion, lost, and the Chair ruled that the 
motion to reconsider, having been spoken to, could not be with- 
drawn, as requested by the mover with the consent of his second. 
The Secretary then cast the ballot of the Convention for J.H. 
Beal of Ohio, F. W. Meissner of Indiana, W. J. Schieffelin of 
New York, and George H. Simmons of Illinois, as members of the 
Board of Trustees, the Chairman of the Convention casting its 
ballot for H. M. Whelpley of Missouri and then announcing the 
election of all the members to their respective offices. 
The Committee on Credentials, through its Chairman, O. T. 
Osborne, then reported that all of the nominees for the General 
Committee of Revision were eligible save F. J. Wulling, who 
was not a member of the Convention. 
On motion of A. H. Brundage, the Secretary cast the ballot 
for the remaining 49 names as members of the General Committee 
of Revision. Nominations were then called for, for the remaining 
member of the General Committee of Revision, the Chair an- 
nouncing that five men had already been nominated. H. W. 
Cattell nominated F. F. Russell of the United States Army and, 
on motion of C. E. Caspari, the nominations were closed. In 
the course of the discussion on this motion S. Solis Cohen with- 
drew in favor of Albert Plaut, and H. P. Hynson requested that 
his own name be withdrawn. The Chair then called for the prep- 
aration of the ballots, appointing the same tellers and the Secre- 
tary announced that there were four names to be voted upon, 
Albert Plaut, L. W. Andrews, C. M. Ford, and F. F. Russell. 
On motion of A. FI. Brundage it was ordered that, if on the first 
ballot there be no majority, the name receiving the lowest number 
38 of votes be dropped. Three ballots were taken, resulting in the 
election of Albert Plaut by a vote of 125 to 97 for F. F. Russell, 
the surviving candidate. A motion by H. W. Cattell to make the 
election of Albert Plaut unanimous was lost, three votes being 
cast in the negative. 
(For list of Officers, Board of Trustees, and Committee of 
Revision, see pages 110-111.) 
The Chairman then, with a brief expression of farewell and 
thanks to the Convention for the support given him, installed the 
officers elected, introducing first the members of the General Com- 
mittee of Revision, then the Board of Trustees, and finally, the 
officers in inverse order, relinquishing the gavel to H. W. Wiley 
who addressed the Convention as follows: 
ADDRESS OF THE PRESIDENT. 
H. W. Wiley. 
Dr. Wall, the members of the Board of Trustees and officers of the 
ciation elect, and heirs apparent to the throne, members of this great 
Convention, and ladies and gentlemen: 
I desire to thank you for the great honor you have conferred upon me. 
I thank you from the bottom of my heart, and I promise you to do the 
best I can, first, to learn what the duties of a presiding officer are, and, 
secondly, to discharge them. I have not mastered the Constitution 
and By-Laws of this association, but I imagine that as in most organi- 
sations of this kind, the President is expected to be a figurehead, ana I 
think I can fill that part without much preliminary study. 
There is one thing, however, to which I beg you to permit me to allude, 
and that is to the distinguished man of science, the patriot, the man of 
deeds, whom you honored with this office ten years ago. If it were not 
an honor to preside over this A ssociation, it would be a great honor to 
follow in the steps of my predecessor. 
I am not going to detain you, at the present time, with an inaugural 
address. I am going to leave that for ten years hence, and then make 
the beautiful speech, if I remember it, which the retiring Chairman made 
to you this morning. I want to imitate my illustrious predecessor in 
the happy way in which he has greeted the incoming officers. It is true, 
my memory may be somewhat dimmed before that decennial period 
39 comes along, but there are others in this long list who, I am sure, will 
be here if I should be absent. 
The duties of this office, it seems to me, are mainly to see that other 
people do their duty and do it promptly. 
There is one thing which I would like to promise you, as an execu- 
tive officer, and that is the prompt beginning of the work and the vigor- 
ous prosecution of the work of revision of the pharmacopoeia. If a 
study of the Constitution and By-Laws and the good nature of my col- 
leagues should permit me to have any authority in this case, I promise 
you to wield it in that direction. What is worth doing is worth doing 
well, and worth doing promptly in a matter of this kind. I am not say- 
ing this at all as a reflection upon the pre\ ious officers, because I know 
nothing about what has been done, but I refer to what I hope may be 
accomplished in the future. i 
I would like to call your attention to the very wise remarks which 
the Secretary of Commerce and Labor addressed to you at the opening 
of this Convention. He called your attention to the character of the 
work which he hoped would be done, and I could not say more in regard 
to it than to echo his words. We want to make a book, if we can, that 
is beyond criticism and one which will require no further explanation 
or elucidation in order to make its meaning clear, and to make it what it 
now is, under the law, a guide not only for pharmacists and physicians 
of the country, but for those who are engaged and are to be engaged in 
in the enforcement of the salutary laws which have been enacted by 
Congress and the legislatures of the various States, looking to the con- 
trol of the food and drug commerce of this country. If I have any suc- 
cess in this work, it will be through the earnest and enthusiastic collab- 
oration of my colleagues on this force, and of the members of this Con- 
vention. 
In the hope and expectation of receiving that enthusiastic support, 
I accept this office at your hands, and promise to do my best to dis- 
charge its duties in the interest of this great Convention. 
H. H. Rusby proposed the following amendment to the By-Laws 
and on motion it was referred to the Board of Trustees. (See 
page 60.) 
Amend the By-Laws . . . Chapter VIII, ‘Of Members/ by mak- 
ing an additional Article IV, to read as follows: 
Article IV. Every incorporated body sending delegates to the Con- 
vention of the corporation shall be assessed $12.00 annually for the 
40 expenses of the corporation, which assessment may be commuted by 
payment of a lump sum of $100.00 at the beginning of each decennial 
period. 
Each body so paying shall receive ten copies of the Pharmacopoeia 
when published. 
(Signed) 
H. H. Rusby, 
S. Solis Cohen, 
David M. R. Culbreth, 
Henry P. Hynson. 
Also to change the title of the Chapter by adding the words “and 
assessments.” 
The Secretary presented a letter expressing the regrets of the 
President of the United States that his engagements made it 
impossible for him to be present at the opening of the Convention. 
A communication from the Philadelphia Branch of the American 
Pharmaceutical Association enclosing a paper on “Patent and 
Trade Marks” by F. E. Stewart was, on motion of J. M. Good, 
referred to the General Committee of Revision. 
On motion of Thomas F. Main, the following communication 
from the Medical Society of New Jersey, with reference to the 
ethical relations of physicians and pharmacists, was presented by 
A. H. Marcy and, on motion of M. I. Wilbert, was referred to the 
Board of Trustees with the recommendation that it be considered 
and if possible, submitted for adoption at a subsequent session. 
(See page 62). 
STATEMENT 
Introduced by the delegation from The Medical Society of New Jer- 
sey, which gave the President to the Convention of 1830 for the first 
decennial revision of the United States Pharmacopoeia: Henry L. 
Coit, M.D., Alexander Marcy, Jr., M.D., Philip Marvel, M.D. 
The United States Pharmacopoeial Convention is the most repre- 
sentative body of men from the professions of scientific medicine and 
scientific pharmacy. It is incorporated and has at least the moral and 
logical right to legislate upon questions growing out of the chief rela- 
tion existing between them, namely, the necessity for the use of medic- 
41 inal agents which are scientifically evolved from nature and the labo- 
ratory by the pharmacist and are rationally employed in medical prac- 
tice by the physician in the treatment of disease. 
Moreover, the people in whose interest this beneficient relation exists 
are dependent upon both these professional classes, not only for hon- 
esty, accuracy and precision in the preparation and use of medicinal 
substances, but for the maintenance of high ideals of conduct between 
them and of both toward the public. 
The delegation from the oldest State Medical Society in the United 
States is prepared to submit a code of tentative rules with the hope that 
it may receive the endorsement of this convention and its adoption as 
an expression of ethical principle for the guidance of the parties con- 
cerned. 
ETHICAL RULES FOR THE GUIDANCE OF PHYSICIANS AND PHARMACISTS 
IN THEIR RELATIONS WITH EACH OTHER AND WITH THE PUBLIC. 
Propositions. 
First: Ethical principles or standards of right conduct exist irrespec- 
tive of their formulation or codification. 
Second: Ethical rules are calculated to elevate standards of moral 
conduct and to foster a spirit of harmony between professional men. 
Third: A code of ethics is designed not only for the restraint of those 
who are actuated by unworthy motives, but for the guidance of those, 
also, who seek to be governed in their actions by high and true prin- 
ciples. 
The Duties of the Physician to the Pharmacist. 
First: The physician has no moral right to discriminate in favor of 
one pharmacist to the detriment of another, except for dishonesty, 
incompetency or unscientific methods of work. 
Second: The physician is never justified in receiving from a pharma- 
cist gratuities in return for patronage; in depositing secret formulas 
with an individual pharmacist, or by word or deed to jeopardize his 
professional reputation. 
Third: The physician may sometimes find it an advantage to the 
patient to dispense the medicine; yet in the main it must be regarded 
as a subterfuge and a hindrance to all interests involved. The phy- 
sician should, if practicable avail himself of the superior technical skill 
of a trained pharmacist in the preparation and dispensing of medicines. 
42 The Duties of the Pharmacist to the Physician. 
Fourth: The pharmacist who recommends drugs or medicines for 
specific remedial purposes either directly or through the avenues of 
advertisement thereby exceeds the limits of his profession and commits 
an act unworthy of his calling. 
Fifth: The pharmacist who consents to diagnose disease or prescribe 
for patients except where emergencies arise, without a proper medical 
training, assumes responsibilities for which he is not qualified and justly 
incurs the disapproval of physicians. 
Sixth: The pharmacist transgresses his true province when for com- 
mercial purposes he issues to physicians printed matter setting forth 
the therapeutic indications for the use of drugs or medicinal prepara- 
tions. The constituents of a drug or compound together with its chem- 
ical and physical properties should be a sufficient guarantee of its utility. 
The Duties of the Physician and the Pharmacist to the Public. 
Seventh: The combined efforts of the physician and the pharmacist 
are required to protect the public from the nostrum maker, the pseudo- 
scientific pharmacist, the sectarian physician and drug vendor, and the 
two should be in continual alliance to demand the extermination of 
these commercial and mercenary institutions. 
Eighth: The physician and the pharmacist should, as far as possible, 
limit the multiplication of manufactured proprietary compounds. It 
must be regarded as reprehensible to encourage the use of these reme- 
dies to the exclusion of those which are official in the pharmacopoeias. 
It is also their plain duty to discourage the use and sale of all medicines 
which lead to baneful drug habits. 
Ninth: The best interests of the patient are undoubtedly conserved 
by the custom of physicians to practice rational therapeutics to the 
exclusion of those methods which tend to the use of many remedies or 
those of unknown composition; and the supreme effort of the dispens- 
ing pharmacist should be to complete the circle of therapeutics by sup- 
plying the demands of experimental and clinical teaching with eligible 
and trustworthy preparations. 
On motion of H. H. Rusby, as amended by J. P. Remington and 
O. A. Wall, the Convention took a recess until 3 o’clock when the 
special order of business would be the report of the Committee on 
the Report of the Chairman of the Revision Committee. 
43 AFTER RECESS, MAY 11, 1910 
The Convention was called to order by the 1st Vice-President, 
N. S. Davis, who appointed Henry Kraemer as temporary Secre- 
tary in the absence of the Secretary. 
The Committee on the Report of the Chairman of the Revision 
Committee reported as follows: 
Mr. Chairman and Gentlemen: 
Inasmuch as several of the items which were recommended in the 
address of the Chairman of the Revision Committee have already been 
passed upon, and some have been established, they may be superflu- 
ous, yet the Committee met before some of these changes were made, 
and these have been incorporated in the report. 
The Committee on Chairman’s Report begs to draw your attention 
to the following recommendations of the Chairman, which in our opin- 
ion are of importance to the success of the future editions of the Phar- 
macopoeia of the United States. 
First the Committee concurs with the opinion of the Chairman to the 
effect that the Committee of Revision should not be bound too strictly 
in matters of detail by the votes of the Convention, since, the rapid 
advances made ip our knowledge of pharmacology and the constantly 
changing conditions frequently cause the overthrowing of the supposed 
facts of today by the light of truth of tomorrow. 
Second. That the Committee of Revision in the matter of admitting 
the various therapeutic sera into the pharmacopoeia exercise the same 
alertness to the needs of today as did the last Committee of Revision. 
Third. Since the former Committees of Revision suffered not a little 
for the lack of necessary funds to carry on their work successfully it is 
the sense of your Committee that the ways-and-means committee should 
be charged to raise more money to pay larger honoraria to those members 
of the Revision Committee who by their arduous work as specialists 
especially merit such remuneration. 
Fourth. It is the opinion of your Committee that the translation of 
the Pharmacopoeia of the United States into Spanish was a most timely 
and happy event and that the future committee should endeavour to 
do all in their power to popularize this and future Spanish editions among 
the Spanish-American nations. 
Lastly, the Committee’s belief is that the enlarged Committee of Re- 
vision can and will make our Pharmacopoeia the true aristocrat among 
44 pharmacopoeias, superior to them all, the best in the world, which it will, 
as it should be. 
(Signed) 
O. T. Osborne, 
Rob’t A. Hatcher, 
Julius Sturmer, 
Henry Beates, Jr. 
I. V. Stanley Stanislaus, 
Chairman. 
This report, on motion of Leo Eliel, was unanimously adopted. 
Under the head of discussion on General Principles to govern 
the action of the General Committee of Revision, the following 
items were presented by the Chairman of the Revision Committee 
and voted upon seriatim. 
Item 1. Scope of the Pharmacopoeia, gave rise to a lengthy 
discussion which at first turned upon the question as to whether 
established “values and use,” or “values or use,” should deter- 
mine the inclusion of any given substance. Finally, by a vote of 
95 to 47, the Convention decided that “there should not be in- 
cluded rarely used substances or those whose value and use have 
not been established.” 
On motion of Wm. J. Schieffelin, the word “solely” in the phrase 
“are intended to apply to substances which are used solely for 
medicinal purposes” was stricken out, and on motion of S. Solis 
Cohen, it was inserted after the word “intended” by a vote of 65 
to 38, making the phrase read “intended solely to apply to sub- 
stances which are used for medicinal purposes.” 
On motion of S. Solis Cohen, the words, and when professedly 
bought, sold, or dispensed as such” were stricken out and the 
words “or in determining the identity and purity of the same” 
were substituted therefor. 
On motion of S. Solis Cohen, the words “there should not be 
included rarely used substances or those whose value and use has 
not been established” were stricken out by a vote of 123 to 40. 
On motion of J. P. Remington, the paragraph on the Scope of 
the Pharmacopoeia was adopted as amended. 
Item 2. Doses. After considerable discussion, in the course of 
which amotion to introduce for potent drugs a maximum, single 
45 and daily dose was defeated by a vote of 49 to 101, the previous 
question was called for, an amendment to strike out the words 
“or as forbidding him to exceed them whenever in his judgment 
this seems advisable” being lost, and the paragraph was adopted 
as originally submitted. 
Item 3. Nomenclature. The paragraph was amended, on 
motion of Torald Sollmann, by adding to the first sentence the 
words “and to eliminate therapeutically suggestive titles,” and, 
on motion of Charles E. Caspari, by substituting the article 
“the” for “a” with reference to the scientific name to be given as 
a synonym, the item was adopted as amended. 
Item 4. Synonyms. On motion of G. M. Beringer, this para- 
graph was amended so as to read “ that substances labeled with an 
official synonym, etc.,” and was adopted as amended. 
Item 5. Purity and Strength of Pharmacopoeial Articles, was, 
on motion of J. W. England adopted as submitted. 
Item 6. International Standards, was adopted after the correc- 
tion of the grammatical error in the first sentence of the second 
paragraph by striking out the words “to them.” 
Item 7. General Formulae, was on motion of H. H. Rusby, 
adopted as submitted. 
Item 8. Appending a List of Preparations in which an Official 
Article is Used, was adopted as submitted. 
Item 9. Alcoholic Percentage in Official Preparations, was 
adopted as submitted. 
Item 10. Assay Processes, was amended by substituting, in 
the last sentence the word “biological” for the word “physio- 
logical” referring to tests or assays and was, on motion of S. Solis 
Cohen, adopted as amended. 
Item 11. Serums and other Biological Products, was adopted 
as submitted. 
Item 12. Weights and Measures, was adopted as submitted. 
Item 13. Supplement, was adopted as submitted. 
On motion of William Jay Schieffelin, a new item was adopted 
as follows: 
Item 14. Publicity, It is recommended that the General Commit- 
tee of Revision make public, for comment and criticism, an 
abstract of new descriptions and standards and of changes in 
descriptions and standards proposed, before final adoption. 
46 By consent the numbers of the following items were correspond- 
ingly changed. 
Item 15. Atomic Weights, Item 16. Physical Constants, Item 
17. Standard Temperature, were referred to the Committee of 
Revision with power. 
Item 18. Compound Preparations, was amended so as to read, 
“It is recommended that the introduction of new compound 
preparations be discouraged as far as possible,” and was adopted 
as amended. An amendment by S. Solis Cohen, to substitute the 
word “composite” for “compound” was lost. 
Item 19. Pharmacognostical Descriptions, was amended by 
changing the word “possible” to “practicable,” and adopted as 
amended. 
Item 20. Powdered Drugs, Item 21. Diagnostical Reagents, 
Item 22. Date when the next Pharmacopoeia becomes Official, were 
adopted as submitted. 
Item 23. Precedents, was amended so as to read, “should 
generally be followed”, and adopted as amended. 
Item 24. Solubilities, “It is recommended that the degree of 
solubility of drugs in various solvents be given as extensively as 
possible” was submitted by Bernard Fantus and, on motion of 
L. H. Taylor, was referred to the Committee of Revision with 
power. 
The General Principles as finally adopted are as follows: 
GENERAL PRINCIPLES TO BE FOLLOWED IN REVISING 
THE PHARMACOPOEIA. 
1. SCOPE OF THE PHARMACOPOEIA. 
We recommend that the Committee of Revision be authorized to ad- 
mit into the Pharmacopoeia any medicinal substance of known origin, 
but no substance or combination of substances shall be introduced if the 
composition or mode of manufacture thereof be kept secret, or if it be 
controlled by unlimited proprietary or patent rights and the list of sub- 
stances should be carefully selected, with standards for identity and 
purity, as far as possible. Substances used only for technical purposes 
should not be admitted to the next Pharmacopoeia, and a statement 
47 should be placed in the preface to the effect that standards of purity 
and strength, prescribed in the text of the Pharmacopoeia, are intended 
solely to apply to substances which are used for medicinal purposes or 
in determining the identity and purity of the same. 
2. DOSES. 
We recommend that after each pharmacopoeial article (drug, chemical, 
or preparation) which is used or likely to be used internally or hypoder- 
mically, the committee be instructed to state the average approximate 
(but neither a minimum nor a maximum) dose for adults, and, where 
deemed advisable, also for children. The metric system to be used, and 
the approximate equivalent in ordinary weights or measures inserted in 
parenthesis. It is to be distinctly understood that neither this Conven- 
tion nor the Committee of Revision created by it intends to have these 
doses regarded as obligatory on the physician or as forbidding him to 
exceed them whenever in his judgment this seems advisable, the Com- 
mittee should be directed to make a distinct declaration to this effect 
in some prominent place in the new Pharmacopoeia. 
3. Nomenclature. 
We recommend that changes in the titles of articles at present official 
be made only for the purpose of insuring greater accuracy, brevity, or 
safety in dispensing, and to eliminate therapeutically suggestive titles. 
In the case of newly admitted articles, it is recommended that such 
titles be chosen as are in harmony with general usage and convenient 
for prescribing / but in the case of chemicals of a definite composition 
the scientific name should be given at least as a synonym. 
There should also be inserted, after each article used by physicians 
in prescriptions, a carefully considered abbreviated name, which may 
be known as an official abbreviation, in order that uniformity may be 
established throughout the Country, with the object of preventing mis- 
takes in reading and compounding prescriptions, and further, to serve 
as authorized abbreviations in labeling the store furniture of the pharm- 
acist. 
4. SYNONYMS. 
We recommend that the list of synonyms should be enlarged for the 
next revision, and the synonyms printed in the text of the Pharmacopoeia, 
immediately after the English name of the substance. A statement should 
48 be made in the preface of the Pharmacopoeia, that substances labeled 
with an official synonym, must comply with the same standards, tests and 
requirements as are demanded for the official article under any name. 
5. PURITY AND STRENGTH OF PHARMACOPCEIAL ARTICLES. 
We recommend that the Committee be instructed to revise as care- 
fully as possible the limits of purity and strength of the pharmacopceial 
chemicals and preparations for which limiting tests are or may be given. 
While no concession should be made towards a diminution of medicinal 
value, allowance should be made for unavoidable, innocuous impurities 
or variations due to the particular source or mode of preparation, or to 
the keeping qualities of the several articles. 
The “Purity Rubric,” which limits the percentage of innocuous im- 
purities, as introduced into the Eighth Revision, should be continued, 
and tests and requirements should be appended to each article carrying 
a “Purity Rubric.” 
In the case of crude drugs and natural products, the limits of admis- 
sible impurities should be placed at such a figure as to exclude any that 
would not be accepted by other countries. 
6. INTERNATIONAL STANDARDS. 
\ 
The International Conference for the Unification of Formulas for 
Potent Remedies performed a signal service for all countries by recom- 
mending the various pharmacopoeias of the world to adopt certain stand- 
ards for potent medicines. It is recommended that the next Commit- 
tee of Revision adopt these standards, but it is believed that it would 
be unwise to require the acceptance of the details of pharmaceutical 
or other processes recommended by the International Conference. 
If the finished product conforms to the International standards we 
believe that each Country should be left free to adopt such detail and 
manipulation as may seem best. Nothing should prevent, however, 
the adoption of the recommendations of the conference, as to details, if 
in the opinion of the next Committee of Revision, by so doing, the Phar- 
macopoeia can be improved. 
7. GENERAL FORMULAS. 
It is recommended that general formulae be introduced, as far as the 
particular nature of the several drugs will permit, for fluid extracts, 
49 tinctures and such other preparations as are made by identical processes, 
and that the general formula to be followed in each case be merely indi- 
cated by reference. 
8. APPENDING A LIST OF PREPARATIONS IN WHICH AN OFFICIAL ARTICLE 
IS USED. 
It is recommended that, especially for the convenience of practicing 
physicians, there should be appended after each article in the text a list 
of the official preparations in which it is used. 
A few exceptions may be made to this in such cases as water, alcohol, 
glycerin, sugar, etc. 
9. ALCOHOLIC PERCENTAGE IN OFFICIAL PREPARATIONS. 
It is recommended that a range of volume content, of absolute alco- 
hol, be stated in the Pharmacopoeia, for each preparation containing 
alcohol. 
10. ASSAY PROCESSES. 
We recommend that the Committee be instructed to introduce assay 
processes for as many of the potent drugs and preparations made there- 
from as may be found practicable, provided that the processes of assay 
are reasonably simple (both as to methods and apparatus required) and 
lead to fairly uniform results in different hands. As regards the products 
of such assays, tests of identity and purity should be added wherever 
feasible. 
It is recommended that biological tests or assays, when accurate and 
reliable, may be admitted. 
11. SERUMS AND OTHER BIOLOGICAL PRODUCTS. 
It is recommended that serums and other biological products, of 
approved usefulness, if standardized by the Government or one of the 
departments, may be admitted to the next Revision of the Pharmaco- 
poeia. 
12. WEIGHTS AND MEASURES. 
It is recommended that the Committee be instructed to retain the 
metric system of weights and measures as adopted in the Eighth Decen- 
nial Revision. 
50 13. SUPPLEMENT. 
It is recommended that the Committee of Revision be authorized to 
prepare a supplement to the Pharmacopoeia at any time they may deem 
such action desirable. 
14. PUBLICITY. 
It is recommended that the General Committee of Revision make 
public, for comment and criticism an abstract of new descriptions and 
standards and of changes in descriptions and standards proposed, before 
final adoption. 
15. ATOMIC WEIGHTS. 
It is recommended that the system of atomic weights, authorized 
by the International Committee (0=16), be adopted for the next 
Revision. 
16. PHYSICAL CONSTANTS. 
It is recommended that official methods for taking physical constants 
be inserted in the “Introductory Notices,” and these shall apply to all 
articles in which physical constants are officially used, unless otherwise 
specifically excepted. 
17. STANDARD TEMPERATURE. 
It is recommended that the standard temperature of 25° C. (77° F.) 
be retained, as used in the present Revision (except in the case of alco- 
hol), and that a table be inserted in the appendix for corresponding 
figures at 15° C. (59° F.). 
18. COMPOUND PREPARATIONS. 
It is recommended that the introduction of new compound prepara- 
tions be discouraged as far as possible. 
19. PHARMACOGNOSTICAL DESCRIPTIONS. 
It is recommended that, with the description of a crude drug, there 
be included brief, pharmacognostical descriptions, both macroscopic 
and microscopic where practicable, and there should be added a state- 
ment of the appearance of the structural elements in the powder, when 
examined microscopically, as a means of detecting adulteration. 
51 20. POWDERED DRUGS. 
It is recommended that, in the next Pharmacopoeia, powdered drugs 
be required to represent the entire drug unless specifically stated other- 
wise. Where the drug can be powdered without residue this should be 
required; in other cases the amount of allowable tailings, gruffs, or resi- 
due should be determined and inserted in the text. 
21. DIAGNOSTICAL REAGENTS. 
It is recommended that there be included in the next Pharmacopoeia, 
such reagents, with standards for strength and purity, as are needed for 
the proper execution of tests that are valuable and important in the 
making of a correct diagnosis. 
22. DATE WHEN THE NEXT PHARMACOPOEIA BECOMES OFFICIAL. 
It is recommended that the Committee of Revision print upon the 
title page of the next Pharmacopoeia a definite date, reasonably distant 
from the actual date of publication, announcing when the new Pharma- 
copoeia is intended to go into effect and to supersede the preceding one. 
23. PRECEDENTS. 
In all matters not specially provided for, in these “General Princi- 
ples” the rules established for previous revisions, if there are any, should 
generally be followed. 
24. SOLUBILITIES. 
It is recommended that the degree of solubility of drugs in various 
solvents be given as extensively as possible. 
On motion of H. C. Wood, Jr., the Convention adjourned until 
Thursday, May 12th, 1910, at 9.30 A. M. 
THIRD DAY, THURSDAY, MAY 12TH, 1910. 
The Convention was called to order byfthe President, H. W. 
Wiley at 9.42 A. M. The President called Vice-President Os- 
borne to the Chair to preside during the morning hours. On 
52 motion of Thomas F. Main, the minutes were read as in the pre- 
ceding sessions and approved. 
W. G. Gregory presented the following communication and 
moved the adoption of the resolutions: 
To the United States Pharmacopoeial Convention, Gentlemen: 
At the final session of the American Pharmaceutical Association, Sat- 
urday, May 7, 1910, it was voted that the publications of the Associa- 
tion be edited to conform with rules for form and style to be adopted 
by a committee comprising representatives of the Association and such 
others, State or National, public or private as might cooperate in a move- 
ment to secure greater uniformity. Other associations were to be in- 
vited to nominate representatives to the General Editing Committee, 
and it was specifically provided that the matter be brought to the atten- 
tion of the Pharmacopoeial Convention at the earliest practicable mo- 
ment. In accord with such instructions we take this opportunity of 
presenting the subject and, with a view to expediting action thereon, 
offer these resolutions: 
“1. That this Convention heartily approves the movement and will 
actively cooperate with other associations in an effort to secure greater 
uniformity by the adoption of general editing rules for form and style. 
“2. That the Executive Committee of Revision appoint a representa- 
tive on the General Editing Committee.” 
According to an amendment by George M. Beringer the reso- 
lutions were referred to the General Committee of Revision. 
George M. Beringer moved that any association or delegate 
having any reports or recommendations to present, be now given 
the opportunity to do so, that the Secretary note and receive 
them, and that they be referred to the General Committee of 
Revision. This motion was seconded and, with the explanation 
from the Chair that the Secretary would present, by name, at 
least, the reports which he had on the table and any other reports 
pertinent to the subject, was agreed to. George M. Beringer 
moved that the reports be not printed, but referred to the General 
Committee of Revision. William H. Seaman offered an amend- 
ment which was passed by a vote of 31 to 21, the Chairman stat- 
ing that these communications would be referred to the General 
Committee of Revision with instructions to abstract them for the 
53 Proceedings. The following communications were then announced 
by the Secretary and referred in accordance with the previous 
motion. 
List of reports and recommendations submitted to the United States Phar- 
macopoeial Convention of 1910. Transmitted, by direction of the Con- 
vention, to the Chairman of the Revision Committee. (For Chairman’s 
Abstract, see page 64.) 
1. Report of the New Jersey Pharmaceutical Association to the Con- 
vention for the Revision of the United States Pharmacopoeia, 1910. 
Compiled from the proceedings of recent years by George M. Beringer, 
Herman J. Lohmann, and George H. White. A volume of 189 type- 
written pages x 13, with an index of 11 pages. (See Proc. New Jersey 
Pharm. Ass., 1901-’09). 
2. Report of the Committee on United States Pharmacopoeia of the 
American Pharmaceutical Association, 1909. 
52 typewritten pages, 8| x 11. (See Proc. Am. Pharm. Ass., 1909, 
v. 57.) 
3. Report of the Committee on United States Pharmacopoeia of the 
American Pharmaceutical Association, 1910. 
58 typewritten pages, x 11. (See Proc. Am. Pharm. Ass., 1910, 
v. 58). 
4. Patents and Trade Marks in Their Relation to Pharmacal Science 
and Practice. 
By F. E. Stewart, M.D., 27 pages, carbon copy. 
5. Reports on Revision of the United States Pharmacopoeia. 
1. By the Committee of the American Medical Association. 
2. By the Committee of the Section on Pathology and Physiology. 
3. By the Committee of the Section on Obstetrics and Diseases 
of Women. A reprint of 15 pages. (See J. Am. M. Ass., 1910). 
6. Reports of the Committees of the Sections on Practice of Medi- 
cine, Ophthalmology and Stomatology and Comments thereon. 
A reprint of sixteen pages. (See J. Am. M. Ass., 1909.) 
7. The Coming Revision of the United States Pharmacopoeia. 
By Torald Sollmann. 
A reprint of 11 pages from the Journal of the American Medical Asso- 
ciation. (See J. Am. M. Ass., 1909.) 
8. Report of the Committee of the Section on Dermatology of the 
American Medical Association. 
W. A. Pusey, M. B. Hartzell, George T. Jackson. 
54 Six pages, typewritten, 8? x 13. (See J. Am. M. Ass., 1910). 
9. Report submitted by delegates of the American Chemical Society 
to the Convention for Revising the United States Pharmacopoeia. 
Launcelot Andrews, Edward Hart, George D. Rosengarten, Delegates. 
10. Resolutions of the Iowa Veterinary Association seeking represen- 
tation for the Veterinary Profession in Pharmacopoeial Revision. 
P. Malcolm, J. W. Bunker, C. W. Anderson, Committee. 
11. Recommendations of the Faculty of the School of Pharmacy, 
University of Michigan. 
A. B. Stevens, Secretary. 
12. Criticisms of the Nomenclature of the Balsams, United States 
Pharmacopoeia. 
E. D. Brown, University of Minnesota. 
The English titles to correspond with the Latin, should be Tolu Bal- 
sam, Peru Balsam, etc., instead of Balsam of Tolu. 
13. Resolutions of the City of Washington Branch, American Phar- 
maceutical Association, April 8, 1910. (See Am. Druggist, 1910). 
14. Resolutions of the New York Branch, American Pharmaceutical 
Association. (See Am. Druggist, 1910). 
15. Thirty-two General Principles submitted by the American Phar- 
maceutical Association. (See Proc. Am. Pharm. Ass., 1910, v. 58.) 
16. Recommendations to the United States Pharmacopoeial Conven- 
tion by delegates from the Kings County Pharmaceutical Society. 
Otto Raubenheimer, Chairman. (See Am. Druggist, 1910.) 
17. Report of the Philadelphia College of Pharmacy upon the United 
States Pharmacopoeia, April 27, 1910. 
Joseph P. Clement B. Lowe, Samuel P. Sadtler, Henry 
Kraemer. George M. Beringer, George D. Rosengarten, Frederick W. 
Haussmann, J. W. England, Charles H. LaWall. 
18. Resolutions of the Medical Society of the State of New York. 
Presented through W. A. Bastedo. 
19. Resolutions of the American Therapeutic Society. N. P. Barnes, 
Secretary. 
On motion of F. G. Wheatley the following resolutions were 
referred to the General Committee of Revision with a recommen- 
dation for favorable action: 
1. Resolved, That this Convention favor decreasing the number of 
vegetable preparations whose only valuable constituent is tannic acid. 
55 2. Resolved, That this Convention favor decreasing the number of 
preparations of some of the more important drugs, for example, iron, 
mercury, opium, aloes, rhubarb. 
On motion of William H. Seaman the following was recom- 
mended to the General Committee of Revision for adoption: 
Recommended, That the official medicine dropper have its delivery 
end 3 millimeters in external diameter and adapted to deliver 20 drops 
of distilled water to a gramme at 16 degrees C. 
On motion of Leo Eliel, seconded by George M. Beringer, the 
following resolution was referred to the Board of Trustees with 
a favorable recommendation: 
Resolved, That this Convention recommend to the Board of Trustees 
that the royalty charged to publishers or authors for permission to use 
the text of the U. S. Pharmacopoeia be greatly increased. 
Joseph Kahn, on behalf of the New York State Pharmaceutical 
Association, presented in some detail a series of general principles 
which, on motion, were referred to the General Committee of 
Revision. 
The following recommendation, as a special heading, Pharmaco- 
dynamic Character, under the head of General Principles, was 
offered by H. P. Hynson and, on motion, referred to the General 
Committee of Revision: 
Conferring upon it power to act, this Convention respectfully recom- 
mends to the General Committee of Revision that it consider the advis- 
ability and propriety of including with the descriptions of the several 
articles that are to be recognized in the ninth revision of the Pharma- 
copoeia, their pharmaco-dynamic character under some one of three 
divisions, to wit, (a) Positive, with description; (6) negative, as nil; 
(c) undetermined, or in such manner as the General Committee of 
Revision may deem most helpful to all concerned. 
A report from the Section on Dermatology of the American 
Medical Association was submitted by Reid Hunt and likewise 
referred to the General Committee of Revision. 
The following recommendation coming from the American 
Pharmaceutical Association was presented by A. B. Lyons and, 
56 on motion of W. L. Cliffe and George M. Beringer referred to the 
joint action of the Board of Trustees and the Committee of 
Revision. 
The recommendation is the formation of a committee on drug markets; 
that the Committee of Revision be requested to appoint a special com- 
mittee to make a thorough investigation of the quality of crude drugs 
in commerce, both in this country and abroad, and to cooperate with 
the United States Government departments in such investigations, and 
that this committee be instructed to endeavor to determine the proper 
limits as to variability due to soil and climatic conditions or improper 
handling, and to suggest such improvements as can be introduced in 
selecting and marketing such wares. 
Joseph Kahn called for the financial report of the Secretary of 
the Board of Trustees and the following was presented by Chair- 
man James H. Beal. 
FINANCIAL REPORT OF THE BOARD OF TRUSTEES. 
The chief source of income has, of course, been from the sales of the 
book, amounting in all to $108,088.03. During the period of stress, 
1902-1905, the Board was obliged to borrow, largely on the credit of the 
individual members, $7,000. It is interesting to note that the interest 
on these loans, $690.21, was more than covered by the interest received 
on deposits with the American Security and Trust Company, amount- 
ing to $882.63. From authors of other text books, who desired to use 
the pharmacopceial text in whole or in part, there were received $2,715.- 
99. Several miscellaneous items, a lost check, the return of a balance 
from an appropriation, and an overpayment on a voucher, amount to 
$106.31. The sum total of the income amounts to $124,491.15, of the 
expenditures to $116,097.14, leaving a balance of $8,394.01 to be turned 
over to our successors, as compared with the balance of $5,698.19 
received from our predecessors. 
The general expenses of the Board of Trustees, amounting to $2,- 
688.99, include office expenses of the Secretary, filing cases, typewriter, 
supplies of stationery, postage, and, in the past year or more, the salary 
of a clerk to the Secretary. The traveling expenses of the Board amount 
to $5,166.34 which includes the expense of the joint conference between 
the Board and the Committee of Revision to consider the question, 
57 referred by the Convention of -900, of the use of the pharmacopoeial 
text in other books: this item amounted to $775.31. Under the head 
of Honoraria et Memorabilia, the item of $19,506 includes with the total 
amount paid to the members of the Committee of Revision, the Rice and 
Ebert memorials and the resolutions engrossed with reference to former 
members of the Board; W. S. Thompson, G. W. Sloan, S. A. D. Shep- 
pard and the first Treasurer of the Convention, W. M. Mew. 
The cost of the publication has been divided into three items, separ- 
ating the seventh and eighth revisions and the Spanish translation. 
From May, 1900, to May, 1905, the cost of printing the seventh revision 
amounted to $2,476.48; from the latter date to the present, the manu- 
facturing of the eighth revision has cost $39,985.42, and the Spanish trans- 
lation of this $7,030.82; a second edition of 2,000 copies having recently 
been ordered on the recommendation of the agents. 
Under the head of miscellaneous expenses are included the re- 
payment of our loans and the cost thereof in interest, amounting to 
$7,690.21, and a repayment toBlakiston of $7,508.97, through an error 
in their account of sales—a number of volumes stored during the rush 
period of the first issue of the eighth revision having inadvertently been 
reported as sold. The total expenses thus charged under the account of 
the Board of Trustees amounts to $92,053.23. 
In this connection, I should also state that, in addition to this cash, 
we have additional assets of 2,000 printed copies of the Spanish trans- 
lation, which have been paid for, printed, but not bound; and I believe 
approximately—because I can only state it approximately—about 2,000 
of the regular edition, most of which have been bound in various styles 
of binding. 
I want to explain that our contract with the agents requires them to 
make settlements at specified times, and in those settlements they pay 
for all books on hand in their possession, in a salable condition. During 
the rush period, when Pharmacopoeias were being manufactured and 
sold rapidly, in making their report they omitted an invoice of a certain 
considerable stock of Pharmacopoeias which they had in their store 
rooms. They reported them as sold and remitted for them. Upon 
the discovery of their error, they reported to the Board, and the Board, 
through a member, investigated the facts, and found that they did have 
those books on hand, so that the Board very properly gave them a check 
for the amount of the books which they had paid for but which had not 
been sold. 
The general expenses of the Committee of Revision include the office 
expenses incident to the preparation and sending to the individual mem- 
58 bers of the Committee of the thousands of pages of circular letters. 
This item totals $6,649.88. The item of clerical expenses for the Com- 
mittee amounts to $10,605.85; the payments to experts employed in 
connection with the work of revision amounts to $5,263.25; the cost 
of supplies for analytical and experimental work, $1,524.93—making 
the total expense chargeable to the Committee of Revision $24,043.91. 
SUMMARY 
Expenditures chargeable to Board of Trustees $92,053.23 
Expenditures chargeable to Committee of Revision $24,043.91 
Unexpended Balance $ 8,394.01 
Total Income $124,491.15 
The books and accounts have been audited regularly each year, except 
for the past twelve months and they are now in the hands of the Audit- 
ing Committee. 
Chairman Osborne announced that “as part of this report is 
still in the hands of the Auditing Committee, perhaps it would be 
better to wait for the report of that Committee before taking 
action on it.” 
The following report was also presented by Chairman James 
H. Beal: 
The Board of Trustees having considered the proposed amendment 
to the By-Laws referred to it by the Convention, respectfully reports as 
follows: 
“Amend the By-Laws, Chapter VIII “Of Members,” by adding an 
additional article, to be known as Article IV, to read as follows: 
“Article IV, Section 1. Every constituent body, sending delegates 
to the Convention, shall within the first year following the decennial 
meeting of the same remit to the Secretary of the Convention the sum 
of fifty dollars ($50) as a contribution to the expenses of the Revision, 
which contribution if so paid, shall be in full of all demands during the 
decennium. If not paid within the first year of the decennium the con- 
tribution shall be seventy-five dollars ($75). Bodies which are hereafter 
admitted to the Convention shall pay the sum of one hundred dollars 
($100) as a first decennial contribution and thereafter the sum of fifty 
dollars ($50), or seventy-five dollars ($75), during each decennium, as 
above stated. 
59 “Section 2. The Secretary of the Board of Trustees shall certify to 
the Committee on Credentials when the same shall have been appointed 
the names of the bodies which have paid the contribution provided for 
by Section 1, with the date and amounts of such payment and the Com- 
mittee on Credentials shall not report the name of any such body or 
delegates from the same to the Convention until such certificate has 
been received.” 
A lengthy discussion ensued, in the course of which it was 
pointed out that the proposed amendments would impose upon 
the institutions and organizations represented the duty of paying 
a part of the expenses of revision and publication and that this 
would result in the exclusion of a great many institutions as well 
as the departments of the Federal Government. On the other 
hand it was claimed that the balance of $8000 now in the treasury 
has been contributed by members of the Revision Committee, 
every one of whom has paid hundreds of dollars out of his own 
pocket for his expenses. In order to provide a fund immediately 
available, a proposition was also presented that the institutions 
represented make a contribution of $25, or more, and that in 
consideration thereof they be entitled to a certain number of 
copies of the Pharmacopoeia when issued. Finally the following, 
presented by H. P. Hynson, was unanimously adopted. 
Moved as an amendment that the recommendation of the Board of 
Trustees be not accepted, and that the said Board be empowered to 
make the price of the Ninth Revision of the Pharmacopoeia such a 
price as will meet the proper expenses of the Revision. 
The Secretary read the following telegram from H. C. Wood, 
Sr.: 
Please express to the U. S. P. Convention my deep appreciation of its 
sympathy, my sorrow in my inability to participate in its labors, and 
my strong belief that by it will be maintained the traditions of the 
fathers and the reputation and usefulness of the U. S. Pharmacopoeia 
increased. 
J. P. Remington presented the tabulated statistics of 117,000 
prescriptions compiled by C. S. N. Hallberg and C. M. Snow, 
which the Chairman announced would be received and referred 
to the General Committee of Revision. 
60 Eli H. Long presented the following resolution: 
Resolved, That the Board of Trustees be authorized to invite contri- 
butions from members of institutions and representatives of other bodies 
here represented, and that in consideration of such contributions they 
be authorized to grant to the contributing body a reasonable number of 
copies of the Pharmacopoeia when published. 
R. A. Hatcher offered as a substitute the following: 
u Resolved, That it is the sense of the delegates here assembled 
that the Board of Trustees require an adequate royalty on all 
books that are offered as substitutes for the Pharmacopoeia, and 
that such books shall pay a royalty equal to the profit on the Phar- 
macopoeia which they displace,” which was ruled out of order and 
finally, on motion, of H. P. Hynson, the whole matter of raising 
sufficient funds was referred to the Board of Trustees with power 
to act. 
The following recommendation, offered by C. S. N. Hallberg 
was referred to the General Committee of Revision: 
Sterilization—That a chapter on sterilization be introduced de- 
scribing the proper methods for sterilizing medicaments and indicating 
to what preparations each method is especially applicable. 
J. H. Beal, on behalf of the Board of Trustees, made the follow- 
ing report on the general declaration of ethical principles, which, 
on motion, was adopted: 
The Board reports upon the general declaration of ethical principles 
which was referred to them for consideration yesterday, as follows: 
“That the Convention endorse the general declaration of ethical 
principles contained in the report, and that the report be referred to the 
Board of Trustees and General Committee of Revision jointly, with 
power to include the same or a modification thereof in the preface to 
the Ninth Revision of the Pharmacopoeia.” 
E. G. Eberhardt suggested that some step should be taken to 
advance the sale of the Pharmacopoeia by prescribing that a copy 
should be in every drug store. The Chairman ruled that this 
subject could not be considered without a motion to reconsider, 
which was made by A. B. Lyons and agreed to, whereupon, E. G. 
Eberhardt offered the following resolution, which was adopted: 
61 Resolved, That this Convention recommend to the National and State 
Food and Drug Inspectors that they urge the purchase of the United 
States Pharmacopoeia by such druggists as they may find to be without 
them. 
H. G. Beyer presented the following recommendation, which 
was agreed to: 
That every physician in this country should be requested by the vari- 
ous medical associations that he should keep in his office a Pharmaco- 
poeia. 
On motion of H. M. Whelpley, the Secretary was instructed to 
furnish the resolutions relative to the use of the Pharmacopoeia 
to the medical and pharmaceutical press of the country. 
On motion of Wilhelm Bodemann, the Secretary was instructed 
to forward, on the part of the Convention, an expression of 
sympathy and regret to Oscar Oldberg. 
At this point the Chair was assumed by the President, H. W. 
Wiley. 
A resolution by C. S. N. Hallberg that the Convention support 
the passage of the bill now before Congress relating to a National 
Department of Health and asking that it be amended by the 
addition of a Bureau of Pharmacy, was, by the Chair, ruled to be 
out of order as it was not business for which the Convention was 
called. 
Torald Sollmann moved that the Convention, for the guidance 
of the Board of Trustees, express its approval of the resolution 
presented by R. A. Hatcher: 
Resolved, That it is the sense of the delegates here assembled that the 
Board of Trustees require an equitable royalty on all books that are in- 
tended to serve as substitutes for the Pharmacopoeia, and that such 
royalty shall be equal to the profit on the Pharmacopoeias which they 
displace. 
The Chair ruled the motion out of order, an appeal was taken, 
a motion to table the appeal was not agreed to and, a vote being 
taken on the appeal, the Chair was sustained. 
On motion of H. M. Whelpley, the Convention extended a 
hearty vote of thanks to O. T. Osborne, M. G. Motter and S. L. 
62 Hilton in recognition of their work, in connection with the Com- 
mittee on Arrangements to insure the success of the Convention. 
On motion of J. P. Remington, a special vote of thanks was 
tendered the Public Health and Marine-Hospital Service for the 
valuable aid given the Committee of Revision, in the publication 
of the Digests and in other work. 
On motion of C. S. N. Hallberg, as amended by J. P. Reming- 
ton, the thanks of the Convention were extended for the able 
assistance given by the Department of Agriculture and by H. W. 
Wiley, in the work of the last revision. This motion was put by 
Vice-President Caspari and unanimously agreed to. 
On motion of 0. A. Wall, an unanimous vote of thanks was 
tendered the out-going Committee of Revision in appreciation of 
their labors in the past decade. 
On motion of J. P. Remington, an unanimous vote of thanks 
was tendered to Charles E. Dohme, retiring Chairman of the 
Board of Trustees. 
On motion of 0. A. Wall, an unanimous vote of thanks was 
similarly extended to the Board of Trustees. 
On motion of William Jay Schieffelin, the President, with con- 
gratulations upon the splendid work done and the harmony 
which had prevailed, declared the Convention adjourned, sine die. 
ABSTRACTS OF REPORTS PRESENTED TO THE CONVEN- 
TION FOR THE REVISION OF THE UNITED 
STATES PHARMACOPOEIA. 
By Joseph P. Remington, Chairman Committee of Revision. 
The Report of the American Chemical Society does not dwell upon the 
scope of the Pharmacopoeia but treats of analyses, assays, and tests of 
various chemical substances, the determination of physical constants 
by uniform methods and standards of purity. The report approves 
of the “Purity Rubric” of the Eighth Revision. Deterioration of 
chemicals is touched upon, with a limit of moisture and water of 
occlusion. The International Standard of Atomic Weights, 0 = 16, is 
recommended for adoption. They also recommend that, in the quan- 
titative estimation of liquids, the method given in the U. S. P., 8th, 
63 under the strong mineral acids, be adopted as type in the next Revision 
and, for solids, they recommend the method used under the alkali 
hydroxides. The introduction of the principle of “General Tests,” 
like the Gutzeit’s Test for Arsenic and the Time Limit Tests for Heavy 
Metals, is approved and the principle recommended for extension in 
the 9th Revision. They recommend that, where a “Purity Rubric” 
is required, a test for determining the limit of innocuous, unavoidable 
impurities be always given. With regard to temperatures, they use the 
following language: “We favor a decided stand for the retention of the 
25°C. temperature standard.” Patented or proprietary products 
should not be recognized and synonyms should be given in the Pharma- 
copoeia and the titles of synthetic chemical compounds shortened where- 
ever possible. 
The Report of the Committee from the American Medical Association 
contains the results of a request that physicians should express an 
opinion on the principles to be followed in revising the Pharmacopoeia, 
especially directed towards the scope. The report deals specifically 
with the articles now official and indicates those which should remain 
and those which should be deleted. 
The report contains the views of the Committee of the Section on 
Pathology and Physiology of the A.M.A.: on Vaccine Virus and Tetanus 
Antitoxin; and the report from the Committee of the Section on Ob- 
stetrics and Diseases of Women. 
The Report of the Section on Dermatology of the A. M. A. offers, among 
others, the following suggestions: “Articles in the Pharmacopoeia which 
are used externally should, we believe, indicate the strength in which 
they are used externally as well as their internal doses.” They propose 
the introduction of carbonic acid, picric acid, goose grease, solution of 
gutta percha and chaulmoogra oil. Additional salts of mercury are 
recommended for introduction for use by hypodermic medication, 
such as benzoate, cyanide, salicylate and succinimide. 
The Report from the Sections on Practice of Medicine, Ophthalmology and 
Stomatology of the A. M. A. contains suggestions upon additions and 
deletions for the Pharmacopoeia. An abstract of a discussion by 
members of the sections and an editorial on Pharmacopoeial Revision 
from the Journal of the American Medical Association completes this 
report. 
The American Pharmaceutical Association presents a communication 
on “General Principles” to be observed in the 9th Revision of the U. S. 
Pharmacopoeia. Many of these suggestions were accepted by the 
Convention. 
64 The Reports of the Committee on the United States Pharmacopoeia of 
the American Pharmaceutical Association for 1909 and 1910 are very 
voluminous, containing not only the views of the A. Ph. A. Committee 
on general subjects but deal with suggestions in detail on the drugs, 
chemicals and preparations of the Pharmacopoeia. 
The Report on the Revision of the U. S. Pharmacopoeia by the New 
York Branch of the American Pharmaceutical Association does not em- 
brace suggestions for preparations in detail, but deals with general 
principles. The key note is found in the following resolution. “Re- 
solved that all articles commonly included in the medicinal stock of 
pharmacists, and not of a proprietary nature should be recognized in 
the Pharmacopoeia and definite standards and tests suitable for the 
use of the practicing pharmacist should be provided for them, in spite 
of the fact that their therapeutical properties may not commend them 
to the better informed practitioners of medicine.” 
Resolutions Adopted by the City of Washington Branch of the Ameri- 
can Pharmaceutical Association. The recommendations in these reso- 
lutions all point in the direction of a Pharmacopoeia much reduced in 
size and the resolutions are devoted almost entirely to the considera- 
tion of the scope of the Pharmacopoeia, only. 
Recommendations Presented to the United States Pharmacopoeial Con- 
vention by the American Therapeutic Society are not limited altogether 
to scope, but suggest: “That the 1910 Pharmacopoeia give official 
approval to only the best of the preparations of the official galenic 
drugs, and not officialize the little used and useless preparations of these 
drugs.” 
Resolutions Presented by the Iowa Veterinary Association endorse one 
of its members as a delegate to the Convention and express the opinion 
that the Veterinary Association should be represented on the Board 
appointed to revise the United States Pharmacopoeia. 
Report of the New Jersey Pharmaceutical Association to the Convention 
for the Revision of the United States Pharmacopoeia is a bound volume of 
189 typewritten pages with an index of eleven pages. It is a compila- 
tion from the Proceedings of the New Jersey Pharmaceutical Associa- 
tion of recent years. It represents much labor and will lighten the work 
of the Committee of Revision. An abstract is being prepared by the 
Chairman of the Committee of Revision which will be sent out to the 
Subcommittees and General Committee. 
Recommendations Presented by the Kings County Pharmaceutical 
Society recommend strict adherence to the Resolutions of the Brussels 
International Congress, especially as to nomenclature, strength of 
65 preparation and normal medicine dropper. A chapter on pasteuriza- 
tion and sterilization in the preface, one on the preservation and storage 
of drugs and a list of antidotes should be included. “It is the belief 
of the Kings County Pharmaceutical Society that 'practical retail phar- 
macists should be submitted to the U. S. P. Revision Committee, espec- 
ially to the Sub-Committee on Galenicals, and that it should be the 
duty of this committee actually to prepare, try, and test these prepara- 
tions, in official quantities, before their admission into the 9th Revision 
of the U. S. P., which book should be made the peer and the aristocrat 
of all the Pharmacopoeias.” 
The Report of the Delegates of the New Jersey College of Pharmacy 
includes many of the suggestions found in the Report of the New 
Jersey Pharmaceutical Association, all of which will be abstracted and 
sent to the Committee of Revision. 
Recommendations Presented by the Medical Society of the State of New 
York. The House of Delegates of this Society suggests a smaller 
Pharmacopoeia with a presentation of the following resolutions: “Re- 
solved, that it is the sense of the Medical Society of the State of New 
York that the interests of medical science require the establishment of 
a Bureau of Materia Medica that shall institute disinterested investi- 
gations into the character and physiological action of new drugs. 
“Resolved, that this Society recommends to the Decennial Con- 
vention of 1910 for the Revision of the United States Pharmacopoeia, 
the creation of such a Bureau, by and under its authority, that shall 
report annually to the Committee of Revision upon matters coming 
properly within the scope of its work; and that the Committee of Revision 
of the United States Pharmacopoeia publish annually a report which shall 
give the conclusions concerning the proposed new drugs.” 
Recommendations Presented by the New York State Pharmaceutical 
Association suggest publicity, table of antidotes and sterilization and 
the following resolution: “All tests and standards should be tried and 
verified by expert chemists; all formulas for the preparation of galenicals 
to be tried and verified by practical retail pharmacists before adoption.” 
Report of the Philadelphia College of Pharmacy contains recommenda- 
tions, mainly on general subjects with a list of articles for deletion and 
admission. The “Purity Rubric” is commended and an increase in 
the list of synonyms and no changes be made in the style of nomen- 
clature. An additional Report on Pharmacognosy by Prof. Henry Krae- 
mer is appended. 
Recommendations from the Faculty of the School of Pharmacy of the 
University of Michigan request the changing of the atomic weight 
66 values to the scale of 0 = 16, the introduction of average and 
maximum doses, the description of the microscopic structure of vege- 
table powders, and that the names of all preparations into which a 
drug or preparation enters, be inserted at the end of the text applying 
to that drug or preparation. 
The nomenclature of the United States Pharmacopoeia is presented by 
E. D. Brown who criticises the Latin of the Pharmacopoeia and desires 
some changes, particularly in the nomenclature of preparations made 
from the Balsams. 
Patents and Trade Marks and their Relation to Pharmacol Science and 
Practice is presented by F. E. Stewart, M.D. and is a voluminous paper 
on this subject, containing arguments, bibliographical references and a 
discussion on the whole subject of patents and trade marks. 
The Coming Revision of the United States Pharmacopoeia consists of a 
paper by Dr. Torald Sollmann, suggesting changes in the formation of 
the Committee of Revision and advocating a larger medical influence 
in the same. 
67 FINANCIAL STATEMENT. 
EXPENDITURES. 
BOARD OF TRUSTEES—MAY, 1900, TO APRIL 30, 1901. 
DATE 
gen’l 
TRAV. 
EX. 
HON. 
PUB. 
26- 7-’00 
7 W. F. Roberts, Chk. Bk 
$20.50 
28- 8-’00 
14 S. A. D. Sheppard, Com. Confer- 
ence 
$14.94 
24-10-’00 
21 
W. S. Thompson 
7.84 
43.14 
24r-10-’00 
22 
A. E. Ebert 
89.11 
24-10-’00 
23 
W. M. Mew 
9.25 
24-10-’00 Pt. 
24 
Chas. Rice 
5.00 
24-10-’00 
25 
Chas. E. Dohme 
11.81 
24-lO-’00 
26 
S. A. D. Sheppard 
22.85 
24-10-’00 
27 
Geo. W. Sloan 
62.00 
24-10-’00 
28 
M. G. Motter 
16.00 
8.00 
30-10-’00 
29 
W. F. Roberts, Staty & ptg 
18.33 
12-ll-’00 
30 
J. Baumgarten & Sons, Seal 
3.50 
4-12-’00 
31 
Chas. E. Dohme, Post 
2.25 
10-12-’00 
33 
J. B. Lippincott Co., Bdg 
$231.25 
10-12-’00 
34 
M. G. Motter, Misc. off. exp 
8.00 
10-12-’00 
35 
Perry & Son, Attys., Incorp 
256.60 
10-12-’00 
37 
Chas. Rice, Treas. Bond 
50.00 
10-12-’00 
39 
Smith Prem. Typewriter, rent 
6.00 
11- 2-’00 
48 
J. B. Lippincott, Abst. Proc 
117.93 
11- 2-’00 
50 
W. F. Roberts, Post cards 
2.00 
11- 2-’00 
51 
H. M. Whelpley 
10.00 
$100.00 
11- 3- ’00 
58 
S. P. Typewriter, Rent 
24.00 
11- 3-’00 
59 
Jeannette Mudd, Clerk 
11.52 
$436.54 
$266.10 
$100.00 
$349.18 
Total 
$1,151.82 
68 COMMITTEE OF REVISION—MAY, 1900, TO APRIL 30, 1901. 
DATE 
gen’l 
CLER. 
EXPT. 
SUP. 
16- 6-’00 
lChas. Rice 
$230.00 
22- 7-’00 
2Fuld Bros. Circ. Letters & Staty. 
$8.25 
22- 7-’00 
3 J. W. Pratt Co. Ptg., env. & lists. 
90.00 
12- 7-’00 
4 Chas. Rice, Off. exp 
40.59 
12- 7-’00 
5 J. W. Pratt Co. Ptg. Circ. & letters 
7.75 
12- 7-’00 
6M. T. Hard, Paper 
10.65 
7- 8-’00 
8Chas. Rice, Post. & Misc 
23.50 
7- 8-’00 
9 
J. W. Pratt Co. Ptg. Lists, etc.... 
53.00 
7- 8-’00 
10 
M. T. Hard, Paper 
15.76 
7- 8-’00 
11 
Schieffelin & Co., Off. sup 
14.10 
7- 8-’00 
12Hull, Grippen & Co., Off. sup... . 
3.50 
7- 8-’00 
13Fuld Bros. Ptg. repts 
2.00 
10- 9-’00 
15 
M. T. Hard, Paper 
11.10 
10- 9-’00 
16 
Chas. Rice, Off. exp 
37.11 
21- 9-’00 
17 
J. W. Pratt Co. Ptg., etc 
54.00 
21- 9-’00 
18 
Sharp & Dohme 
5.92 
24-10-’00 
19 
J. W. Pratt Co., Pub. Stp 
6.00 
24-10-’00 
20 
Hull, Grippen & Co., Pans 
8.00 
24-10-’00 Pt. 
24 
Chas. Rice 
34.95 
237.00 
10-12-’00 
32 
M. T. Hard, Paper 
33.49 
10-12-’00 
36 
J. W. Pratt Co., Ptg. Lists 
22.00 
10-12-’00 Pt. 
37 
Chas. Rice 
17.08 
83.10 
10-12-’00 
38 
Sharp & Dohme, Assays 
$26.65 
10- l-’Ol 
40 
J. W. Pratt Co., Ptg. env 
3.00 
10- l-’Ol 
41 
Chas. Rice 
20.41 
127.50 
10- l-’Ol 
42 
Sharp & Dohme, Assays 
11.20 
10- l-’Ol 
43 
Stallman & Fulton, Assays 
2.45 
11- 2-’01 
44 
Virgil Coblentz, Post., exp. etc .. 
9.70 
11- 2-’01 
45 
Eimer & Amend, Thermometers.. 
20.00 
11- 2-’01 
46 
M. T. Hard. Paper 
16.65 
11- 2-’01 
47 
Kalish Pharmacy, Assays 
11.84 
11- 2-’01 
49 
Chas. Rice 
25.04 
88.50 
11- 3-’01 
52 
Emil Greiner, Lysimeters 
12.50 
11- 3-’01 
53 
J. B. Lippincott Co., Ptg 
40.00 
11- 3-’01 
54 
A. B. Lyons, Filing book 
2.50 
11- 3-’01 
55 
J. W. Pratt Co., Ptg. adv. lists .. 
12.50 
11- 3-’01 
56 
Chas. Rice 
36.38 
75.25 
11- 3-’01 
57 
Sharp & Dohme, Assays 
57.25 
10- 4-’01 
60 
Chas. Rice 
32.91 
88.50 
10- 4r-’01 
61 
Dan’l Slote & Co., Filing cases .. 
61.60 
$759.44 
$929.85 
$159.35 
Total 
69 BOARD OF TRUSTEES—MAY 1, 1901, TO APRIL 30, 1902. 
DATE 
gen’l 
TRAY. 
EX. 
HON. 
PUB. 
15- 6-’01 
68 
VV. M. Mew, Clerk 
$5.00 
25- 7-’01 Pt. 
78 
J. B. Lippincott, Ptg. & Bdg... 
$561.98 
12- 8-’01 
79 
Amer. Bond. Co., Treas. Bond. 
12.50 
12- 8-’01 
88 
M. G. Motter, Misc. off. exp. . . 
7.66 
14—11—’01 
102 
M. G. Motter 
4.56 
$70.75 
14—11—’01 
103 
Jeannette Mudd, clerk 
3.15 
14—11—’01 
105 
Est. W. S. Thompson, Misc. off. 
exp 
10.00 
12- 1—’02 
112 
M. G. Motter, Post., stat., etc.. 
33.05 
14- 2-’02 
118 
J. B. Lippincott, Ptg. & Bdg... 
659.86 
14- 2-’02 
121 
Wyckoff, S. & B., Typewriter.. 
100.00 
10- 4—’02 
123 
Estate Chas. Rice 
$1000.00 
$175.92 
$70.75 
$1000.00 
$1221.84 
Total.... 
$2,468.51 
COMMITTEE OF REVISION—MAY 1, 1901, TO APRIL 30, 1902. 
DATE 
gen’l 
CLER L 
EXPT. 
SUP. 
f-H 
O 
1 
o 
i-H 
62 
Virgil Coblentz 
$1.30 
$10.00 
$4.31 
10- 5—’01 
63 
J. W. Pratt Co., Ptg 
12.00 
10- 5-’01 
64j 
Estate Chas. Rice 
23.17 
$73.00 
10- 5-’01 
65 
Wilbur L. Scoville 
4.35 
10- 5-’01 
66 
R. W. Wilcox 
2.46 
15- 6-’01 
67 
Clarence Fountain 
79.75 
15- &-’01 
69 
J. P. Remington 
108.44 
26.25 
15- fr-’Ol 
70 
Sharp & Dohme, Assays 
11.40 
15- 6-’01 
71 
E. R. Squibb & Sons, Assays 
6.34 
10- 7-’01 
72 
C. Fountain 
15.60 
10- 7-’01 
73 
O. J. Griffin, Moving 
15.95 
10- 7-’01 
74 
Wm. H. Hoskins Co., Off. sup ... 
57.33 
10- 7-’01 
75 
J. B. Lippincott Co., Staty 
43.25 
10- 7-’01 
76 
J. P. Remington 
50.73 
101.00 
10- 7-’01 
77 
Florence Yaple “Digest” 
190.00 
25- 7-’01 Pt. 
78 
J. B. Lippincott Co., ptg. let. hds. 
30.60 
12- 8-’01 
80 
Amer. Can Co., Ext 
5.85 
12- 8-’01 
81 
A. B. Dick Co., Mimeo. supplies. 
6.95 
12- 8-’01 
82 
A. G. Elliott & Co., Paper 
30.60 
12- 8-’01 
83 
C. S. N. Hallberg, Ung 
30.00 
13.20 
o 
00 
t—4 
84 
M. T. Hard, Paper 
9.00 
70 COMMITTEE OF REVISION—CONTINUED—MAY 1, 1901, TO APRIL 30, 1902 
DATE 
qen’l 
cler’l 
EXPT. 
SUP. 
12- 8-’01 
85 
Wm. H. Hoskins, Office supplies . 
$4.65 
i—i* 
to 
i 
00 
l„ 
© 
86 
Henry Kraemer 
20.03 
12- 8-’01 
87 
J. B. Lippincott, Env. & ptg 
30.00 
12- 8-’01 
89 
J. P. Remington 
35.29 
$85.00 
$13.03 
12- 8-’01 
90 
S. P. Sadtler 
2.25 
12- 8-’01 
91 
Sharp & Dohme, Assays 
47.07 
12- 8-’01 
92 
Smith, Kline & F. Co., Ext 
51.27 
12- 8-’01 
93 
E. R. Squibb & Sons, Ext 
54.30 
12- 8-’01 
94 
Henry Troemner, (Wgts)ext 
3.60 
12- 8-’01 
95 
Wickersham Ptg. Co., Lists, ele- 
ments 
95.25 
11- 9-’01 
96 
Henry Kraemer 
1.65 
35.00 
$60.00 
11- 9-’01 
97 
J. P. Remington 
55.63 
85.00 
6.80 
11- 9-’01 
98 
Smith, Kline & F. Co., Ext 
22.35 
11- 9-’01 
99 
E. R. Squibb & Sons, Ext 
19.87 
14—11—’01 
100 
P. Blakiston’s Son & Co., Books.. 
10.13 
14—11—’01 
101 
C. S. N. Hallberg, Ung 
4.50 
40.00 
1.40 
14-11-’01 
104 
J. P. Remington 
89.73 
65.00 
14—11—’01 
106 
E. R. Squibb & Sons, Ext 
15.90 
22-ll-’01 
107 
P. Blakiston’s Son & Co., B.Ph.. 
3.84 
22-ll-’01 
108 
C. Lewis Diehl, Filing cases 
8.80 
22-ll-’01 
109 
Fred’k. Diehl, Filing cases 
42.55 
22-ll-’01 
110 
J. P. Remington 
49.12 
75.00 
13- l-’02 
111 
V. Coblentz 
50.00 
13- l-’02 
113 
J. P. Remington 
36.14 
45.00 
17- l-'02 
114 
J. B. Lippincott Paper & ptg 
8.75 
17- l-’02 
115 
J. P. Remington 
38.04 
75.00 
17- l-’02 
116 
Wickersham Ptg. Co., Digest III.. 
312.34 
17- l-’02 
117 
Sharp & Dohme, Assays 
10.90 
14- 2-’02 
119 
J. P. Remington 
65.11 
60.00 
14- 2-’02 
120 
Smith, Kline & F. Co., Ext 
12.98 
10- 3-’02 
122 
V. Coblentz 
50.00 
10- 4~’02 
124 
Edw. Kremers Bibl. Arom. Waters 
35.00 
$1344.93 
$1010.60 
$240.00 
$300.57 
Total. 
$2,896.10 
71 BOARD OF TRUSTEES—MAY 1, 1902, TO APRIL 30, 1903. 
DATE 
gen’l 
TRAV. 
EX. 
HON. 
PUB. 
23- 5-’02 
125 
C.H.Kimmig (Thompson mem.) 
$35.00 
16- 6-’02 
131 
W. M. Mew, Clerk 
$5.00 
16- 6-’02 
133 
Amer. Bond. Co., Treas. bond... 
25.00 
18- 7-’02 
134 
J. H. Beal, Longport conference. 
$20.00 
18- 7-’02 
138 
J. B. Lippincott, Bdg 
$47.50 
18- 7-’02 
142 
S. A. D. Sheppard, Longport Con. 
27.60 
15- 8-’02 
145 
M. G. Motter, Longport misc... 
5.65 
13.65 
15- 9-’02 
151 
Yawman & Erbe, Filing cases.... 
33.55 
14-ll-’02 
155 
W. F. Roberts, Statv 
32.00 
14-ll-’02 
156 
Chas. E. Dohme, (Phila.) 
9.00 
14-ll-’02 
157 
J. H. Beal 
24.00 
14-ll-’02 
158 
A. E. Ebert, (Phila.) 
1.73 
68.00 
14-ll-’02 
159 
S. A. D. Sheppard, (Phila.) 
24.44 
14-ll-’02 
160 
Geo. W. Sloan, (Phila.) 
37.58 
Ck. 
14-ll-’02 
161 
M. G. Motter, (Phila.) 
24.00 
lost 
14-ll-’02 
162 
C. Lewis Diehl, (Phila.) 
51.56 
see 194 
14-ll-’02 
163 
R. W. Wilcox, (Phila.) 
7.00 
14-ll-’02 
164 
A. R. L. Dohme, (Phila.) 
9.50 
14-ll-’02 
165 
Jno. J. Abel, (Phila.) 
7.90 
14-ll-’02 
166 
Chas. Caspari, Jr., (Phila.) 
9.24 
14-ll-’02 
167 
V. Coblentz, (Phila.) 
9.00 
14-11-’02 
168 
Jas. M. Good, (Phila.) 
32.60 
14-ll-’02 
169 
Walter S. Haines, (Phila.) 
59.00 
14r-ll-’02 
170 
C. S. N. Hallberg, (Phila.) 
59.00 
14-ll-’02 
171 
Edw. Kremers, (Phila.) 
65.00 
14-ll-’02 
172 
A. B. Lyons, (Phila.) 
28.00 
14-ll-’02 
173 
Geo. F. Payne, (Phila.) 
47.92 
14-11-’02 
174 
H. H. Rusby, (Phila.) 
11.37 
14-ll-’02 
175 
Sami. P. Sadtler, (Phila.) 
1.25 
14—11 —’02 
176 
L. E. Sayre, (Phila.) 
57.25 
14-ll-’02 
177 
W. L. Scoville, (Phila.) 
24.44 
14-ll-’02 
178 
A. B. Stevens, (Phila.) 
27.48 
14-ll-’02 
179 
Edw. H. Squibb, (Phila.) 
11.25 
15-12-’02 
180 
J. P. Remington, U. L. Dinner.. 
67.80 
15-12-’02 
181 
Amer. Bond. Co., Treas. Bond.. 
$12.50 
15-12-’02 
182 
J. B. Lippincott, Bdg 
$208.25 
15-12-’02 
185 
M. G. Motter, Secy 
14.10 
$10.00 
Mew 
3- 3-’03 
194 
Geo. W. Sloan, (Phila.) Dupl... 
37.58 
seel60 
13- 2-’03 
195 
J. H. Beal, (Phila.) 
38.92 
13- 2-’03 
196 
Chas. E. Dohme, (Phila.) 
1.75 
13.50 
CO 
p 
I 
<M 
1 
CO 
rH 
197 
A. E. Ebert, (Phila.) 
.50 
69.00 
13- 2-’03 
198 
S. A. D. Sheppard, (Phila.) 
31.25 
13- 2-’02 
199 
M. G. Motter, Secty. (Phila.)... 
1.35 
11.00 
(U.S.P 
13- 2-’03 
201 
J. B. Lippincott Bdg. & ship.... 
48.10 
Comp. 
13- 2-’03 
213 
S. A. D. Sheppard, misc. exp... 
6.03 
VII) 
4- 4-’03 
216 
South End Nat. Bk., Int. on Note 
41.67 
$187.26 
$1035.0£ 
$45.06 
)$255.75$41.67 
Total.. 
$1,565.76 
72 COMMITTEE OF REVISION, MAY 1, 1902, TO APRIL 30, 1903. 
DATE 
qen’l 
CLER. 
EXPT. 
SUP. 
23- 5-’02 
126 
J. P. Remington 
$100.77 
$135.00 
23- 5-’02 
127 
Smith, Kline & F. Co., ext 
$13.42 
23- 5-’02 
128 
Wickersham Ptg. Co., Post., Ext. 
32.25 
16- 6-’02 
129 
V. Coblentz 
2.00 
$77.60 
15.03 
16- 6-’02 
130 
Gordon L. Curry, Arom. sps & 
wtr 
15.00 
16- 6-’02 
132 
J. P. Remington 
61.95 
70.00 
18- 7-’02 
135 
Geo. M. Beringer, Sub. 11 
13.57 
18- 7-’02 
136 
Cupples Env. Co., Env 
68.39 
18- 7-’02 
137 
A. G. Elliot & Co., Paper 
34.60 
18- 7-’02 
139 
J. P. Remington 
68.75 
130.00 
18- 7-’02 
140 
H. H. Rusby, Trav. & Misc 
22.00 
18- 7-’02 
141 
Sharp & Dohme, Assays 
1.70 
190.75 
15- 8-’02 
143 
Walter S. Haines 
10.30 
36.30 
15- 8-’02 
144 
Henry Kraemer, Sub. 8 
10.00 
45.00 
15- 8-’02 
146 
J. P. Remington 
40.91 
70.00 
15- 8-’02 
147 
Sharp & Dohme, Sub. 3, 5, 6, as- 
says 
177.33 
15- 8-’02 
148 
Smith, Kline & F. Co., Sub 8, 11. 
25.71 
15- 9-’02 
149 
V. Coblentz 
3.75 
60.00 
2.46 
15- 9-’02 
150 
Sharp & Dohme, Assays 
5.40 
25.00 
28.20 
14-ll-’02 
152 
V. Coblentz 
11.25 
5.30 
195.00 
14.26 
14-ll-’02 
153 
J. B. Lippincott, Ptg. & staty.. . 
33.50 
14-ll-’02 
154 
J. P. Remington 
104.43 
225.00 
2.17 
15-12-’02 
183 
V. Coblentz 
60.00 
15-12-’02 
184 
Edw. Kremers, Reprint vol., oils. 
23.00 
15-12-’02 
186 
J. P. Remington 
25.38 
85.00 
15-12-’02 
187 
S. P. Sadtler 
2.50 
15-12-’02 
188 
Sharp & Dohme, Assays 
19.50 
14- l-’03 
189 
V. Coblentz 
3.90 
60.00 
4.63 
14- l-’03 
190 
John Marshall 
2.15 
8.24 
14- l-’03 
191 
J. P. Remington 
28.92 
85.00 
.79 
14- l-’03 
192 
Sharp & Dohme, Assays 
2.00 
14- l-’03 
193 
C. E. Stechert, Books 
11.31 
13- 2-’03 
200 
Wm. H. Hoskins, Off. supplies... 
48.65 
13- 2-’03 
202 
J. P. Remington 
31.59 
90.00 
13- 2-’03 
203 
S. P. Sadtler 
1.50 
50.00 
11.59 
13- 2-’03 
204 
Sharp & Dohme, Assays 
22.90 
13- 2-’03 
205 
G. E. Stechert, Ph. Gr. Russ. Ser. 
12.43 
25- 2-’03 
206 
P. Blakiston’s Son & Co., Bks... 
3.83 
Iff- 3-’03 
207 
V. Coblentz 
120.00 
2.38 
16- 3-’03 
208 
A. G. Elliot & Co., Paper 
45.95 
16- 3-’03 
209 
J. Goldberg, Book case 
20.00 
16- 3-’03 
210 John Marshall 
! 40.00 
73 COMMITTEE OF REVISION—CONTINUED—MAY 1, 1902, TO APRIL 30, 1903. 
DATE. 
gen’l. 
CLER. 
EXPT. 
SUP. 
16- 3-’03 
211 
J. P. Remington 
$28.41 
$90.00 
16- 3-’03 
212 
S. P. Sadtler 
1.00 
$50.00 
16- 3-’03 
214 
Smith, Kline & F. Co 
$10.42 
16- 3-’03 
215 
G. E. Stechert, Book 
6.73 
14- 4-’03 
217 
V. Coblentz 
3.10 
60.00 
14- 4-’03 
218 
Wm. H. Hoskins Co., Off. sup — 
27.65 
14- 4-’03 
219 
John Marshall 
.22 
5.73 
14- 4-’03 
220 
J. P. Remington 
34.34 
90.00 
$974.51 
$1145.30 
$823.90 
$571.08 
Total... 
$3,514.79 
BOARD OP TRUSTEES—MAY 1, 1903, TO APRIL 30, 1904. 
DATE 
gen’l 
TRAV. 
EX. 
HON. 
PUB. 
24r~ 6-’03 
222 
Chas. E. Dohme, (Phila.)-• 
$17.00 
24r- 6-'03 
223 
A. E. Ebert, Sloan fun. 
(Phila.) 
$20.20 
73.00 
24- 6-’03Pt. 
224 
J. B. Lippincott, Bdg. pro- 
posals 
34.85 
$53.58 
24r- 6-03 
226 
M. G. Motter, Secy., Phila. 
14.70 
24— 6-’03 
227 
Nixon Jones Ptg. Co.,Env. 
H. M. W 
6.60 
24- 6-’03 
229 S. A. D. Sheppard, Phila.. . 
26.10 
24- 6-’03 
231H. M. Whelpley, Phila 
69.75 
24- 6-’03 
232 
South End Nat. Bk., Int. on 
note 
$31.25 
20- 7-’03 
233 
J. H. Beal, Phila 
39.64 
20- 7-’03 
234 
Chas. E. Dohme 
2.05 
$10.00 
20- 7-’03 
235 
J. B. Lippincott 
125.00 
20- 7-’03 
236 
M. G. Motter, Secy., Phila. 
2.66 
8.60 
20- 7-’03 
237 
H. C. Wood, Phila 
24.00 
22- 7-’03 
238 
S. A. D. Sheppard (Rice 
memorial) 
$250.00 
22- 7-03 
239 
H. M. Whelpley, Phila. & 
Rice. Mem 
84.00 
22- 7-’03 
240 
Chas. E. Dohme, Phila 
6.00 
22- 7-’03 
241 
A. H. Kelly, Typewriting... 
4.00 
8- 8-’03 
242 
A. E. Ebert, Phila. & Rice 
Mem 
.55 
83.00 
8- 8-’03 
243 
Nixon Jones Ptg. Co., H. M. 
W. Lt. hd 
11.50 
74 BOARD OP TRUSTEES—CONTINUED—MAY 1, 1903, TO APRIL 30, 1904. 
DATE 
gen’l 
TRAY. 
EX. 
HON. 
PUB. 
8- 8-’03Pt. 
244J. P. Remington, Phila. & 
Rice mem 
31.20 
22- 9-’03 
245 J. H. Beal, Mackinac 
30.00 
22- 9-’03 
248Kimmig Studio, Mew Mem. 
35.00 
5-10-’03 
251South End Nat. Bk., Int. 
on Note 
$31.25 
16-10-’03 
253Chas. E. Dohme, Mackinac 
58.20 
16-10-’03 
254A. E. Ebert, Mackinac 
28.65 
16-10-’03 
256 M. G. Motter, Secy., Mack- 
inac 
90.65 
16-10-’03 Pt. 
257 J. P. Remington, Mackinac 
87.50 
16-10-’03 
260S. A. D. Sheppard, Mack- 
inac 
31.25 
16-10-03 
261H. M. Whelpley, Mackinac. 
38.25 
13-11-’03 
262Amer. Bond. Co., Treas. 
Bond 
25.00 
13—11—’03 
264 J. B. Lippincott, Bdg 
140.25 
13—11—’03 
266 W. F. Roberts, Ptg. & Staty 
15.50 
13-11-03 
268 Yawman & Erbe,Filing cases 
41.98 
ll-12-’03 
271 Kimmig Studio, Sloan Mem. 
35.00 
4- l-’04 
276 
South End Nat. Bk., Int. on 
Loan 
33.68 
2- 4-’04 
284 
South End Nat. Bk., Int. on 
Loan 
31.25 
13- 4^’04 
287 
M. G. Motter, Secy. Clerk 
&Misc 
12.15 
$177.04 
$851.49 
$320.00 
$318.83 
$127.43 
Total 
COMMITTEE OF REVISION—MAY 1, 1903, TO APRIL 30, 1904. 
DATE 
gen’l 
CLER. 
EXPT. 
SUP. 
24- 6-’03 
221 
V. CoblAitz 
$21.35 
62.00 
71.20 
$120.00 
$12.69 
24- 6-’03 Pt. 
24- 6-’03 
224 
225 
228 
J. B. Lippincott, Ptg. Lists, &... 
Wm. Mann, Scrap books 
24- 6-’03 
J. P. Remington 
84.85 
$225.00 
250.00 
24r- 6-’03 
8- 8-’03 Pt. 
230 
244 
Smith, Kline & F. Co., Ext 
J. P. Remington 
66.91 
9.04 
22- 9-’03 
246 
V. Coblentz 
120.00 
75 COMMITTEE OF REVISION—CONTINUED—MAY 1, 1903, TO APRIL 30, 1904. 
DATE 
GEN*L 
CLER. 
EXPT. 
SUP. 
22- 9-’03 
247 
Wm. H. Hoskins, Office supplies, 
etc 
83.44* 
22- 9-’03 
249 
J. P. Remington 
24.40 
100.00 
22- 9-’03 
250 
S. P. Sadtler 
1.75 
50.00 
9.65 
16-10-’03 
252 
V. Coblentz 
145.00 
12.96 
16-10-’03 
255 
H. A. Hare 
30.00 
16-10-’03Pt. 
257 
J. P. Remington 
45.82 
100.00 
16-10-’03 
258 
S. P. Sadtler 
1.00 
50.00 
3.50 
16-10-’03 
259 
Sharp & Dohme, Assays 
.99 
17.37 
13-ll-’03 
263 
V. Coblentz 
85.00 
13—11—’03 
265 
J. P. Remington 
20.89f 
88.00 
36.00 
13—11—’03 
267 
Sharp & Dohme, Assays 
12.96 
ll-12-'03 
269 
P. Blakiston’s Son & Co., Bk 
4.50 
11-12-’03 
270 
V. Coblentz 
10.62 
60.00 
1.09 
ll-12-’03 
272 
Henry Kraemer 
8.45 
18.75 
ll-12-’03 
273 
J. P. Remington 
24.96 
120.00 
3.95 
ll-12-’03 
274 
S. P. Sadtler 
6.10 
50.00 
ll-12-’03 
275 
Sharp & Dohme, Assays 
7.73 
28 l-’04 
277 
V. Coblentz 
60.00 
28- l-’04 
278 
A. G. Elliot & Co., Paper 
28.50 
28- l-’04 
279 
Wm. H. Hoskins Co., Off. supplies. 
74.16 
28- l-’04 
280 
J. P. Remington 
25.77 
125.00 
20- 2-’04 
281 
V. Coblentz 
1.25 
60.00 
.90 
20- 2-’04 
282 
Germania Pub. Co. Rpts. vol. oils 
19.55 
20- 2-’04 
283 
J. P. Remington 
24.96 
125.00 
13- 4-’04 
285 
V. Coblentz 
4.00 
120.00 
1.30 
13- 4-’04 
286 
Chas. H. LaWall 
.35 
48.50 
2.40 
13- 4-’04 
288 
J. P. Remington 
54.68 
201.00 
13- 4-’04 
289 
Sharp & Dohme, Assays 
4.00 
$780.70 
$1352.75 
$1034.50 
$99.54 
Total.. 
$3,267.49 
"“Error See Number 265. 
fSee Number 247 Overcharge of $8.25 Deducted. 
76 BOARD OF TRUSTEES—MAY 1, 1904, TO APRIL 30, 1905. 
DATE 
gen’l 
TRAV. 
EX. 
PUB. 
18- 5-’04 Pt. 
291 
J. B. Lippincott, Staty. (Wood) 
$9.30 
18- 5-’04 
294 
J. H. Beal, Atlantic City 
$40.52 
18- 5-’04 
295 
Chas. E. Dohme, Atlantic City.. 
.80 
18.00 
18- 5-’04 
296 
A. E. Ebert, Atlantic City 
.50 
78.00 
18- 5-’04 
297 
S. A. D. Sheppard, Atlantic City. 
2.00 
18- 5-’04 
298 
H. M. Whelpley, Atlantic City... 
71.40 
18- 5-’04 
299 
H. G. Wood, Atlantic City 
9.00 
18- 5-’04 
300 
M.G. Motter, Secy.,Atlantic City 
2.15 
25.75 
17- 6-’04 
305 
W. F. Roberts, Env 
19.75 
17- 6-’04 
307 
South End Nat. Bk., Int. on Note 
$31.25 
8- 8-’04 Pt. 
313 
J. B. Lippincott, Ptg. & Bdg... 
$100.50 
ll-10-’04 
322 
South End Nat. Bk.,Int. on Note 
31.25 
8-ll-’04 
323 
J. H. Beal, Longport 
40.00 
8—11—’04 
330 
Amer. Bond. Co., Treas. bond 
25.00 
10-12-’04 
331 
E. Clinton Rhodes, Atty 
10.00 
10-12-’04 
333 
Chas. E. Dohme 
.50 
9.30 
10-12-’04 
334 
M. G. Motter, Secy., Misc. Off. 
Ex 
11.10 
14- l-’05 
347 
J. B. Lippincott, Ptg. & Bdg 
230.38 
O 
~l 
1 
H 
349 
South End Nat. Bk., Int. on Note 
31.25 
14- l-’05 
350 
Chas. E. Dohme, Phila 
5.00 
11- 2-’05 
353 
W. F. Roberts, Stat’y 
8.00 
1- 4-’05 
357 
South End Nat. Bk., Int. on 
Note 
31.25 
$87.10 
$298.97 
$330.88 
$125.00 
Total... 
$841.95 
COMMITTEE OF REVISION—MAY 1, 1904 TO APRIL 30, 1905. 
DATE 
gen’l 
CLER. 
EXPT. 
SUP. 
18-5-’04 
290 
V. Coblentz 
$60.00 
$9.25 
18-5-’04 Pt. 
291 
J. B. Lippincott, Envelopes 
$3.25 
18-5-’04 
292 
J. P. Remington 
50.93 
$108.00 
18-5-’04 
293 
S. P. Sadtler 
2.00 
50.00 
3.35 
17-6-’04 
301 
V. Coblentz 
3.60 
60.00 
1.01 
17-6-’04 
302 
A. G. Elliot & Co., Paper 
20.80 
17-6-’04 
303 
Wm. H. Hoskins, Office supplies 
57.90 
17-6-’04 
304 
J. P. Remington 
79.54 
125.00 
3.40 
5-7-’04 
306 
V. Coblentz 
5.00 
60.00 
.27 
14-7-’04 
308 
J. P. Remington 
39.60 
125.00 
77 DATE 
gen’l 
CLER. 
EXPT 
SUP. 
8-8-’04 
3091. W. Brandel 
$50.00 
8-8-’04 
310 V. Coblentz 
60.00 
8-8-’04 
311 A. G. Elliot & Co., Paper 
$18.37 
8-8-’04 
312jEdw. Kremers 
25.00 
8-8-’04 Pt. 
3131J. B. Lippincott, Ptg.Lists 
18.50 
8-8-’04 
314 J. P. Remington 
61.24 
$125.00 
8-8-’04 
315S. P. Sadtler 
4.25 
$8.30 
ll-10-’04 
3161. W. Brandel 
50.00 
ll-10-’04 
317 V. Coblentz 
4.24 
60.00 
ll-10-’04 
318Germania Pub. Co., Rpts 
7.25 
ll-10-’04 
319[Henry Kraemer 
7.25 
30.00 
ll-10-’04 
320iJ. P. Remington 
55.17 
150.00 
ll-10-’04 
321 
Smith, Kline & F. Co., Ext 
14.28 
8-ll-’04 
324P.Blakiston’s Son & Co., Allen’s 
Anal 
20.50 
8-ll-’04 
325 V. Coblentz 
13.53 
120.00 
10.92 
8-ll-’04 
326iC. Lewis Diehl 
31.30 
10.00 
8-ll-’04 
327 
A. G. Elliott & Co., paper 
19.67 
8-ll-’04 
328 
J. P. Remington 
110.03 
300.00 
8-ll-’04 
329 
S. P. Sadtler 
8.01 
25.00 
10-12-’04 
332 
V. Coblentz 
1.20 
60.00 
.60 
10-12-’04 
335 
J. P. Remington 
36.13 
150.00 
.27 
10-12-’04 
336 
S. P. Sadtler 
1.00 
25.00 
3.30 
10-12-’04 
337 
Sharp & Dohme, Assays 
1.95 
10-12-’04 
338 
A. R. L. Dohme Trav. ex. Long- 
port 
10.30 
10-12-’04 
339 
W. S. Haines, Trav. ex.., Long- 
port '. 
81.40 
10-12-’04 
340 
Edw. Kremers, Trav. ex., Long- 
port 
72.64 
10-12-’04 
341 
A. B. Lyons, Trav. ex., Long- 
port 
36.00 
10-12-’04 
342 
John Marshall, Trav. ex., Long- 
port 
1.95 
10-12-’04 
343 
Oscar Oldberg, Trav. ex., Long- 
port 
60.00 
10-12-’04 
344 
Geo. F. Payne, Trav. ex., Long- 
port 
62.37 
10-12-’04 
345 
E.H.Squibb,Trav. ex., Longport 
6.20 
14- l-’05 
346V. Coblentz 
2.20 
60.00 
.85 
14- l-’05 
348 J. P. Remington 
26.10 
150.00 
11- 2-’05 
351V. Coblentz 
1.41 
60.00 
11- 2-’05 
352]J. P. Remington 
19.73 
125.00 
23- 3-’05 
354V. Coblentz 
1.60 
60.00 
20.51 
COMMITTEE OF REVISION—CONTINUED—MAY 1, 1904 TO APRIL 30, 1905. 
78 COMMITTEE OF REVISION—CONTINUED—MAY 1, 1904, TO APRIL 30, 1905. 
DATE. 
gen’l. 
CLER. 
EXPT. 
SUP. 
23- 3-05 355 
J. P. Remington 
$40.97 
$125.00 
23- 3-’05 356 
14- 4-’05 358 
Smith, Kline & F. Co., Ext. . . . 
V. Coblent z 
.80 
$60.00 
$12.93 
14- 4-’05 359 
14- 360 
Wm. H. Hoskins, Off. supplies. . 
Joseph P. Remington 
16.14 
20.85 
125.00 
$1134.62 
$1669.30 
$930.00 
$91.19 
Total 
.. $3,825.11 
BOARD OF TRUSTEES—MAY 1, 1905, TO APRIL 30, 1906 
DATE. 
gen’l. j 
TRAV. 
EX. 
HON. 
PUB. 
8- 6-’05 
363 
J. H. Beal, (Phila.) 
$4.62 
$35.50 
8- 6-’05 
364 
A. E. Ebert, (Phila.) 
70.00 
8- 6-’05 
365 
M. G. Motter, (Phila.). 
Clk. andMisc 
17.45 
14.00 
8- 6-’05 
366 
Nixon Jones, env. H. M. 
W 
12.00 
8- 6-’05Pt. 
367 
J. P. Remington, (Phila.) 
16.15 
8- 6-’05 
368 
H.M.Whelpley, (Phila.) 
69.50 
8- 6-’05 
369 
H. C. Wood, Washing- 
ton 
8.00 
17- 7-’05 
370 
South EndNat. Bk., Int. 
on note 
$31.25 
14- 9-’05 
374 
J. B. Lippincott, U. S. 
P. VIII 
$14,880.60 
18- 9-’05 
378 
J. B. Lippincott, Shp. 
comps 
18.75 
26- 9-’05 
382 South End Nat. Bk., Int. 
and Note Boston 
2531.25 
26- 9-’05 
383 
Farmers& Prod .Nat Bk., 
Scio, Int.note 
2772.50 
26- 9-’05 
384 
J. B. Lippincott, Int. 
Note 
' 
2061.11 
13—11—’05 
386 
Amer. Bond. Co., Treas. 
bond 
25.00 
13—11—’05 
391 
J. B. Lippincott, U. S. 
P. VIII, 4th ed 
4217.16 
13-ll-’05 
393 
M. G. Motter, Sec’y . . . 
20.30 
13—11—'05 
396 
W. F. Roberts, env 
18.00 
13—11—’05 
398 
H. C. Wood, Trav. Exp . 
9.25 
79 BOARD OF TRUSTF.ES—CONTINUED—MAY 1, 1905, TO APRIL 30, 1906 
DATE 
gen'l 
TRAY. 
EX. 
HON. 
PUB. 
18-11-05 
18—11—’05 
18-ll-’05 
18-ll-’05 
18-11-05 
18—11—’05 
18—11—’05 
18-ll-’05 
18-lt-’05 
18-11-05 
18—11—’05 
18-ll-’05 
18-ll-’05 
18-ll-’05 
18-ll-’09 
18—11—’05 
18—11—’05 
18—11—’05 
18-ll-’05 
18-ll-’05 
18-ll-’05 
18- 
19- 
18—11—’05 
18-ll-’05 
18-lq-’05 
18-ll-’05 
20- 
20-12-’05 
399 
Jno. J. Abel 
$200 
400 
401 
200 
V. Coblentz 
200 
402 
N. S. Davis 
200 
403 
G Lewis Diehl 
200 
404 
A P. Ti. Dohme 
200 
465 
Jas M. Good 
200 
406W. G. Gregory 
200 
407|Walter S. Haines 
200 
408iC. S N. Hallberg 
200 
200 
200 
411Edw. Kremers 
200 
412 A. B. Lyons 
200 
413 John Marshall 
200 
414 Oscar Oldberg 
200 
415 George F. Payne 
200 
416H H Rusby 
200 
417|S. P. Sadtler 
200 
418|L. E. Sayre 
200 
419W.L Scoville 
200 
420. Fdw H Smiibb 
200 
421 
A. B. Stevens 
200 
422 
R. W. Wilcox 
200 
423 
H.C. Wood 
200 
424 
425 
426 
427 
G. Wythe Cook, Treas.. 
M.G. Motter, Sec’y 
J. H. Beal, Pittsburgh.. 
Chas. E. Dohme, Pitts- 
$33.00 
29.00 
200 
500 
© 
H 
o 
<M 
430 
M. G. Motter, Sec’t 
Pittsburgh 
29.35 
20-12-,05 Pt 
432 
J. P. Remington, 
Pittsburgh 
24.00 
20-12-’05 
433 
S. A. D. Sheppard, Pitts- 
burgh 
49.78 
20-12-’08 
434 
Chas. E. Dohme, Post, 
and Exp 
$4.02 
18- l-’06 
22- l-’06 
435 
439 
A. E. Ebert, Pittsburgh 
J. B. Lippincott, Ptg. 
44.25 
$7195.521, 
13- 2 ’06 
13- 2-’06 
440 
441 
J. B. Lippincott, Bdg.. 
J P. Remington 
5000.00 
290.00 
! 
— 
80 BOARD OF TRUSTEES—CONTINUED—MAY 1, 1905, TO APRIL 30, 1906 
DATE 
qen’l 
1RAV. 
EX. 
HON. 
PUB. 
12-4-’06 
12-4-’06 
12^-’06 
12-4-’06 
442 
443 
444 
445 
P. Blakiston’sSon & Co. 
M. G. Motter, Sec’t off.. 
H. M. Whelpley, Pitts- 
burgh 
$15.90 
16.35 
$37.50 
$2710.00 
J. B. Lippineott,5th Ed. 
$161.64 $460.03 
$10700.00 
$29293.28 
$7396.11 
Total $48011.06 
DATE 
1 
gen’l 
CLER. 
EXPT. 
SUP. 
8- 5-’05 
361V. Coblentz 
$ 0.77 
$60.00 
$1.18 
8- 5-’05 
362 J. P. Remington 
20.38 
$155.00 
8- 6-’05 Pt. 
367 J. P. Remington 
38.52 
150.00 
17- 7-’05 
371 
J. P. Remington 
37.08 
75.00 
17- 7-’05 
372 
S. P. Sadtler 
2.50 
14- 9-’05 
373 
Wm. H. Hoskins, Labels, off. 
sup 
42.84 
14- 9-’05 
375 
J. P. Remington 
27.52 
75.00 
18- 9-’05 
376 
Wm. H. Hoskins, Labels 
8.00 
18- 9-’05 
377 
Henry Kraemer 
4.00 
38.25 
18- 9-’05 
379 
N. S. P. Eng. Co., Embossed 
stat’y 
41.37 
18- 9-’05 
380 J. P. Remington 
26.09 
75.00 
18- 9-’05 
381 IE. H. Squibb, Post and env. 5 yrs. 
18.30 
26- 9-’05 
385 Clemens Kleber 
50.00 
13—11—’05 
387 
C. Lewis Diehl 
11.30 
30.00 
20.00 
13-11-05 
388 
Wm. H. Hoskins, Labels, etc.... 
14.93 
13-11-05 
389 
Chas. H. LaWall 
27.00 
13-1l-’O 
390 
H. J. LaWall 
75.00 
13-1l-’O5 
392 
John Marshall, Post 
1.03 
13-11-05 
394 
N. S. P. Eng. Co., Embossed env . 
6.25 
13—11—’05 
395 
J. P. Remington 
61.29 
150.00 
13—11—’05 
397 
R. W. Wilcox, Post 
4.16 
20-12-’05 
428 
Herman Englehardt 
100.00 
20-12-’05 
429 
Wm. Hoskins, Labels 
14.75 
20-12-’05 
431 
Geo. F. Payne 
17.52 
20-12-’05 Pt. 
432 
J. P. Remington 
10.12 
75.00 
18- l-’06 
436 
H. A. Hare, Post 
15.00 
18- l-’06 
437 J. P. Remington 
4.08 
75.00 
COMMITTEE OF REVISION—MAY 1, 1905, TO APRIL 30, 1906. 
81 DATE. 
qen’l. 
CLER. 
EXPT. 
8UP. 
18- l-’06 
16- 4-’06 
438 S. P. Sadtler 
446 J. P. Remington 
$2.00 
45.52 
$15.00 
$0.30 
16- 4-’06 
447 A. B. Stevens 
12.18 
$14.80 
65.00 
$487.50 
$883.05 
$422.00 
$21.48 
Total 
.. $1,814.03 
COMMITTEE OF REVISION—MAY 1, 1905, TO APRIL 30, 1906. 
DATE. 
gen’l. 
TRAV. 
EX. 
HON. 
PUB. 
1- 5-’06 
448 V. Coblentz 
$800.00 
1- 5-’06 
449 A. R. L. Dohme 
800.00 
1- 5-’06 
450!S. P. Sadtler 
800.00 
1- 5-’06 
451 A. B. Lyons 
800.00 
1- 5-’06 
452Chas. Caspari, Jr 
400.00 
1- 5-’06 
453 C. Lewis Diehl 
400.00 
1- 5-’06 
454 
C. S. N. Hall berg 
400.00 
1- 5-’06 
455 
Henry Kraemer 
400.00 
1- 5-’06 
456 
E. H. Squibb 
400.00 
1- 5-’06 
457 
Walter S. Haines 
200.00 
1- 5-’06 
458 
Edw. Kremers 
200.00 
1- 5-’06 
459 
Henry H. Rusby 
200.00 
1- 5-’ 06 
460 
Wilbur L. Scoville 
200.00 
1- 5-’06 
461 
A. B. Stevens 
200.00 
26- 5-’06 
462 
Edw. Kremers, Exhibit A. M. A.. 
150.00* 
31- 5-’06 
463 
C. S. N. Hallberg, Ed. Ad. in Bull. 
100.00 
14- 7-’06 
464 
J. H. Beal, Washington 
32.00 
14- 7-’06 
465 
W. F. Roberts, Statv. & ptg 
23.00 
14- 7-’06 
466 
S. A. D. Sheppard, Washington . 
21.60 
14- 7-’06 
467;H. M. Whelpley, Washington .... 
70.00 
6- 8-’06 
468Chas. E. Dohme, Wash. & Phila.. 
1.50 
11.50 
6- 8-’06 
469P. Blackiston’s & Co., Overpay . 
7508.97 
3-1l-’06 
470 
Amer. Bond. Co., Treas. bond ... 
25.00 
3-ll-’06 
471 
P. Blakiston’s Son & Co., Post... 
3.63 
31-12-’06 
472 
P. Blakiston’s Son & Co., Post... 
1.32 
31-12-’06 
473 
Chas. E. Dohme, Post exp. & 
Phila 
1.61 
8.40 
31-12-’06 
474 
J. B. Lippincott, Ptg. & bdg 
2572.00 
31-12-’06 
475M. G. Motter, Secy., Wash. & 
Phila 
4.30 
33.90 
BOARD OF TRUSTEES—MAY 1, 1906, TO APRIL 30, 1907. 
* Returned $55.93 balance. 
82 BOARD OF TRUSTEES—CONTINUED—MAY 1, 1906, TO APRIL 30, 1907. 
DATE. 
gen’l. 
TRAV. 
EX. 
HON. 
PUB. 
31-12-’06 
176 
H. M. Whelpley, Phila. & Ebert 
Funeral 
110.00 
16- 2-’07 
177 
J. H. Beal, Phila. & Ebert Funeral 
37.50 
16- 2-’07 
480 
E. Clinton Rhoads, Atty 
$50.00 
16- 2-’07 
481 
W. F. Roberts, Ptg. & Staty 
30.95 
16- 2-’07 
483 
S. A. D. Sheppard, Rice Mem. & 
Phila 
5.50 
21.85 
$396.81 
$346.75 
$6200.00$2572.00 
Total.. 
$17,024.53 
DATE. 
gen'l. 
CLER. 
EXPT. 
SUP. 
16- 2-’07 
16- 2-’07 
16- 2-’07 
5- 4-’07 
5- 4-’07 
478 W. Walter Dye, Stenog 
479 Wm. H. Hoskins, Off. sup 
482 S. P. Sadtler 
484 V. Coblentz 
485Wilkinson Bros. & Co., Paper.... 
$17.90 
1.20 
28.50 
10.00 
$20.00 
$52.00 
170.00 
$57.60 
$20.00 
$222.00 
Total 
$299.60 
COMMITTEE OF REVISION—MAY 1, 1906, TO APRIL 30, 1907. 
BOARD OF TRUSTEES—MAY 1, 1907, TO APRIL 30, 1908. 
DATE. 
gen'l. 
TRAY. 
EX. 
HON. 
PUB. 
SPANISH 
14-6-’07 
14-6-’07 
486 
488 
J. H. Beal, St. Louis 
Chas. E. Dohme, St. 
Louis 
$40.25 
78.00 
1-7-’07 
30-8-’07 
30-8-’07 
492 
493 
494 
M. G. Motter, Sec’y 
J. G. Diaz, Translator.. 
C. S. N. Hallberg, Ed. 
Bull 
$300.00 
$500.00 
$1500.00 
9-11-07 
495 
Amer. Bond. Co., Treas. 
bond 
25.00 
83 BOARD OF TRUSTEES—CONTINUED—MAY 1, 1907, TO APRIL 30, 1908. 
1 
DATE 
GEN*L 
TRAY. 
EX. 
HON. 
PUB. 
SPANISH 
9-11-’07 
9-ll-’07 
9-ll-’07 
496 
497 
498 
J. H. Beal, New York. 
R. Beresford, Env 
F. W. Meissner, St. L. 
&N. Y 
$13.24 
$41.00 
95.00 
9-ll-’07 
27-11-’07 
499 
500 
S. A.D. Sheppard, N. Y. 
J. B. Lippincott, Ptg. 
and Bdg 
21.50 
$2708.89 
14-12-’07 
501 
P. Blakiston’s Son & 
& Co., Post 
14.14 
14-12-’07 
26-12-’07 
502 
503 
Chas.E.Dohme, (Phila.) 
H. W. Brown Co., Ins. 
on plates 
0.50 
22.80 
5.60 
6-l-’08 
504 
G. P. Engelhard Co., 
Ebert port 
134.00 
6-l-’08 
6-l-’08 
20-2-’08 
505 
506 
508 
H. M. Whelpley, N. Y.. 
M. G. Motter, Sec’y 
J. B. Lippincott, Cor. & 
and Wrap 
67.75 
500.00 
$10.75 
$16.50 
$375.68 
$349.10 $1134.00 
$2719.64 
$1516.50 
Total 
$6,094.92 
COMMITTEE OF REVISION—MAT 1, 1907, TO APRIL 30, 1908 
DATE 
gen'l 
CLER. 
EXPT. 
SUP- 
PLIES 
14- 6-’07 
487 
V. Coblentz 
$19.50 
$133.35 
14— 6-’07 
489 
Joseph P. Remington, Trav., etc. 
262.88 
$1080.00 
14r- 6-07 
490 
S. P. Sadtler 
60.00 
14- 6-’07 
491 
Wilkinson Bro. and Co., paper. 
14.89 
20- 2-’08 
507 
V. Coblentz 
5.50 
100.00 
24- 2-’08 
509 
V. Coblentz 
1.05 
50.00 
17.20 
24- 2-’08 
510 
Gilpin, Langdon and Co., Ext... 
16.51 
24- 2-’08 
511 
E. F. Greatland, Index Books... 
62.00 
24- 2-’08 
512 
Wm. H. Hoskins, off. supplies... 
20.48 
24r- 2-’08 
513 
J. P. Remington, Trav., Etc 
114.44 
700.00 
a 
o 
o 
G 
1 4^ 
$1780.00 $343.35 
$33.71 
Total 
.... $2,657.80 
84 BOARD OF TRUSTEES—MAY 1, 1908, TO APRIL 30, 1909. 
DATE 
gen’l 
TRAY. EX. 
PUB. 
SPANISH 
26-5-’08 
514 
P. Blakiston, exp. comps 
$1.28 
26-5-’08 Pt. 
517 
M. de Pablo, proof reader 
$75.00 
23-6-’08 
519 
J. H. Beal, Bost 
$65.10 
23-6-’08 
520 
Chas. E. Dohme Bost 
54.75 
23-6-’08 
521 
M. G. Motter, Secty., Bost 
2.40 
49.65 
23-6-’08 Pt. 522 
J. P. Remington, Bost 
45.10 
23-6-’08 
523 
S. A. D. Sheppard, Bost 
22.50 
23-6-’08 
524 
H. M. Whelpley, Bost 
88.75 
30-6-’08 
525 
J. B. Lippincott “G” 
$1384.00 
17-9-’08 
527 
P.Blakiston, post and Exp. comp. 
1.00 
17-9-’08 
532 
F. W. Meissner, Bost 
75.00 
11—11—’08 
534 
Amer. Bond. Co., Treas. bond... 
25.00 
11—11—’08 
536 
W. F. Roberts, Ptg. circ. env 
15.00 
14-12-’08 
537 
J. H. Beal, post and exp 
7.17 
14r-12-’08 
538 
P. Blakiston, Exp 
.32 
14-12-’08 
539 
J. B. Lippincott “G” 
2027.00 
14-12-’08 
540 
M. G. Motter, Secty., Hot Spgs.. 
4.20 
92.55 
10- 4-’09 
547 
J. H. Beal, Balto 
38.36 
10- 4-’09 
548 
F. W. Meissner, Balto 
60.00 
10- 4-’09 
549 
S. N. Mills, Stenographer 
15.00 
10- 4-’09 
550 
M. G. Motter, Secy., Balto 
3.75 
30.75 
$75.12 
$622.51 
$3411.00 
$75.00 
Total.. 
... $4,183.63 
COMMITTEE OF REVISION—MAY 1, 1908, TO APRIL 30, 1909. 
DATE 
gen'l 
CLER 
EXPT. 
SUP. 
26-5-’08 
515 
V. Coblentz 
$2.80 
60.50 
$150.00 
$19.68 
26-5-’08 
516 
C. S. N. Hallberg, Trav 
26-5-’08Pt. 
517 
J. P. Remington, Trav 
6.00 
$225.00 
26-5-’08 
518 
Smith, Kline & F. Ext 
24.56 
23-6-’08 Pt. 
522 
J. P. Remington 
75.00 
10-7-’08 
526 
Otto B. May 
50 00 
17-9-’08 
528 
I. W. Brandel 
100 00 
17-9-’08 
529 
V. Coblentz 
2.20 
100.00 
42.79 
17-9-’08 
530 
C. S. N. Hallberg, Ed 
147.40 
17-9-’08 
531 
Edw. Kremers, Trav 
65.00 
17-9-’08 
533 
J. P. Remington 
63.95 
225.00 
85 COMMITTEE OF REVISION—MAY 1, 1908, TO APRIL 30, 1909. 
DATE. 
gen’l. 
CLER. 
EXPT, 
SUP. 
11—11—’08 
535 V. Coblentz 
$3.54 
$100.00 
50 00 
$6.5.0 
12-2-’09 
5411. W. Brandel 
12-2-’09 
542 V. Coblentz 
1.00 
150.00 
5.93 
12-2-09 
27.81 
9.05 
$425.00 
72.56 
12-2-’09 
10-3-’09 
544 
545 
G. E. Stechert, For. Journ. Dig. . . 
V. Coblentz 
50.00 
2.65 
10-3-’09 
546 
E. Steiger & Co., For. Jour. Dig.. 
22.51 
$411.76 
$950.00 
$750.00 
$174.67 
Total. . . . 
. . $2,286.43 
DATE. 
gen’l. 
TRAY. 
EX. 
HON. 
PUB. 
SPANISH. 
11-5-’09 
551 
R. Beresford,Ptg. const, 
etc 
$69 00 
ll-5-’09 
ll-5-’09 
26-5-’09 
552 
553 
H. M. Whelpley, Balto. 
S. N. Mills, Clerk 
15.00 
$68.75 
554 
J. B. Lippincott, Com- 
position 
$2690.37 
15-6-’09 
555 
Chas. E. Dohme, Chi- 
cago 
76.00 
15-6-’09 
15-6-’09 
556 
S. nTmUIs, Clerk 
15.00 
557 
M. G. Motter, Sec’y., 
Chicago 
4.05 
60.00 
15-6- 09 
10-7-’09 
558 
562 
H.M. Whelpley,Chicago. 
Louis A. Matas, Proof 
reader 
27.05 
$250.00 
10-7-’09 
10-7-’09Pt. 
563 
565 
S N. Mills, Clerk 
15.00 
J. P. Remington, Chi- 
58.85 
6-8-’09 
6-8-’09 
6-8-’09 
14-9-’09 
l4-9-’09 
567 
568 
569 
570 
572 
.T B Lippincott, 
$1558.02 
S. N. Mills, Clerk 
M. G. Motter, Sec’y 
R Beresford, Env 
15.00 
13.25 
11.50 
J. B. Lippincott, Bdg. 
129.12 
17—11—’09 
579 
R. Beresford, Stat’y 
and Ctfs 
29.36 
17-1l-’09 
17—11—’09 
580 
581 
J. C. Hatton 
$7.00 
J. B. Lippincott “H”.. 
$959.50 
BOARD OF TRUSTEES—MAY 1, 1909, TO APRIL 30, 1910. 
86 BOARD OF TRUSTEES—CONTINUED— M AY 1, 1909, TO APRIL 30, 1910. 
DATE. 
GEN L. 
TRAV. 
EX. 
HON. 
PUB. 
SPANISH. 
17—11—’09 
583 
Amer. Bond. Co., Treas. 
bond 
$25.00 
15-12-’09 
584 
J. H. Beal, Phila 
$38.15 
15-12-’09 
585 
F. W. Meissner, Phila... 
71.00 
15-12-’09 
586 
G. H. Simmons, Phila.. 
67.50 
15-12-’09 
587 
H. M. Whelpley, Phila.. 
74.00 
15-12-’09Pt. 
588 
M. G. Motter, Sec’y. 
Phila. Ck 
31.90 
25.80 
15-12-’09 
590 
Remington Typewriter 
Co. Reps 
12.50 
15-12-’09 
591 
S.N. Mills, Clerk 
50.00 
12-l-’10Pt. 
592 
M. G. Motter, Sec’y. 
Clk.and Stat 
74.33 
14-2-’10 
593 
J. H. Beal, Post, and 
Exp 
2.85 
14-2-’10 
595 
M. G. Motter, Sec’y, 
Columb 
10.13 
41.96 
1 
to 
1^ 
o 
597 
Geo. H. Simmons, 
Columb 
24.00 
14-2-’ 10 
598 
H. M. Whelpley, 
Columb 
39.00 
14-2-’10 
599 
A. M. A. Directory 
7.00 
10-3-’10 
600 
J. H. Beal 
25.00 
10-3-’10 
601 
R. Beresford, Circ. & 
Env 
12.06 
10-3-’10 
602 
Church & Church, 
Att’y. Copyrt 
25.00 
10-3-’10 
603 
M. G. Motter, Sec’y, 
Clk. and Sup 
55.00 
10-3-’10 
604 
J. P. Remington, Col- 
umbus 
53.05 
14-3-’ 10 
605 
J. B. Lippincott “I” 
and Span. “B” 
$1030.00 
$789.25 
14- 4-10 
606 
J. H. Beal, Com. on Cre. 
and Ar. Wash 
24.70 
T 
o 
608 
S. L. Hilton, Com. on 
Cre. and Ar. Phil 
8.75 
14- 4-’10 
609 
F. W. Meissner, Col- 
umbus 
26.00 
14- 4-’10 
610 
O. T. Osborne, Com. on 
C.and A 
50.00 
14- 4-’10 
611 
Manuel de Pablo, Proof 
reader 
22.56 
87 BOARD OF TRUSTEES—CONTINUED—MAY 1, 1909, TO APRIL 30, 1910. 
DATE 
gen’l 
TRAV. 
EX. 
HON. 
PUB. 
SPANISH 
14- 4-’ 10 
14- 4-’10 
14- 4-’10 
612 
613 
614 
M. G. Motter, Sec’y. 
Clk, etc 
S.N. Mills, Clerk 
J. P. Remington (Fen- 
ner) 
58.75 
30.00 
34.20 
5.00 
$515.88 $864.56 
$ 7.00 
$1989.50 
$5439.32 
Total $8,916.26 
COMMITTEE OF REVISION—MAY 1, 1909, TO APRIL 30, 1910. 
DATE 
gen’l 
CLER. 
EXPT. 
SUP. 
15-6-’09 
559 
E. Steiger Journals “Dig” 
$27.84 
15-6-’09 
560 
G. E. Stechert, Journals" Dig”... 
17.71 
10-7-09 
561 
V. Coblentz 
1.85 
$50.00 
$2.30 
10-7-’09 
564 
E. R. Squibb & Sons 
4.90 
10-7- 09Pt. 
565 
J. P. Remington 
91.46 
$375.00 
6-8-’09 
566 
V. Coblentz 
2.75 
50.00 
6-8-’09 
569 
M. G. Motter, Sec’y. (Menge, 
Phar. const.) 
37.50 
14-9-'09 
571 
Wm. H. Hoskins 
6.70 
14-9-’09 
573 
B. F. Lovelace, Trav. exp 
7.45 
14-9-’09 
574 
M. G. Motter, Sec’y. (Menge) — 
50.00 
14-9-’09 
575 
J. P. Remington 
3.33 
150.00 
13-10-’09 
576 
V. Coblentz 
100.00 
13-10-’09 
577M. G. Motter, Sec’y (Menge) 
50.00 
13-10-’09 
578E. Steiger, Journals “Dig” 
1.75 
17-ll-’09 
582 M. G. Motter, Sec’y (Menge) 
50.00 
15-12-’09 
588M. G. Motter Sec’y (Menge) 
50.00 
15-12-’09 
589Z. D. Gilman (Phar. Const.) 
29.61 
12-l-’10Pt. 
592 
M. G. Motter, Sec’y, Dig. &Pharm. 
Const 
11.35 
7.00 
14-2-’10 
594 
Wm. H. Hoskins, off. supt., etc... 
12.90 
14-2-’10 
596 J. P. Remington 
12.99 
340.00 
14-4-’10 
607 V. Coblentz 
60.00 
29.53 
$198.08 
$865.00 
$497.50 $73.54 
Total 
$1,633.92 
88 FINANCIAL SUMMARY. U. S. PHARMACOPCEIAL CONVENTION 
1900-1910 
(.Fiscal Year, May 1 to April 80) 
RECEIPTS. 
YEAR 
BALANCE 
SALES 
BRRD. 
INT. 
TEXT 
MISCL. 
AN. TOTAL J EXPENDED. 
1900-1901 
$5698.19 
$1547.27 
$4.34 
$7249.80 $3000.46 
1901-1902 
4249.34 
4031.63 
76.39 
8357.36 5364.61 
1902-1903 
2992.75 
1817.25 
$2500.00 
50.55 
b$37.58 
7398.13 5080.55 
1903-1904 
2317.581 
2057.25 
2500.00 
36.31 
$755.00 
7666.14 5062.28 
1904-1905 
2603.86 
919.88 
2000.00 
35.66 
20.00 
5579.40 4667.06 
1905-1906 
912.34' 
57511.79 
41.58 
1460.00 
59925.71 49825.09 
1906-1907 
10100.62 
17091.06 
124.44 
104.99 
c55.93 
27477.04 17324.13 
1907-1908 
10152.91 
7312.55 
178.72 
10.00 
17654.18 8752.72 
1908-1909 
8901.46 
7283.40 
166.68 
315.00 
<112.80 
16679.34 6470.06 
1909-1910 
10209.28 
a8515.95 
167.96 
51.00 
18944.19 10550.18 
$52440.14 $108088.03 $7000.00 
$882.63 
$2715.99 
$106.31 
$116097.14 
J_ 
1 
Notes: a, $5755.73 from regular, $2760.22 from Spanish edition, b, credit check 
lost, c, Unexpended balance, A. M. A. exhibit, Boston, d, correcting error in 
voucher of Chairman, Rev. Com. 
EXPENDITURES. 
Board of Trustees 
YEAR 
gen’l 
TRAY. 
EX. 
HON. ET 
MEM. 
PUBLICATION 
U.8.P. VII U.S.P. VIII 
8PAN. 
MISCL. 
AN. TOT. 
1900-1901 
$436.54 
$266.10 
$100.00 
$349.18 
$1151.82 
1901-1902 
175.92 
70.75 
1000.00 
1221.84 
2468.51 
1902-1903 
187.26 
1036.08 
45.00 
255.75 
a$41.67 
1565.76 
1903-1904 
177.04 
851.49 
320.00 
318.83 
al27.43 
1794.79 
1904-1905 
87.10 
298.97 
0.00 
330.88 
al25.00 
841.95 
1905-1906 
161.64 
460.03 
10700.00 
$29293.28 
b7396.11 
48011.06 
1906-1907 
396.81 
346.75 
6200.00 
2572.00 
c7508.97 
17024.53 
1907-1908 
375.68 
349.10 
1134.00 
2719.64 
$1516.50 
6094.92 
1908-1909 
75.12 
622.51 
0.00 
3411.00 
75.00 
4183.63 
1909-1910 
615.88 
864.56 
7.00 
1989.50 
5439.32 
8916.26 
$2688.99 
$5166.34 
$19506.00 
$2476.48 
$39985.42 $7030.82 
$15199.18 
$92053.23 
Notes: a, Interest on notes, b, Notes cancelled and interest accrued, c, Repay- 
ment correcting error in Blakiston’s account, of sales. 
89 Committee of Revision. 
TEAR. 
gen'l. 
CLERICAL. 
EXPERT. 
SUPPLS. 
AN. TOT. 
1900-1901 
$759.44 
$929.85 
$159.35 
$1848.64 
1901-1902 
1344.93 
1010.60 
$240.00 
300.57 
2896.10 
1902-1903 
974.51 
1145.30 
823.90 
571.08 
3514.79 
1903-1904 
780.70 
1352.75 
1034.50 
99.54 
3267.49 
1904-1905 
1134.62 
1669.30 
930.00 
91.19 
3825.11 
1905-1906 
487.50 
883.05 
422.00 
21.48 
1814.03 
1906-1907 
57.60 
20.00 
222.00 
0.00 
299.60 
1907-1908 
500.74 
1780.00 
343.35 
33.71 
2657.80 
1908-1909 
411.76 
950.00 
750.00 
174.67 
2286.43 
1909-1910 
198.08 
865.00 
497.50 
73.34 
1633.92 
$6649.88 
$10605.85 
$5263.25 
$1524.93 
$24043.91 
INCOME SUMMARY. 
Balance from Committee of 1890 $5698.19 
Borrowed 7000.00 
Sales 108088.03 
From Use of Pharmacopceial Text 2715.99 
Interest on Deposits 882.63 
Miscellaneous 1 106.31 
$124491.15 
EXPENSE SUMMARY. 
Board of Trustees: 
General Expenses $2688.99 
Traveling Expenses 5166.34 
Honoraria et Memorabilia 19506.00 
PublicationU. S. P. Co VII 2476.48 
PublicationU. S. P. VIII 39985.42 
Publication Spanish Ed 7030.82 
Miscellaneous 15199 18 
Total $92053.23 
Committee of Revision: 
General Expenses $6649.88 
Clerical Expenses 10605.85 
Experts 5263.25 
Supplies 1524.93 
Total $24043.91 
Unexpended balance 8394.01 
$124491.15 
90 CONSTITUTION AND BY-LAWS. 
AS REVISED BY THE CONVENTION OF 1910. 
CONSTITUTION. 
Article I. 
NAME AND OBJECTS. 
Section 1. The corporate name of this organization shall be “The 
United States Pharmacopoeial Convention/’ 
Section 2. Its objects shall be those declared in its Certificate of 
Incorporation, and shall include the revision and publication of the 
Pharmacopoeia of the United States of America. 
Article II. 
MEMBERSHIP. 
Section 1. The members of the United States Pharmacopceial Con- 
vention, in addition to the Incorporators and their associates, shall be 
delegates elected by the following organizations in the manner they 
shall respectively provide: Incorporated Medical Colleges, and medical 
Schools connected with Incorporated Colleges and Universities; Incor- 
porated Colleges of Pharmacy, and Pharmaceutical Schools connected 
with Incorporated Universities; Incorporated State Medical Associa- 
tions; Incorporated State Pharmaceutical Associations; the American 
Medical Association, and the American Chemical Society; provided 
that no such organization shall be entitled to representation unless it 
shall have been incorporated within and shall have been in continuous 
operation in the United States for at least five years before the time fixed 
for the decennial meeting of this corporation. 
Section 2. Delegates appointed by the Surgeon-General of the United 
States Army, the Surgeon-General of the United States Navy, and the 
Surgeon-General of the United States Marine-Hospital Service, the Sec- 
91 retary of Agriculture, the Secretary of Commerce and Labor, the Associ- 
ation of Official Agricultural Chemists, the Association of State and 
National Food and Dairy Departments, the National Wholesale Drug- 
gists’ Association, and the National Dental Association, and by the organ- 
izations not hereinbefore named which were admitted to representation 
in the Convention of 1900, shall also be members of the corporation. 
Each body and each branch of the United States Government above 
mentioned shall be entitled to send three delegates to the meetings of 
this corporation. But no such delegates as are provided for in this 
article shall be members until their credentials shall haye been exam- 
ined and acted upon as provided for by the By-Laws. Delegates admit- 
ted as members at any decennial meeting shall continue to be members 
of the United States Pharmaeopoeial Convention until their successors 
shall have been appointed and admitted as delegates to the ensuing 
Convention and no longer. 
Article III. 
OFFICERS. 
The officers of the United States Pharmacopceial Convention shall be 
a President, five Vice-Presidents, a Secretary and an Assistant Secre- 
tary, and a Treasurer, to be elected by ballot at each decennial meeting. 
The Board of Trustees (or Directors) named in the certificate of incor- 
poration, or their successors, shall elect these officers to serve until the 
first regular decennial meeting and until their successors shall have been 
elected and qualified. 
Article IV. 
COMMITTEES AND TRUSTEES. 
The members of the United States Pharmacopceial Convention shall 
also at each decennial meeting elect a Nominating Committee, a General 
Committee of Revision, and a Board of Trustees. Until the first decen- 
nial meeting, the Board of Trustees shall be the persons named as such 
Board in the certificate of incorporation, who shall serve as such Trustees 
until their successors shall have been elected and qualified. The By- 
Laws shall provide for the method of election and shall prescribe the 
duties of said Committees and Board of Trustees. The Board of Trus- 
tees named in said certificate, or their successors, shall also appoint all 
other committees that may be required for the operation of the corpor- 
ation until its first decennial meeting. 
92 Article V. 
MEETINGS. 
The regular meetings of this corporation shall be held once in ten years. 
The time of holding the decennial meeting shall be upon the second 
Tuesday in May, in the first year in each decade ending in zero, and the 
place of meeting shall be in the City of Washington, D. C. The first 
decennial meeting shall be held in the year 1910. 
Article VI. 
AMENDMENTS. 
Every proposition to alter or amend this Constitution shall be sub- 
mitted in writing to the Board of Trustees, and having received the votes 
of at least five members of the Board of Trustees, shall be published in 
the medical and pharmaceutical journals at least three months before 
the decennial meeting of the United States Pharmacopoeial Convention, 
when, upon receiving the votes of at least three-fourths of the members 
present and voting, it shall become a part of this Constitution. 
BY-LAWS. 
Chapter I. 
of the president and vice-presidents. 
Article I. The President shall preside at all meetings of the United 
States Pharmacopoeial Convention until his successor shall have been 
elected. In the event of his absence or inability to serve, one of the 
Vice-Presidents, or in the absence of all, a President pro tempore, to be 
elected by the Board of Trustees, shall perform the duties of the Presi- 
dent. 
Article II. In the absence of the Secretary and Assistant Secretary, 
the President shall appoint a Secretary pro tempore. 
Article III. At each session of every meeting the President shall take 
the chair at the proper time, announce all business, receive all motions, 
resolutions, reports, and communications, and order the vote upon all 
proper questions. 
Article IV. In all balloting, and on questions upon which the ayes 
and nays are required, the President is required to vote, but his name 
93 shall be called last; in other cases he shall not vote unless the members 
be equally divided, or unless his vote, if given to the minority, will 
make the decision equal; and in case of such equal division the motion 
is lost. 
Article V. He shall enforce order; it is his duty to hear all that is 
spoken in debate, and in case of personality and impropriety he shall 
promptly call the speaker to order. He shall decide all questions of 
order, subject to the right of appeal, unless he should prefer to submit 
the matter to the meeting; decide promptly who is to speak when two or 
more members rise at the same moment, and be careful to see that busi- 
ness is brought forward in the proper order. 
Article VI. He shall have a right to call a member to the chair in order 
that he may take the floor in debate. He shall see that the Constitu- 
tion and By-Laws are properly enforced. 
Article VII. He shall appoint all committees not otherwise provided 
for; and authenticate by his signature, when necessary, the proceedings 
of the Convention. 
Article VIII. He shall issue on or about the first of May of the year 
immediately preceding that of the decennial meeting, a notice inviting 
the several bodies, entitled under the Constitution to representation 
therein, to send delegates to the next meeting. He shall repeat the noti- 
fication eight months later, and shall request the medical and pharmaceu- 
tical journals of the United States to publish the call for the said meeting. 
Article IX. He shall present at each decennial meeting an address, 
embodying such subjects as may seem to him suitable to the occasion. 
Chapter II. 
OF THE SECRETARY AND ASSISTANT SECRETARY. 
Article I. The Secretary shall keep the minutes of each meeting and 
carefully preserve all reports, essays, and papers of every description 
presented to the said meeting and hold them subject to the order of 
the Board of Trustees. 
Article II. He shall read all papers handed to him for that purpose 
by the President, and shall record the ayes and nays when required; he 
shall notify the Chairman and members of every committee of their 
appointment, giving the Chairman a list of his colleagues, and stating 
the business upon which the committee is to act. 
Article III. He shall act as Secretary of the next ensuing meeting 
until his successor shall have been elected and qualified. 
94 Article IV. It shall be the duty of the Assistant Secretary to aid the 
Secretary in his official duties, or, in the absence of the latter, to act as his 
substitute. 
Chapter III. 
OF THE TREASURER. 
Article I. The Treasurer shall receive all moneys coming from any 
source to the corporation, Board of Trustees, or Committee of Revision, 
and shall pay out such moneys as may be directed by the Board of Trus- 
tees. 
Article II. He shall pay no moneys except on the written order of 
the Board of Trustees. All bills must be accompanied by proper vouch- 
ers and all payments shall be by checks, and such checks drawn by the 
Treasurer for the payment of moneys shall be countersigned by the 
Chairman of the Board of Trustees to become valid. 
Article III. The Treasurer shall present a report at the decennial 
meeting of the United States Pharmacopceial Convention showing the 
receipts and disbursements during his term of office, and he shall present 
annually a report to the Board of Trustees showing the receipts and 
disbursements. His reports, in all cases, must be properly audited and 
placed on file. He shall act as Treasurer until his successor shall have 
been elected and qualified. 
Article IV. The Treasurer, in order that he may qualify for his office, 
shall procure and file a sufficient bond or bonds to the amount of ten 
thousand dollars with the President of the United States Pharmacopoeial 
Convention for the faithful performance of his duties as Treasurer; this 
bond or bonds to be signed and executed by a trust company acceptable 
to the Board of Trustees. The expense attending the procurement of 
the bond shall be paid by the United States Pharmacopceial Convention. 
Article V. Any vacancy occurring in the office of Treasurer shall be 
filled in the same manner as a vacancy occurring in the Board of Trus- 
tees. 
Chapter IV. 
OF THE TRUSTEES. 
Article I. The Board of Trustees shall consist of five delegates to be 
elected by the members of the Convention at each decennial meeting, 
together with the President of the Convention and the Chairman of the 
Committee of Revision. Four members shall constitute a quorum. 
Until such Board shall have been elected the Board of Trustees shall 
95 consist of those persons named as such in the certificate of incorporation 
or their successors. 
Article II. The Board of Trustees shall have the management and 
control of the affairs and funds of this Convention, except as is herein 
otherwise provided. It shall be the duty of the Board of Trustees to 
invest the funds of the Convention, to execute any and all legal contracts 
or agreements, for the publication of the Pharmacopoeia, to pay experts 
and others for services performed, to transact business involving finan- 
cial or other matters that may be for the best interests of the Conven- 
tion, and to perform such other duties as the Convention may from time 
to time direct. 
Article III. Vacancies occurring in the Board of Trustees shall be 
filled by the Board of Trustees and the officers of the Convention jointly. 
A majority of the votes of the whole number shall be necessary to elect 
a member to fill the vacancy, and only accredited and admitted delegates 
to the last preceding decennial meeting shall be eligible for election for 
the vacancies on the Board of Trustees. 
Article IV. The officers of the Board of Trustees shall consist of a 
Chairman and a Secretary, who shall be elected by ballot by the Board. 
A majority of the votes of the Board shall be sufficient to elect. The 
Secretary need not be a member of the Board of Trustees. The Secre- 
tary shall issue in writing a notice of each meeting. 
Article V. There shall be an annual meeting of the Board of Trus- 
tees, unless in any year such meeting shall have been declared unneces- 
sary by a special vote of the Board. For the taking of such vote and for 
other matters, the Board shall have the right to transact business by cor- 
respondence. Special meetings of the Board of Trustees shall be called 
upon the written request of at least three members, and the Chairman 
shall have the power to call a special meeting whenever he shall deem it 
necessary. The members of the Board of Trustees shall receive no com- 
pensation for their services, but traveling and other necessary expenses 
which may be incurred by them shall be paid from the funds of the Con- 
vention. 
Chapter V. 
OF THE GENERAL COMMITTEE OF REVISION. 
Article I. The General Committee of Revision shall consist of fifty 
members to be elected at the decennial meeting, together with the presi- 
dent of the Convention, ex officio. The business of the Committee may 
be transacted by correspondence. 
96 Article II. Section 1. The General Committee of Revision shall, 
before the adjournment of the decennial Convention, or within one day 
thereafter, organize by the election of a Chairman, two Vice-Chairmen 
and a Secretary. 
Section 2. The General Committee of Revision shall elect from its own 
numbers an Executive Committee of fifteen members to have immediate 
charge of the work of revision. 
Section 3. Vacancies occurring in the Executive Committee of Revi- 
sion shall be filled by vote of the General Committee of Revision. 
Article III. The Executive Committee of Revision shall execute such 
orders or resolutions as have been assigned to it by the Convention, the 
General Committee of Revision or the Board of Trustees, and have 
entire charge of the preparation of the manuscript and reading of proof 
for the revised Pharmacopoeia. It shall also be authorized to carry on 
research work and to make preparation for the ensuing revision. 
Article IV. The Chairman and Secretary of the General Committee 
of Revision shall be, ex officio, Chairman and Secretary respectively 
of the Executive Committee of Revision. The Chairman shall direct 
the work of revision, receive and announce the votes, attend to the cor- 
respondence, and prepare the final manuscript of the work. A vacancy 
occurring in the office of Chairman shall be filled by the votes of the Gen- 
eral Committee of Revision, a majority of the whole number being neces- 
sary to elect. 
Article V. The Chairman of the Executive Committee of Revision 
shall receive such salary for his services as may be determined by the 
Board of Trustees. He shall appoint all subcommittees, research com- 
mittees, and experts with the advice and consent of the General Com- 
mittee of Revision and Board of Trustees, and shall present to the de- 
cennial meeting a report of the work of the Executive Committee of 
Revision, and shall hold office until his successor is elected. The Execu- 
tive Committee of Revision shall receive such compensation for their 
services as the Board of Trustees shall direct. 
Article VI. Section 1. The General Committee of Revision and the 
Executive Committee of Revision shall each have the power to make such 
rules and regulations, not in conflict with the Constitution and By-Laws, 
as may be necessary to the proper discharge of their respective functions. 
Section 2. The General Committee of Revision shall have the power 
to decide all such questions as may be referred to it by the Chairman or 
by vote of the Executive Committee of Revision. 
Article VII. The members of the Executive Committee of Revision 
shall be elected for their special fitness and technical knowledge of the 
97 various subjects required for the proper revision of the work, and shall 
hold office subject to action by the General Committee of Revision. 
Vacancies in the General Committee of Revision may be filled, by elec- 
tion by ballot, by the General Committee of Revision. 
Chapter VI. 
OF THE NOMINATING COMMITTEE. 
Article I. The Nominating Committee shall be selected from the 
delegates present at the decennial meeting, each delegation designating 
one of its members to serve on this Committee. 
Article II. The Nominating Committee shall nominate the officers 
of the Convention, the Board of Trustees, and the General Committee 
of Revision for the ensuing ten years. 
Chapter VII. 
OF THE COMMITTEE ON CREDENTIALS AND ARRANGEMENTS. 
Article I. The Committee on Credentials and Arrangements shall 
consist of five members and shall be appointed by the President from 
among the delegates to the decennial meeting, not less than two months 
before the meeting. 
Article II. It shall be their duty to examine carefully the creden- 
tials of all delegates. Immediately before the meeting of the Convention 
they shall furnish to the President a roll containing the names of the 
Incorporators, the Officers of the Convention, the Board of Trustees, 
the General Committee of Revision and of those delegates whose cre- 
dentials are unquestioned and approved. They shall also make report 
to the Convention concerning all credentials which have been questioned, 
or appear to them to be of doubtful validity. 
Article III. This Committee shall continue in office until their suc- 
cessors are appointed, and shall be charged with the duty of making the 
necessary arrangements for holding the said decennial meeting. The 
President, Secretary, and Assistant Secretary of the Convention shall 
be ex officio members of the Committee. 
Article IV. Vacancies in this Committee shall be filled by appoint- 
ment by the President of the Convention. 
98 Chapter VIII. 
OF MEMBERS. 
Article I. Every delegate shall present his credentials to the Com- 
mittee on Credentials and Arrangements, and, upon report by that Com- 
mittee that such credentials are unquestioned, shall be admitted to a 
seat in the Convention. All cases of doubtful or disputed credentials 
shall be finally settled by the Convention after report upon them shall 
have been made by the Committee on Credentials. Delegates who are 
not present at the Convention shall not be considered members, but 
alternates of such absent delegates, if present, may be members subject 
to the foregoing provisions. In no case, however, shall any body be 
represented by more than three delegates. Each member shall be en- 
titled to only one vote in the Convention upon all questions. 
Article II. Resignations of membership shall be made in writing, to 
the Secretary. All resignations shall be acknowledged, in writing, by the 
Secretary, and shall be reported to the Board of Trustees. 
Article III. Any member may be expelled for improper conduct or 
for violations of the Constitution or By-Laws by a vote of not less than 
two-thirds of the members present and voting. 
Chapter IX. 
OF MEETINGS. 
Article I. The regular decennial meetings of the Convention shall 
be held upon the second Tuesday in May every tenth year as provided 
in the Constitution, and the place of meeting shall be in the City of Wash- 
ington, D. C. Twenty-five members shall constitute a quorum. 
Article II. The order of business at the first session of each decen- 
nial meeting shall be as follows: 
Section 1. Promptly at the time named in the notice issued for the 
meeting the President or, in his absence, one of the Vice-Presidents, or 
in their absence, a President pro tempore shall organize the Convention 
by calling the roll furnished to him by the Committee on Credentials 
and Arrangements. 
Section 2. In the absence of the Secretary and Assistant Secretary, 
the President shall appoint a Secretary pro tempore. 
Section 3. The President’s address may then be read. 
Section 4. The report of the Committee on Credentials and Arrange- 
ments shall then be considered. 
99 Section 5. The Secretary shall then call the roll of bodies entitled to 
send delegates, and the delegation from each body shall designate one 
of its number who may be present to serve upon the Nominating Com- 
mittee. 
Section 6. Incidental business. 
Article III. The order of business at the second session of each 
meeting of the Convention shall be as follows: 
Section 1. The President shall call the meeting to order. 
Section 2. The Secretary shall read the minutes of the preceding meet- 
ing, which may be amended, if necessary, and shall then be approved. 
Section 3. The report of the Committee on Nominations shall be re- 
ceived and the Convention shall proceed to the election, by ballot, of the 
Officers of the Convention, the Board of Trustees, and the General Com- 
mittee of Revision. 
Section 4. The President shall announce the result of the ballot and 
install the officers-elect. 
Section 5. Discussion on general principles to govern the action of the 
General and Executive Committees of Revision shall next be considered. 
Article IV. The order of business for subsequent sessions shall be 
determined as the Convention may direct, 
Chapter X. 
OF THE COPORATE SEAL. 
Article I. The seal of the Corporation shall contain the words: 
United States Pharmacopceial Convention. Corporate—1900-— Seal, 
D. C 
Chapter XI. 
OF AMENDMENTS. 
Article I. Every proposition to alter or amend these By-Laws shall 
be submitted in writing, and may be acted upon at any subsequent 
session of the meeting, when, upon receiving the votes of at least three- 
fourths of the members present and voting, it shall become a part of 
these By-Laws. 
100 MEMBERS OF THE U. S. PHARMACOPCEIAL CONVENTION OF 1910. 
INCORPORATORS. 
G. Lloyd Magruder, 
Thomas C. Smith, 
Murray Galt Motter, 
Frank N. Criswell. 
H. C. Wood, President. 
Otto A. Wall, Second Vice-President. 
Reynold W. Wilcox, Third Vice-President. 
N. S. Davis, Fourth Vice-President. 
A. L. Lengfeld, Fifth Vice-President. 
Henry M. Whelpley, Secretary. 
Murray Galt Motter, Assistant Secretary. 
G. Wythe Cook, Treasurer 
OFFICERS. 
Charles E. Dohme, 
James H. Beal, 
Henry M. Whelpley, 
BOARD OF TRUSTEES. 
Frederick W. Meissner, 
George H. Simmons. 
COMMITTEE OF REVISION (1909-1910) 
Joseph P. Remington, 
C. Lewis Diehl, 
Reynold W. Wilcox, 
Alfred R. L. Dohme, 
John J. Abel, 
Charles Caspari, Jr. 
Virgil Coblentz, 
N. S. Davis, 
James M. Good, 
Willis G. Gregory, 
Walter S. Haines, 
Carl S. N. Hallberg, 
H. A. Hare. 
Henry Ivraerner, 
Edward Kremers, 
A. B. Lyons, 
John Marshall, 
Oscar Oldberg, 
George F. Payne, 
Henry H. Rusby, 
Samuel P. Sadtler, 
Lucius E. Sayre, 
Wilbur L. Scoville, 
Edward H. Squibb, 
Alviso B. Stevens. 
101 REGISTERED DELEGATES. 
N.B. This list is based upon the ruling of the Chair (See. p. 38), from which no 
appeal was taken, as follows: 
“The Chair feels compelled to rule that anyone elected a delegate here who has 
not come, is not a member of this Convention, cannot be elected a member of any 
committee or as an officer.” 
U. S. GOVERNMENT SERVICES. 
Surgeon-General's Office, United States War Department: Walter D. McCaw, Carl 
R. Darnall, Frederick F. Russell. 
Bureau of Medicine and Surgery, United States Navy Department: H. G. Beyer, 
G. L. Angeny, P. J. Waldener. 
Bureau of Public Health and Marine-Hospital Service, United States Treasury De- 
partment: John F. Anderson, Reid Hunt, Martin I. Wilbert. 
United States Department of Agriculture: Rodney H. True, John R. Mohler, Ly- 
man F. Kebler. 
American Medical Association, {Inc. 1897): W. A. Puckner, George H. Sim- 
mons. 
American Pharmaceutical Association, (Inc. 1888): Albert B. Lyons, Charles IIolz- 
hauer, Thomas F. Main. 
American Chemical Society, {Inc. 1877): George D. Rosengarten, L. W. Andrews, 
Edward Hart. 
Association of Official Agricultural Chemists: W. D. Bigelow, L. P. Brown, C. E. 
Parker. 
Association of State and National Food and Dairy Departments: Charles D. Woods, 
V. K. Chesnut. 
National Wholesale Druggists’ Association: W. J. Schieffelin, C. M. Kline, J. K. 
Lilly. 
National Dental Association: M. F. Finley, Joseph Head, 
ARKANSAS. 
Arkansas Medical Society, {Inc. 1875): L. J. Kominsky, William Crutcher. 
Arkansas Association of Pharmacists, {Inc. 1889): W. L. Dewoody, Jesse D. 
Hodges. 
CALIFORNIA. 
Medical Society, State of California, {Inc. 1872): A. L. Lengfeld. 
COLORADO. 
Colorado State Medical Society, {Inc. 1888): E. C. Hill, George A. Moleen. 
Colorado Pharmacal Association, {Inc. 1890): Charles M. Ford, S. L. Bresler. 
CONNECTICUT. 
Connecticut State Medical Society {Inc. 1792): Samuel M. Garlick. 
Yale Medical School, New Haven, {Inc. 1810): Oliver T. Osborne, Clarence G. 
Spalding. 
102 Connecticut Pharmaceutical Association, (Inc. 1889): Charles A. Rapelye, Charles 
W. Whittlesey. 
DELAWARE. 
Delaware Pharmaceutical Society, (Inc. 1890): H. J. Watson, William Poole, J. 
T. Challenger. 
DISTRICT OF COLUMBIA. 
Medical Society of the District of Columbia, (Inc. 1819). Murray Galt Motter, 
John W. Chappell. 
Georgetown University, School of Medicine, (Inc. 1815): George M. Kober, Wilfred 
M. Barton. 
George Washington University, Department of Medicine, (Inc. 1881): Sterling Ruf- 
fin, B. M. Randolph, Noble P. Barnes. 
Howard University, Medical College, (Inc. 1867): William H. Seaman, J. Herve 
Purdy. 
Howard University, Pharmaceutical College, (Inc. 1867): Paul Bartsch. 
George Washington University, National College of Pharmacy, (Inc. 1872). Henry 
E. Kalusowski, Samuel L. Hilton, Lewis Flemer. 
GEORGIA. 
Atlanta College of Physicians and Surgeons, (Inc. 1898). C. C. Aven, I. W. Cum- 
mings. 
Georgia Pharmaceutical Association, (Inc. 1890): Max Morris, W. S. Elkin, Jr. 
Atlanta College of Pharmacy; (Atlanta College of Physicians and Surgeons, Depart- 
ment of Pharmacy) (Inc. 1874): George F. Payne, N. T. Ritter, W. F. Beden- 
baugh. 
University of Georgia, School of Pharmacy, Athens, (Inc. 1903): Robert C. Wilson. 
Atherton Seidell, Thad. B. Rice. 
ILLINOIS. 
Illinois State Medical Society, (Inc. 1903): N. S. Davis. 
Chicago Medical Society, (Cook County), (Inc. 1897). Walter S. Haines. 
Northwestern University, Medical School, Chicago, (Inc. 1864): Arthur R. Edwards, 
John H. Long. 
University of Illinois, Medical Department, College of Physicians and Surgeons of 
Chicago, (Inc. 1881): Bernard Fantus. 
Chicago College of Medicine and Surgery, (Inc. 1902): Clyde M. Snow. 
Illinois Pharmaceutical Association, (Inc. 1881): Wilhelm Bodemann, W. C. Simp- 
son, Herman Fry. 
University of Illinois, School of Pharmacy: (Chicago College of Pharmacy), (Inc. 
1859). C. S. N. Hallberg, A. H. Clark, W. B. Day. 
Northwestern University, School of Pharmacy, (Inc. 1886): Harry Mann Gordin, 
Charles W. Patterson. 
INDIANA. 
Indiana State Medical Association, (Inc. 1875): Samuel Kennedy. 
Indiana University, School of Medicine, (Inc. 1830): C. Richard Schaefer, A. D. 
Thorburn. 
103 Indiana Pharmaceutical Association, (Not Inc.): Fred W. Meissner, Leo Eliel, 
William H. Rudder. 
University of Notre Dame, School of Pharmacy, Notre Dame, {Inc. 1844). J. W. 
Sturmer, Louis Kelley. 
Purdue University, School of Pharmacy, Lafayette, {Inc. 1869): Harvey W. Wiley, 
Ernest C. Eberhardt, Charles E. Vanderkleed. 
Valparaiso University, School of Pharmacy, {Inc. 1898): J. Newton Roe. 
IOWA. 
State University of Iowa, College of Medicine, Iowa City, {Inc. 1869): Charles S. 
Chase, Charles E. Riggs. 
Iowa Pharmaceutical Association, {Inc. 1888): George Judisch. 
University of Iowa, College of Pharmacy, Iowa City, {Inc. 1885): Wilber J. Teeters. 
Highland Park College of Pharmacy, Des Moines, {Inc. 1890): George A. Menge. 
KANSAS. 
University of Kansas, School of Medicine, Lawrence, {Inc. 1905): S. J. Crumbine. 
Kansas Pharmaceutical Association, {Inc. 1880): Frank Holliday, Matt. Noll, 
W. S. Amos. 
University of Kansas, School of Pharmacy, Lawrence, {Inc. 1886): L. E. Sayre. 
KENTUCKY. 
Kentucky State Medical Association, {Inc. 1855): J. N. McCormack, Virgil E. 
Simpson. 
Kentucky Pharmaceutical Association, {Inc. 1888): C. Lewis Diehl, L. A. Brown. 
LOUISIANA. 
Tulane University, Medical Department, New Orleans, {Inc. 1847): Abraham Louis 
Metz. 
New Orleans University, Flint Medical College, {Inc. 1878): W. H. Harrison. 
Lotiisiana State Pharmaceutical Association, {Inc. 1884): Philip Asher, F. C. 
Godbold, Adam Wirth. 
New Orleans College of Pharmacy, {Inc. 1900): C. D. Sauvinet, John E. Scott. 
MAINE. 
Maine Pharmaceutical Association, {Inc. 1858): Charles H. Davis. 
MARYLAND. 
Medical and Chirurgical Faculty of Maryland, {Inc. 1799): John D. Blake, Elmer 
R. Freeman, C. Urban Smith. 
University of Maryland, School of Medicine, Baltimore, {Inc. 1812): Joseph E. 
Gichner. 
College of Physicians and Surgeons, Baltimore, {Inc. 1872): John Rurah, S. J 
Fort, Harvey G. Beck. 
Baltimore Medical College, {Inc. 1881): William Caspari, Charles O'Donovan 
104 Johns Hopkins University, Medical Department, {Inc. 1898): Leonard G. Rowntree. 
Maryland Medical College, {Inc. 1898): G. C. Dohme, W. S. Love. 
Maryland Pharmaceutical Association, {Inc. 1889): A. R. L. Dohme, Charles 
Morgan, E. F. Kelly. 
University of Maryland, Department of Pharmacy, Baltimore {Inc. 1841): David 
M. R. Culbreth, Henry P. Hynson, Charles Caspari, Jr. 
MASSACHUSETTS. 
Massachusetts Medical Society, {Inc. 1881): Frank G. Wheatley. 
Harvard Medical School, {Inc. ?): F. L. Pleadwell, J. L. Neilson, C. N. Fiske. 
Tufts College Medical School, Boston, {Inc. 1850): Alfred William Balch. 
College of Physicians and Surgeons, Boston, {Inc. 1880): I. E. Leonard. 
Massachusetts Pharmaceutical Association, {Inc. 1883): Charles F. Nixon, Ernest 
O. Engstrom, Fred A. Hubbard. 
Massachusetts College of Pharamcy, Boston, {Inc. 1852): Elie H. LaPierre, Irving 
P. Gammon, John G. Godding. 
MICHIGAN. 
University of Michigan, Department of Medicine and Surgery, Ann Arbor, {Inc. 1850): 
Charles W. Edmunds, Worth Hale, J. W. Trask. 
Detroit College of Medicine, {Inc. 1885): Walter J. Wilson, Jr., E. M. Houghton. 
Michigan State Pharmaceutical Association, {Inc. 1887): Leonard A. Seltzer, J. 
M. Francis. 
University of Michigan, School of Pharmacy, Ann Arbor, {Inc. 1886): J. O. Schlot- 
terbeck, A. B. Stevens. 
MINNESOTA. 
University of Minnesota, College of Medicine and Surgery, Minneapolis, {Inc. 1888): 
E. D. Brown. 
Minnesota State Pharmaceutical Association, {Inc. 1888): John Nielson, J. W. 
Harrah, A. D. Thompson, 
Minnesota State University, College of Pharmacy, Minneapolis, {Inc. 1868): 
W. A. Frost. 
MISSOURI. 
University of Missouri, School of Medicine, Columbia, {Inc. 1839): W. O. Emory, 
H. L. Shantz, W. H. Schultz. 
St. Louis Medical Society, {Inc. 1834): Otto A. Wall. 
Washington University, Medical School, St. Louis, {Inc. 1855): Henry M. Whelp- 
ley. 
Missouri Pharmaceutical Association, {Inc. 1878): Charles Gietner, H. M. Pettit. 
St. Louis College of Pharmacy, {Inc. 1865): James M. Good, Charles E. Caspari. 
University of Nebraska, College of Medicine, Lincoln, {Inc. 1869): Rufus Ashley 
Lyman. 
NEW HAMPSHIRE. 
New Hampshire Medical Society, {Inc. 1791): C. H. Bowker. 
105 NEW JERSEY. 
Medical Society of New Jersey, {Inc. i750):Henry L. Coit, Alexander Marcy, Jr., 
Philip Marvel. 
New Jersey Pharmaceutical Association, {Inc. 1874). George M. Beringer, Her- 
man J. Lohmann, George B. White. 
New Jersey College of Pharmacy, Newark, {Inc. 1892). Rudolph Breves, Adolph 
Marquier, Philemon E. Hommell. 
NEW YORK. 
Medical Society of the State of New York, {Inc. 1806). William A. Groat, W. A. 
Bastedo, Samuel W. S. Toms. 
Albany Medical College, {Inc. 1889). Spencer Lyman Dawes. 
Medical Society of the County of Kings, {Inc. 1818). Murrett F. DeLorme. 
Brooklyn Medical Society, {Inc. 1895): Albert H. Brundage. 
Long Island College Hospital, Brooklyn, {Inc. 1858).: Elias H. Bartley. 
University of Buffalo, Medical Department, {Inc. 1846): Eli H. Long, Edward J. 
Kiepe. 
New York Academy of Medicine, {Inc. 1851): Frank Sherman Meara. 
Columbia College, College of Physicians and Surgeons, New York, {Inc. 1807): S. 
W. Lambert, W. R. Williams, C. C. Leib, Jr. 
University and Bellevue Hospital Medical College, New York, {Inc. 1881): George 
B. Wallace, C. F. Claassen. 
Cornell University, Medical College, New York, {Inc. 1865): Robert A. Hatcher. 
Syracuse University, College of Medicine, {Inc. 1812): William Dewey Alsever, 
Frank P. Knowlton, H. L. Taylor. 
New York Pharmaceutical Association, {Inc. 1879): Joseph Kahn, John Hurley, 
Joseph Weinstein. 
Albany College of Pharmacy, {Department of Pharmacy, Union University), {Inc. 
1881): Alfred B. Huested, Harry B. Mason. 
Kings County Pharmaceutical Society, Brooklyn, {Inc. 1877): Otto Raubenheimer, 
Fred P. Tuthill, K. C. Mahegin. 
Brooklyn College of Pharmacy, {Inc. 1886): William C. Anderson, Henry W. 
Schimpf, A. P. Lohness. 
University of Buffalo, Department of Pharmacy, {Inc. 1846): Willis G. Gregory, 
Frank E. Lock. / 
Literary and Scientific Society of the German Apothecaries of the City of New York, 
{Inc. 1867): William C. Alpers, G. C. Drobegg. 
New York College of Pharmacy, {Inc. 1881) Albert Plaut, George C. Diekman, 
Henry H. Rusby. 
NORTH CAROLINA. 
Medical Society of the State of North Carolina, {Inc. 1858): William DeB. Mac- 
Nider. 
North Carolina Pharmaceutical Association, {Inc. 1880): W. H. Wearn. 
University of North Carolina, Department of Pharmacy, Chapel Hill, {Inc. 1897): 
E. V. Howell. 
NORTH DAKOTA. 
North Dakota Pharmaceutical Association, {Inc. 1886): Oscar Hallenberg. 
106 OHIO. 
Ohio State Medical Association, {Inc. 1904): Torald Sollmann, Julius Eichberg. 
University of Cincinnati, Medical Department, {Inc. 1896). H. Kennon Dunham. 
Western Reserve University, Medical Department, Cleveland, {Inc. 1884): John 
P. Sawyer, Richard Dexter, J. W. Kerr. 
Ohio State Pharmaceutical Association, {Inc. 1880): Lewis C. Hopp, Theodore D. 
Wetterstroem, George B. Topping. 
Cincinnati College of Pharmacy, {Inc. 1850): John C. Otis. 
Northern Ohio Druggists’ Association, {Inc. 1899): Eugene R. Selzer, Virgil 
Coblentz. 
Clevdand School of Pharmacy, Western Reserve University, Department of Pharm- 
acy, {Inc. 1892): Harry V. Arny, Joseph Feil, William T. Hankey. 
Ohio State University, College of Pharmacy, Columbus, {Inc. 1896): George B. 
Kauffman, C. A. Dye, William McPherson. 
OKLAHOMA. 
University of of Oklahoma, School of Pharmacy, {Inc. 1890). Homer C. Washburn. 
OREGON. 
Oregon Agricultural College, Department of Pharmacy, {Inc. 1885): E. R. Lake, 
C. M. McKellips. 
PENNSYLVANIA. 
Medical Society of the State of Pennsylvania, {Inc. 1890): Adolph Koenig, Henry 
Beates. 
Philadelphia County Medical Society, {Inc. 1877): Henry W. Cattell. 
College of Physicians of Philadelphia, {Inc. 1789): H. C. Wood, Jr., Solomon Solis- 
Cohen. 
University of Pennsylvania, School of Medicine. Philadelphia, {Inc. 1791): John 
Marshall. 
Jefferson Medical College, of Philadelphia, {Inc. 1838): H. A. Hare, J. W. Holland, 
E. Q. Thorton. 
Medico-Chirurgical College of Philadelphia, {Inc. 1867): Judson Daland, I. V. 
Stanley Stanislaus, Herbert J. Smith. 
Temple University, Medical Department, Philadelphia, {Inc. 1888): Horace Bin- 
ney Morse, E. B. Rogers. 
Allegheny County Medical Society, Pittsburgh, {Inc. 1892): Thomas Turnbull, 
J. C. Burt. 
University of Pittsburgh, Medical School, {Inc. 1892): Albert Floyd Judd. 
Pennsylvania Pharmaceutical Association, {Inc. 1873): Lucius L. Walton, W. L. 
Cliffe, C. B. Lowe. 
Philadelphia College of Pharmacy, {Inc. 1822): Joseph P. Remington, Samuel P. 
Sadtler, Henry Kraemer. 
Alumni Association of the Philadelphia College of Pharmacy, {Inc. 1894): Charles 
H. LaWall, E. Fullerton Cook, Joseph W. England. 
Temple University, Pharmacy Department, Philadeplhia, {Inc. 1888): H. Evert 
Kendig, John R. Minehardt. 
University of Pittsburgh, Department of Pharmacy, {Inc. 1878): Julius A. Koch, 
James H. Beal, Louis Saalbach. 
107 RHODE ISLAND. 
Rhode Island Medical Society, {Inc. 1812): William J. McCaw, George M. Bailey 
Charles W. Higgins. 
Rhode Island Pharmaceutical Association, {Inc. 1875): Howard A. Pearce, A. W. 
Fenner, Frank S. Jackson. 
Rhode Island College of Pharmacy and Allied Sciences, {Inc. 1903): James O’Hare. 
SOUTH CAROLINA. 
South Carolina Medical Association, {Inc. 1848): C. P. Aimar. 
Medical College of the State of South Carolina, {Inc. 1832): A. R. Taft, E. S. Burn- 
ham. 
SOUTH DAKOTA. 
South Dakota State Pharmaceutical Association, {Inc. 1887): David F. Jones, I. 
A. Keith, Edward C. Bent. 
TENNESSEE. 
Tennessee Pharmaceutical Association, {Inc. 1898): J. O. Burge. 
University of Tennessee, School of Pharmacy, {Inc. 1807): Charles O. Hill. 
Vanderbilt University, Department of Pharmacy, Nashville, {Inc. 1873): William 
R. White: 
TEXAS. 
University of Texas, Schools of Medicine and Pharmacy, {Inc. 1887): E Iward 
Randall. 
Texas Pharmaceutical Association, {Inc. 1895): J. C. Buchner, E. G. Eberle, 
Herman Nester. 
Baylor University, Pharmacy Department, Dallas. {Inc. 1903): J. Connor Chisolm. 
University of Vermont, School of Medicine, {Inc. ?): J. N. Jenne. 
VIRGINIA. 
Medical Society of Virginia, {Inc. 1871): John Staige Davis. 
University of Virginia, Department of Medicine, Charlottesville, {Inc. 1819): J. A. 
E. Eyster, J. C. Flippin. 
Medical College of Virginia, Richmond, {Inc. 1854): Frank M. Reade. 
University College of Medicine, Richmond, {Inc. 1893): Albert Bolenbaugh, 
Wortley F. Rudd. 
Virginia Pharmaceutical Association, {Inc. 1886): C. B. Fleet, Gordon Blair. 
WASHINGTON. 
Washington State Pharmaceutical Association, {Inc. ?): P. Jensen. 
University of Washington, School of Pharmacy, {Inc. 1862): Charles W. Johnson. 
WISCONSIN. 
State Medical Society of Wisconsin, {Inc. 1841): A. S. Loevenhart. 
Wisconsin Pharamceutical Association, {Inc. 1881): Otto J. S. Boberg, Edward 
G. Raeuber. 
University of Wisconsin, School of Pharmacy, {Inc. 1883): Edward Kremers. 
108 OFFICERS 1910. 
President Harvey W. Wiley, Cosmos Club, Washington, D. C. 
1st Vice-President N. S. Davis, 70 Madison St., Chicago, 111. 
2d Vice-President Chas Caspari, Jr., University of Maryland, Baltimore, Md. 
Sd Vice-President O. T. Osborne, 252 York St., New Haven, Conn. 
Vice-President Leo Eliel, 230 Washington St., South Bend, Ind. 
5th Vice-President W. A. Bastedo, 57 West 58th St., New York, N. Y. 
Secretary Murray Galt Motter, 25th and E Sts., N. W., Washington, D. C. 
Assistant Secretary. . .N. P. Barnes, 212 Maryland Ave., N. E., Washington, D. C. 
Treasurer S. L. Hilton, 22d and L Sts., N. W., Washington,D. C. 
BOARD OF TRUSTEES. 
J. H. Beal, Chairman, Scio, Ohio. 
F. W. Meissner, 820 Main St., La Porte, Ind. 
Wm. Jay Schieffelin, 170 William St., New York, N. Y. 
George H. Simmons, 535 Dearborn Ave., Chicago, 111. 
II. M. Whelpley, Secretary, 2342 Albion Place, St. Louis, Mo. 
Ex officio. 
Harvey W. Wiley, Cosmos Club, Washington, D. C. 
Joseph P. Remington, 1832 Pine St., Philadelphia, Pa. 
GENERAL COMMITTEE OF REVISION. 
Joseph P. Remington, Chairman, 1832 Pine St., Philadelphia, Pa. 
C. Lewis Diehl, 1st Vice-Chairman, 932 Cherokee Road, Louisville, Ky. 
Horatio C. Wood, Jr., id Vice-Chairman, 434 South 44th St., Philadelphia, Pa. 
C. H. La Wall, Secretary, 39 South 10th St., Philadelphia, Pa. 
W. C. Alpers, 495 Columbus Ave., New York, N. Y. 
John F. Anderson, Hygienic Laboratory, 25th & E Sts., N. W., Washington, D.C. 
H. V. Arny, 356 Superior St., Cleveland, Ohio. 
E. H. Bartley, 65 S. Portland Ave., Brooklyn, N. Y. 
Geo. M. Beringer, 501 Federal St., Camden, N. J. 
Wilhelm Bodemann, Lake Avenue and 50th St., Chicago, 111 
Chas. Caspari, Jr., University of Maryland, Baltimore, Md 
C. E. Caspari, 4060 Westminster PL, St. Louis,Mo. 
Virgil Coblentz, 115 West 68th St., New York, N. Y. 
N. S. Davis, 70 Madison St., Chicago, 111. 
Geo. C. Diekman, 115 West 68th St., New York, N. Y 
A. R. L. Dohme, 303 West Pratt St., Baltimore, Md. 
E. G. Eberle, 416 Jackson St., Dallas, Texas. 
C. W. Edmunds, Ann Arbor, Mich. 
J. W. England, 415 North 33d St., Philadelphia, Pa. 
J. M. Francis, 719 Atwater St., Detroit, Mich. 
J. M. Good, 2601 Olive St., St. Louis, Mo. 
H. M. Gordin, 13 East Chestnut St., Chicago, 111. 
109 W. G. Gregory, 344 Richmond Ave., Buffalo, N. Y. 
W. S. Haines, Rush Medical College, Chicago, 111. 
C. S. N. Hallberg, 74 East 26th St., New York, N. Y. 
R. A. Hatcher, 414 East 26th St., New York, N. Y. 
Lewis C. Hopp, 1104 Euclid Ave., Cleveland, Ohio. 
Reid Hunt, Hygienic Laboratory, 25th and E Sts., N. W., Washington, D. C. 
L. F. Kebler, Bureau of Chemistry, Department of Agriculture, Washington, 
D. C. 
J. A. Koch, Pride and Bluff Sts., Pittsburg, Pa. 
Henry Kraemer, 424 South 44th St., Philadelphia, Pa. 
Edward Kremers, University of Wisconsin. Madison, Wis. 
J. H. Long, Northwestern University Medical School, Chicago, 111. 
A. B. Lyons, 72 Brainard St., Detroit, Mich. 
Philip Marvel, 1616 Pacific Ave., Atlantic City, N. J. 
C. F. Nixon, Leominster, Mass. 
O. T. Osborne, 252 York St., New Haven, Conn. 
Albert Plaut, 120 William St., New York, N. Y. 
W. A. Puckner, 535 Dearborn Ave., Chicago, 111. 
Otto Raubenheimer, 1341 Fulton St., Brooklyn, N. Y. 
Geo.D. Rosengarten, P. O. Box 1625, Philadelphia, Pa. 
H. H. Rusby, 776 De Graw Ave., Newark, N. J. 
S. P. Sadtler, 39 South 10th St., Philadelphia, Pa. 
L. E. Sayre, University of Kansas, Lawrence, Kan. 
J. O. Schlotterbeck, 1319 Israel Ave., Ann Arbor, Mich. 
Torald Sollmann, 1353 East 9th St., Cleveland, Ohio. 
A. B. Stevens, Chemistry & Pharmacy Building, Ann Arbor, Mich. 
R. II. True, Bureau of Plant Industry, Iiepartment of Agriculture, Washington, 
D. C. 
C. E. Vanderkleed, 426 South 13th St., Philadelphia, Pa. 
M. I. Wilbert, Hygienic Laboratory, 25th & E. Sts., N. W., Washington, D. C. 
Ex officio. 
Harvey W. Wiley, Cosmos Club, Washington, C. D. 
110